Complexation of Copper and Iron by Biologically Relevant Sulfur- and Selenium-Containing Small Molecules by Murphy, Jaime Melissa
Clemson University
TigerPrints
All Dissertations Dissertations
8-2018
Complexation of Copper and Iron by Biologically
Relevant Sulfur- and Selenium-Containing Small
Molecules
Jaime Melissa Murphy
Clemson University, jmbean@g.clemson.edu
Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations
This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been accepted for inclusion in All Dissertations by
an authorized administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.
Recommended Citation
Murphy, Jaime Melissa, "Complexation of Copper and Iron by Biologically Relevant Sulfur- and Selenium-Containing Small
Molecules" (2018). All Dissertations. 2201.
https://tigerprints.clemson.edu/all_dissertations/2201
 COMPLEXATION OF COPPER AND IRON BY BIOLOGICALLY RELEVANT 
SULFUR- AND SELENIUM-CONTAINING SMALL MOLECULES 
A Dissertation 
Presented to 
the Graduate School of 
Clemson University 
In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy 
Chemistry  
by 
Jaime Melissa Murphy 
August 2018 
Accepted by: 
Julia L. Brumaghim, Committee Chair 
Brian A. Powell 
William T. Pennington 
Andrew G. Tennyson  
 ii 
ABSTRACT 
 
 
 Misregulation of cellular copper and iron can increase labile pools of these metal 
ions, increasing oxidative damage and leading to neurodegeneration in Wilson’s, 
Parkinson’s, and Alzheimer’s diseases.  Chapter 1 of this dissertation provides an 
overview of the thermodynamic stability constants of Cu(II), Cu(I), Fe(II), and Fe(III) 
with weakly binding amino acid ligands, including sulfur- and selenium-containing 
amino acids and drugs such as methimazole and penicillamine. Understanding these 
metal-amino-acid interactions provides insight into the role of cellular amino acids as 
ligands for labile metals. 
 Stability constants of Cu(II) and Fe(II) with the sulfur- and selenium-containing 
amino acids methionine, selenomethionine, methylcysteine, methylselenocysteine, and 
penicillamine are reported in Chapter 2. Potentiometric titration data and characterization 
by X-ray structural analysis, infrared spectroscopy, and mass spectrometry indicate that 
the coordination modes and stabilities of thio- and selenoether-amino acids with Cu(II) 
are similar to glycine and do not involve coordination of the sulfur or selenium atom. 
Fe(II) stability constants with these amino acids were considerably lower than those with 
Cu(II), indicating that Fe(II) complexes of these amino acids likely do not form under 
biological conditions. Fe(II) binding to the thiol penicillamine, used to treat copper 
overload in Wilson’s disease, is significantly more stable, suggesting potential 
competition with Cu(II) for penicillamine binding. 
 The thione methimazole is a redox-active, hyperthyroid drug that strongly 
coordinates copper. Reactions of methimazole with Cu(II) or Cu(I) and the effects of 
 iii 
oxidation state and oxygen availability on the resulting copper-coordinated products  
were explored (Chapter 3). Dinuclear, polymeric, and mononuclear complexes are 
obtained that involve redox reactions of both copper and methimazole, some of which 
result from sulfur elimination from the oxidized methimazole disulfide ligand. An 
updated mechanism is proposed for this unusual reaction.  
 Under air-free conditions, treating Cu(I) with methimazole disulfide results in 
disulfide bond cleavage to afford a copper-bound methimazole complex (Chapter 4). The 
analogous selenomethimazole complex forms from methimazole diselenide, and copper 
coordination chemistry of selenomethimazole is even more complex than that of 
methimazole. The remarkable diversity of copper methimazole and selenomethimazole 
complexes highlights the redox chemistry of metal and ligand and is highly dependent 
upon reaction time, solvent, and oxygen availability.  
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CHAPTER ONE 
STABILITY CONSTANTS OF BIOLOGICALLY RELEVANT, REDOX-ACTIVE 
METALS WITH AMINO ACIDS: THE CHALLENGES OF  
WEAKLY BINDING LIGANDS 
 
1.1  Introduction 
Metal uptake and transfer in biological systems is essential to enzyme function,1 
oxygen and electron transfer,1 infection control,2 and redox balance.3 Biological 
mechanisms for metal transfer and redox activity are often poorly understood due to the 
complexities of biological environments and a limited understanding of the quantities and 
localization of high-affinity and weakly binding ligands present in cells. For example, mis-
regulation of copper and iron homeostasis is implicated in initiation and/or progression of 
Parkinson’s and Alzheimer’s diseases,4,5 but the role of weakly chelating biomolecules in 
these diseases has not been addressed. It is often assumed that non-protein-bound metal 
ions are coordinated to low-molecular-weight oxygen- and nitrogen-containing ligands, but 
the nature of these ligands and how these interactions affect cellular processes is unknown. 
Determination of in vitro stability constants is used to predict equilibria that may 
occur in more complex systems6-12 and to model speciation in biological fluids.7 The goals 
of this review are to 1) examine weakly coordinating ligand interaction with copper and 
iron under biological conditions, with an emphasis on sulfur and selenium amino acids, 2) 
examine the methods and method limitations for determination of stability constants 
describing complexation of redox-active metal ions with weakly binding ligands, and 3) 
emphasize specific needs for methods development and further research on these systems.  
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A comprehensive discussion of stability constants for weakly binding ligands 
present in significant quantities in the cell is lacking and is presented in this review. The 
Smith and Martell database (NIST v.46)8 is a large set of externally evaluated stability 
constants that involves some of the iron and copper complexes of interest to this review. 
However, the database is no longer being critically analyzed and curated. Specifically, this 
review focuses on the stability constants of amino acids with the biologically relevant, 
redox-active metals copper and iron. Copper and iron are of particular interest due to their 
availability in the cell, potential for chelation by wide variety of ligands, and known 
contribution to reactive oxygen species generation and oxidative damage. Ligand 
coordination to these metal ions can be difficult to assess, due to their variable oxidation 
states and coordination geometries.  
This review places special emphasis on sulfur and selenium amino acids, since 
coordination of these ligands with copper and iron is of particular biological interest, and 
thiol and thioether coordination can stabilize the reduced forms of copper and iron.6-8 A 
range of stability constant determination methods including potentiometric, 
spectrophotometric, and voltammetric analyses have been used to quantify formation of 
iron and copper complexes with amino acids under biologically relevant conditions. The 
review discusses and identifies the limitations of each method as it pertains to each metal 
and oxidation state and will evaluate the potential impact of amino acids on biologically 
relevant metal interactions by modeling of more complex systems. 
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1.2  Cellular Redox-Active Metal Ions and Amino Acids 
 Copper, iron, zinc, manganese, and cobalt are essential redox-active metal ions in 
biological systems that play crucial biochemical roles as cofactors in enzymes. Iron and 
copper of are particular interest due to their stability in multiple oxidation states which are 
often essential to biological processes,9,10 but this activity makes assessing the validity of 
in vitro ligand coordination difficult. The association and distribution of copper and iron, 
not only within the highly selective binding pockets of proteins, but also with more weakly 
binding ligands such as single amino acids has implications for the uptake, transfer, and 
redox states of these metal ions throughout the cell.  
 Complex formation is dependent on amino acid concentration, metal concentration, 
and the thermodynamic driving forces controlling complex formation. In human plasma, 
free amino acid concentrations can be divided into three categories: high abundance (200-
500 μM), low abundance (10-200 μM), and trace abundance (less than 10 μM).11-13 
Alanine, glutamine, glycine, leucine, lysine, proline, threonine, and valine fall into the high 
abundance category. With the exception of threonine, these amino acids have non-polar or 
positively charged side chains at pH 7, which limit their cation binding abilities to bidentate 
binding of the amine nitrogen and carboxylate oxygen groups. Arginine, aspartic acid, 
asparagine, cysteine, glutamic acid, histidine, isoleucine, serine, methionine, 
phenylalanine, tryptophan, and tyrosine fall into the low abundance category, and most of 
these have polar or negatively charged side chains at pH 7 that may allow tridentate 
coordination through the amine, carboxylate, and side chain groups. Trace-level amino 
acids include methylcysteine and the selenoamino acids, selenmethionine, 
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selenomethylcysteine, and selenocysteine. Methylcysteine concentrations in urine are 
reported to be 0.2-5 μM;14 plasma or cellular concentrations are not reported. Selenoamino 
acid concentrations are also not reported, but total selenium concentration in human plasma 
averages 1.5-1.6 μM, with an estimated 90% incorporated into selenoprotein as 
selenocysteine or selenomethionine.15 Although the abundance of selenoamino acids is 
extremely low, soft selenoether or selenolate groups may strongly interact with softer 
metals such Cu(I) and Fe(II) according to the Pearson hard-soft acid-base theory.   
Penicillamine is an amino acid not naturally found in cells, but it bears close 
structural resemblance to cysteine. It is a highly effective copper chelator used routinely to 
treat Wilson’s disease.16,17 With a typical dosage of 750 mg/day, serum penicillamine 
levels can reach 100 μM.18 Although it is known to bind copper, it may also influence iron 
homeostasis.19,20  
 Stability constant determination is discussed with Cu(I) and Cu(II) and Fe(II) and 
Fe(III) as separate ions due to their unique cellular roles and significantly different 
coordination characteristics. Each of these metal ions serves essential biological roles in 
electron transfer, oxygen transport, and catalysis.21 Iron and copper are two of the most 
abundant transition metal ions in cells, and control of these potentially toxic ions is heavily 
regulated by metallochaperones and storage proteins such as ferritin.22,23 Total copper 
concentrations are in the range of 10-25 μM in human serum24 and up to 100 μM in human 
brain tissue.25 Labile (non-protein-bound) copper pools are also identified in cells, 
primarily as Cu(I).26 Cellular concentrations of labile copper are not quantified, but  
significant recent strides have been made in the development of methods to detect this 
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labile copper.27-29  
 Total iron concentrations are 20 to 30 μM in human serum,30 but are approximately 
300 times higher in human liver (6315 μM).31 Jhurry and coworkers quantified labile iron 
concentrations in the cytosol of human cells at 30 μM and in mitochondria at 210 μM.32 
Mis-regulation of copper and iron homeostasis can lead to increased oxidative damage and 
protein misfolding or aggregation and is implicated in the development of 
neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases.3,33-36 In 
addition, redox cycling between Cu(I) and Cu(II) that is critical for the function of most 
copper enzymes is often controlled by amino acid coordination and protonation state.37-39 
In conjunction with reliable and complete stability constant determination and species 
identification, as well as the biological concentrations of the amino acids and metal ions, 
the extent of biological amino-acid-metal complex formation under equilibrium conditions 
can be predicted. The work in this chapter was completed in collaboration with Dr. Brian 
A. Powell of Clemson University. 
 
1.3  Amino Acids as Weakly Binding Ligands 
 Biological regulation of metal ions is dominated by strong chelation in highly 
specific binding pockets of proteins, often contributing to protein structural support and/or 
enzyme activation. It is more difficult to ascertain the role of metal-coordinating, small 
molecules, particularly at high metal concentrations resulting from loss of 
homeostasis.26,40-44 These small, coordinating molecules may play a number of roles 
including: 1) cellular signaling, such as various hormones, 2) molecules required for 
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metabolism, such as sugars, 3) molecules needed for anabolism, such as amino acids or 
lipids, and 4) exogenous molecules, such as drugs, antioxidants, or toxins. Entire databases 
in bioinformatics and cheminformatics are committed to sorting, analyzing, and predicting 
chemical properties and biomolecular pathways for these types of coordinating small 
molecules.45 We focus on the coordination and stability of amino-acid-metal complexes, 
since amino acids coordinate strongly enough to Cu(I)/Cu(II) and Fe(II)/Fe(III) to infer that 
these complexes may form within the cell.46  
 
Potentially Bidentate Amino Acids 
Because amino acids have varied potential metal-binding modes, discussion of 
amino acid coordination will be grouped according to their predicted denticity. Most amino 
acids only have the capability for bidentate coordination, through the α-carboxylate oxygen 
and α-amine nitrogen atoms, forming a five-membered chelate ring with the metal ion 
(Figure 1.1). Since glycine is the simplest amino acid and primarily binds metals with 
bidentate coordination, this type of bidentate metal-amino-acid coordination is often 
referred as glycine-like binding.47 
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Figure 1.1. Amino acids with non-coordinating aliphatic or aromatic side chains that have the capability to 
coordinate metal ions in a bidentate fashion. In box: complex showing bidentate binding to a metal ion (M) 
through the carboxylate oxygen and amine nitrogen, using glycine as an example. 
 
Potentially Tridentate Amino Acids 
Amino acids with polar or charged side chains may have the capability to bind in a 
tridentate fashion (Figure 1.2), but often do not achieve full tridentate coordination. 
Alcohol, amine, and carboxylate groups all can potentially coordinate metals, but the 
influence of thermodynamic factors such as pKa, steric strain, and entropy cost can lessen 
or prevent metal interactions. Predicting the likelihood of an amino acid binding in a 
tridentate fashion is not straightforward. For example, the polar side chains of arginine and 
lysine are positively charged at pH 7 (Figure 1.2), with pKa values above 10 properties that 
inhibit metal binding.  
Perhaps the best measure of the ability of an amino acid side chain to bind copper 
and iron is to consider the amino acid residues most often found in metalloprotein binding 
pockets. In a 2007 survey of the Protein Database, the three amino acids most commonly 
found in copper metalloprotein binding pockets were histidine, cysteine, and  
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Figure 1.2. Amino acids with polar or charged side chains that have the capability to bind metals in a 
tridentate fashion. In box: complex showing potential tridentate binding to a metal ion (M) through the α-
carboxylate oxygen and α-amine nitrogen as well as a side chain atom, using binding to the oxygen atom of 
the deprotonated alcohol group in serine as an example.  
 
methionine, respectively.48 Aspartic acid, glutamic acid, serine, threonine, glutamine, and 
asparagine also bind copper but much less commonly. For iron metalloproteins, histidine, 
glutamic acid, cysteine, aspartic acid, methionine, and tyrosine were the primary iron- 
binding amino acids, with serine and asparagine as minor players. Based these reports, it 
is reasonable to assume that these free amino acids also would potentially bind copper and 
iron.  Higher stability constants are expected for metal-amino acid complexes with 
tridentate binding compared to those with only bindentate coordination, since greater 
chelation confers higher thermodynamic stability. 
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Figure 1.3. Amino acids with sulfur- or selenium-containing side chains; all have the capability to bind 
metals in a tridentate fashion. In box: complex showing potential tridentate binding to a metal ion (M) through 
the α-carboxylate oxygen and α-amine nitrogen atoms as well as a side chain atom, using deprotonated sulfur 
in cysteine or penicillamine as an example 
 
Sulfur- and Selenium-Containing Amino Acids 
In this review, special emphasis is given to iron and copper interactions with sulfur- 
and selenium-containing amino acids, including penicillamine, methylcysteine, and 
selenomethylcysteine (Figure 1.3). These amino acids not only show preferential binding 
to soft and borderline metal ions, such as Cu(I), Cu(II), and Fe(II), but they also influence 
redox activity of these metals.49 Metal-sulfur and -selenium redox interactions can make it 
difficult to clearly interpret stability constant data for these systems, especially for 
thiol/selenol-containing amino acids with reduced metal ions.50 
Because of the S/Se atom in the side chain, these amino acids can potentially act as 
tridentate chelators to metal ions. Although selenoamino acids are less prevalent in the cell 
than their sulfur analogs, metal-selenocysteine binding is required for the activity of 
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enzymes such as NiFeSe hydrogenases.51 Selenoether-containing amino acids are not 
known to have primary metal-binding roles in metalloproteins. Selenomethionine can 
substitute indiscriminately for methionine when Se levels are high,52 and has been well-
studied for its ability to prevent metal-mediated oxidative damage.53  
 
1.4 Comparing Apples to Apples: Defining Parameters of Stability Constant 
Determination 
 The sheer volume of stability constant data for transition metal ions with amino 
acids is overwhelming and has been the subject of databases54 and extensive reviews.47,50,55-
57 Previous reviewers50,58 noted that the wide range and seemingly inconsistent reports of 
these stability constants is attributable to the sensitivity of these systems to the specific 
conditions under which determinations are performed. Even when using the same 
analytical method, variables including the nature and concentration of supporting 
electrolyte, pH range, temperature, and solvent significantly affect the resulting stability 
constants. Whenever possible in this review, stability constants were chosen that represent 
the most consistent results, both with each other and with biological conditions. Thus, 
typical experimental conditions are 25-37 ˚C with 0.1-3.0 M supporting electrolyte. If 
limited data are available, the best or only reported metal-amino-acid stability constants 
are provided. 
 Clearly defining equilibrium constants is crucial to correctly interpreting stability 
constant data and identifying species formed across various analyses, especially for amino 
acids where charges can differ. In this review, amino acids are divided into three categories: 
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1) those likely to bind as bidentate ligands, composed of aliphatic or aromatic amino acids 
with nonpolar side chains (Figure 1.1), 2) those that can potentially bind as tridentate 
ligands, composed of amino acids with polar or charged side chains (Figure 1.2), and 3) 
sulfur- and selenium-containing amino acids (Figure 1.3). Since the sulfur and selenium-
containing amino acids have greater potential for redox activity compared to other amino 
acids, especially upon iron or copper coordination, it is useful to treat these amino acids 
separately. 
 For all the amino acids, proton association constants can be expressed as stepwise 
protonation constants shown in equilibrium expressions 1 and 2. 
H+  +  L-    HL  protonation of –NH2 group   (1) 
H+  +  HL    H2L+ protonation of –COO- group   (2) 
The equilibrium constant KHL relates to the first protonation (equation 1) according to 
equation 3 and the equilibrium constant KH2L relates to the second protonation (equation 2) 
according to equation 4. 
KHL    =    
[HL]
[L
−][H
+
]
 (3) KH2L    =    
[H2L
+]
[HL][H
+]
  (4) 
 Equilibrium constants 3 and 4 apply for all amino acids that do not have side chains 
that can protonate or deprotonate, such as those shown in Figure 1.1 and the thioethers 
shown in Figure 1.3. The remaining amino acids have ionizable side chains that must be 
accounted for in additional equilibrium expressions.   
 For amino acids that are positively charged at pH 7, such as lysine, arginine, and 
histidine, the protonation equilibrium reactions 5, 6, and 7 apply. 
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H+  +  L-    HL protonation of –NH2 group (5) 
H+  +  HL    H2L+ protonation of side chain (6) 
H+  +  H2L+    H3L2+ protonation of –COO- group (7) 
Thus, for protonation reactions of amino acids with ionizable side chains, equilibrium 
constants (3) and (4) apply, along with the additional equilibrium constant KH3L (8). 
KH3L =    
[H3L
2+]
[H2L
+][H
+
]
 (8) 
For amino acids that are negatively charged at pH = 8, including glutamic acid, aspartic 
acid, cysteine, homocysteine, and penicillamine, the representative equilibria are 9, 10, and 
11. 
H+  +  L2-    HL- protonation of –NH2 group (9) 
H+  +  HL-    H2L protonation of side chain (10) 
H+  +  H2L    H3L+ protonation of –COO- group (11) 
The related association constants are similar to those defined in equations 3, 4, and 8, 
although it is important to note that the charge on each species is different. 
 Association constants for metal-amino-acid coordination are defined in a similar 
manner. Because the charge of the metal ions (M) studied varies from +1 to +3 and the 
charges of the amino acids (L) also vary, charges on the species are typically not indicated 
in these general equilibrium expressions. When discussing specific species, charges will 
be shown whenever possible. Equilibrium equations for mono- and bis-coordinated 
complexes as well as their formation constant () expressions are represented by equations 
12 and 13, respectively. The formation constant β is related to the thermodynamic stability 
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of a complex, the association constant K, for each stepwise addition of a new ligand.  At 
lower pH, the side chain of the amino acid may or may not be protonated, as shown in 
equation 14 and 12, respectively. At higher pH, some metal-amino acid systems coordinate 
a hydroxyl ligand, or deprotonate a coordinated water molecule, resulting in the ternary 
metal-ligand-hydroxide species MLOH (15).  
 
M  +  L    ML βML   =    
[ML]
[L][M]
 (12) 
M  +  2 L    ML2 βML2=    
[ML2]
[L]2[M]
   (13) 
M  +  HL   MLH  βMLH  =    
[ML]
[H][ML]
 (14) 
ML + OH   MLOH  βMLOH  =    
[ML]
[OH][ML]
 (15) 
The thermodynamic parameter for each stepwise formation constant, K can then be 
related to the standard free energy change (ΔG° ) at constant pressure (16). The total 
enthalpy change ΔH0 can be determined from the temperature dependence of K according 
to the van’t Hoff equation (17). Although potentiometry is commonly used to determine 
metal-ligand formation constants, calorimetry is often used for enthalpy determinations, 
since potentiometric measurements may not be stable across the full temperature range 
needed to calculate a free energy change. The thermodynamic parameters free energy and 
enthalpy are not discussed in detail in this review.  
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ΔG̥̥ ° =  -RT lnK    (16) 
𝑑(ln 𝐾)
𝑑𝑇
  = 
𝛥𝐻°
𝑅𝑇2
    (17)   
 To determine stability constants for metal-amino-acid complexes, any method can 
be used that can actively measure the formation and elimination of the species present, and 
books dedicated to methods development and analysis have been published.59-61 General 
problems associated with determining metal-amino-acid stability constants for all metals 
are thoroughly reviewed,47,56,62-65 although these reviews are data-heavy and do not include 
new methods development. This review will focus specifically on the best methods for 
amino acid stability constant determination with Cu(I), Cu(II), Fe(II) and Fe(III), and the 
particular experimental limitations associated with these ions. Common methods are 
introduced here, and less common methods are discussed in each metal-specific section as 
relevant. 
 The three most common methods for stability constant determination are 
potentiometric, voltammetric, and spectrophotometric titrations. Potentiometric analyses 
are the most frequently used method for amino acid-metal binding constant determinations. 
The precision and stability of this method makes it the ideal choice of method, when 
conditions allow, and permits detection of minor species when coupled with the 
computational abilities of modeling software.47,50,57,66 While many of these species are 
inconsequential under biologically relevant titration conditions for simple systems, 
incorporation of these species into studies of more complex systems is imperative and can 
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have significant effects, since their formation may influence formation of competitive 
species.67  
Potentiometric analyses are not always an option, and independent analyses are 
helpful, and in some cases necessary, in confirming complex speciation. Voltammetric or 
polargraphic techniques permit measurements at a constant pH for pH-sensitive systems.68 
Often the resulting data are not as precise or as consistent as potentiometric methods, since 
only changes to the metal ion are typically measured. Spectrophotometric analyses work 
well with metal ions, ligands, and/or complexes that absorb in UV or visible wavelengths, 
but these methods do not indicate binding mode of multidentate interactions. Development 
of methods such as paper electrophoresis, involving solvent-extraction of species, is a 
growing area.  Table 1.1 provides an overview of the most common methods and their 
advantages and limitations. 
For amino-acid-metal complex determinations, potentiometry is the most common 
method utilized, because the uptake and release of protons can be measured 
precisely.47,56,63-65,69-71 Electrode stability limits the analysis range, and data can be 
questionable at pH extremes  (typically pH < 2 and pH > 12).47,65 Although robust and 
precise, potentiometric analyses are limited to ligands or hydrolyzed metals with protons 
that associate and dissociate in the pH range investigated and can be limited by ligand 
and/or complex solubility across this pH range. 
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Table 1.1. Advantages and limitations of stability constant determination methods  
Method Advantages Limitations 
Potentiometric titration High precision 
High accuracy 
Ligands must protonate/deprotonate 
Species must be soluble across wide pH range 
Disproportionation issues with Cu(I) 
Curve fitting technique with no direct measurement 
of the metal or metal-ligand complex 
Spectrophotometric titration Can be run at narrow pH 
Direct probe of metal and metal-
ligand complex 
Either metal or ligand must be UV-vis active 
Electrophoresis 
(paper or solution) 
Simple detection 
Easy to identify species charges  
Low precision 
Temperature and oxygen control more difficult 
Conditions differ from solution determination 
Redox titration Redox-active metals can be 
controlled 
Species identification must be confirmed using  
independent methods 
Solubility Low solubility systems such as 
Fe(III) 
Lengthy experiments due to slow equilibria 
between solid and solution 
   16
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The IUPAC stability constant database contains a comprehensive list of all stability 
constant and associated thermodynamic data available for metal-amino-acid stability 
constant data reported up through 1989.54 Stability constants for most of the amino acids 
with a variety of metals are available for a wide range of temperatures and supporting 
electrolyte concentrations. Various reviews present a more selective list of stability 
constants of metals with amino acids up until 1997.47,50,55-57 While the database and reviews 
are comprehensive for the time periods indicated, they are cumbersome in the quantity of 
analyses given for some metals such as Cu(II) and reflect the lack of data for other metals 
such as Cu(I). Our analysis draws on these data and also comprehensively covers iron and 
copper data with amino acids up until early 2018. 
 
1.5   The Gold Standard: Proof of Speciation 
 Unambiguous identification of the thermodynamically stable species present in 
solution is required to understand the solution equilibria of a metal-ligand complex.59,60 For 
potentiometric determinations, glass electrodes are used to track the change in potential as 
acid/base titrations are performed. Before the advent of modeling programs, best fit 
analyses were determined for the most likely species formed in the given system using 
graphical methods documented by Bjerrnum72,73 and Fronaeus.74 More recently, programs 
such as SCOGS,75 HYSS,76 HYPERQUAD,77 and MINIQUAD78 have made modeling and 
model-matching much easier to perform and have allowed for more precise data analysis. 
As a result of computational modeling methods and perhaps a more comprehensive 
understanding of solution equilibria for metal-amino acid complexes, the number of 
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identified species in recent reports has expanded. While incorporation of additional species 
certainly improves model fit to the data, due to their low concentration and limited 
influence on metal complex formation, the existence of such species are often difficult to 
confirm from titration data alone. For example, minor species such as complexes with 
protonated, unbound side chains may not play an active role in metal binding, but they may 
contribute to buffering in the cell.50,79  Thus, the gold standard for species determination 
should incorporate secondary methods to unambiguously identify these minor species. In 
this review, we describe the most consistent reported species, particularly emphasizing 
investigations that have demonstrated a high level of control of experimental conditions or 
used multiple methods of analysis to independently confirm the identified species. 
 
1.6  Stability Constants of Non-Sulfur and -Selenium-Containing Amino Acids 
 with Cu(II)  
Cu(II) Complexes of Potentially Bidentate Amino Acids  
 Whether or not labile Cu(II) exists in the cell, Cu(II) plays a major role in organisms 
since activity and stability of Cu(II) metalloproteins depend on copper-amino acid 
interactions.1 Compared to Cu(I), Fe(II), and Fe(III), Cu(II) is the most chemically well-
behaved ion for analytical measurements. Most Cu(II) salts are soluble in aqueous solution 
and are not sensitive to air oxidation. It is not surprising, therefore, that hundreds of 
analyses to determine Cu(II)-amino-acid stability constants are reported47,50,56,62-64 using a 
wide variety of methods: polarography,80 spectrophotometry,81 circular dichroism,82 
optical rotary dispersion,83 and electrophoresis.84,85 Although solubility of Cu(II)-amino 
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acid complexes with hydrophobic side chains is limited in the basic pH range, this issue is 
not always discussed in published reports. 
Table 1.2 shows a summary of the stability constants for Cu(II) for amino acids 
with non-coordinating side chains that are limited to bidentate coordination through the 
carboxylate oxygen and amine nitrogen of the amino acid (Figure 1.1). Due to the plethora 
of available data for Cu(II)-amino-acid stability constants,54 the selected stability constants 
in Table 1.2 are those “recommended” in previous reviews due to their data quality and 
reproducibility,47,50,55-57,66 where possible. Beyond that, selected constants were 1) reported 
with errors, 2) determined within 25-37 ˚C, and 3) were conducted in a constant ionic 
strength medium (range 0.1-3 M).86  
 Analysis of Cu(II)-amino-acid stability constants with bidentate-coordinating 
amino acids (Figure 1.1) is fairly straightforward and consistent. Coordination is typically 
through the α-carboxylate oxygen and α-amine for both ML and ML2 species and is 
supported by solid-state structures. The structure of Cu(Gly)2, a representative bidentate-
ML2 species, is square planar with bidentate glycine ligands creating two five-membered, 
equatorial chelate rings around Cu(II) (Figure 1.4A).87 The axial positions are vacant, 
with occasional coordination of water molecules or supporting electrolyte, such as in 
Cu(Gly2)(H2O) (Figure 1.4B).
87-90  
No trend in stability constants relating to side chain hydrophobicity is observed for 
the aliphatic amino acids. Potential intermolecular interactions of aromatic side chains 
(e.g., phenylalanine) also do not impart added stability to the complexes, since all of the   
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Table 1.2. Stability constants for Cu(II) and Cu(I) with potentially bidentate amino acids 
Stability Constants for Cu(II)  
Ligand ML 
(log βML)a 
ML2 
(log βML2)b 
Temp. 
 (°C) 
Ionic Strength 
 (M) 
    Method Ref. 
Alanine 8.17(3) 14.94(5) 30 0.1 KNO3 Potentiometry 91 
Glycine 8.07(2) 14.86(3) 30 0.1 NaClO4 Potentiometry 92 
Isoleucine 8.50(6) 15.79(8) 25 0.1 NaNO3 Potentiometry 93 
Leucine 8.276(1) 15.174(1) 25 0.1 KNO3 Potentiometry 62 
Phenylalanine 7.93(1) 14.83(1) 25 0.1 KNO3 Potentiometry 62 
Proline 8.60(3)c 15.09(7)c 25 0.1 NaNO3 Potentiometry  94 
Tryptophan 8.02(1) 15.56(1) 25 0.1 KNO3 Potentiometry 62 
Valine  8.05(2) 14.91(2) 30 0.1 NaClO4 Potentiometry 95 
Stability Constants for Cu(I)  
Alanine 9.6c  25 0.3 K2SO4 Redox 96 
Glycine 10.0c  25 0.3 K2SO4 Redox 96 
a log βML = [M][L]/[ML]    b log βML2 = [M][L]2/[ML2]    c Authors also reported the minor species Cu(Pro)(OH)  
(log β = 1.29(4)) and [Cu(Pro)(OH)2]- (log β = -8.58(3)). 
2
0
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Figure 1.4. A) Crystal structure diagram for Cu(Gly)2 showing carboxylate and amine coordination with 
square planar geometry around the central Cu(II) ion.87 B) Crystal structure diagram of Cu(Gly)2(H2O) also 
showing carboxylate and amine coordination in the equatorial position, but with a water molecule coordinated 
in the axial position of the square pyramidal geometry.88,90 The Cu(II) ion is shown in orange, oxygen atoms 
are red, carbon atoms are grey, and nitrogen atoms are blue. Hydrogen atoms are not shown. 
 
Cu(II) stability constants with bidentate amino acids are within one log unit of each other 
(Table 1.1). This stability constant uniformity indicates glycine-like ML and ML2 complex 
formation for all these amino acids with Cu(II). 
Minor species have also been identified for these relatively simple systems. Blais 
and coworkers67 claim to have identified [Cu(HVal)]2+ and [Cu(HVal)(Val)]+ as well as 
[Cu(HGly)]2+, [Cu(HGly)(Gly)]+, and [Cu(HGly)2]
3+ in their Val and Gly analyses, 
respectively. Because the side chains of Val and Gly cannot protonate, it can be assumed 
that these species arise from amine protonation and monodentate binding of the metal 
through the carboxylate oxygen. All of these species form below pH 3 and represent only 
a very small change in buffering of the system. While these species are chemically 
reasonable in terms of competition between a high proton concentration and Cu(II) for 
amino acid binding, they are formed at the accuracy limits of potentiometric measurements 
when formed at low pH and remain to be independently confirmed.  
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On the other end of the pH range, species with hydroxyl coordination, such as 
MLOH and ML2OH, are reasonable and expected, especially since water is known to 
coordinate in the axial position in the solid state (Figure 1.4B).87,97 However, Cu(II)-amino 
acid complexes typically precipitate in the alkaline range (pH > 9). Arena and coworkers 
note that signal drift can occur in potentiometric measurements at more basic pH when 
precipitation is seeding,98 and this signal drift can be misinterpreted as new species 
formation.99  Thus, distinguishing between signal drift and minor hydroxyl species 
formation at basic pH is a core issue in determining accurate speciation. 
Analyses across methods also are consistent for Cu(II) titrations with potentially 
bidentate amino acids, a promising sign for methods development, particularly for the 
determination of stability constants for ligands that may not have the ionizable protons 
needed for potentiometric analysis. Paper electrophoresis is an excellent method for 
separating species, although it is limited in precision and may not accurately represent 
“solution” equilibria. For potentiometric and paper electrophoresis results for the Cu(II)-
alanine system, the paper electrophoresis stability constants reported by Jokl100 are slightly 
higher: 8.5 and 15.2 for the [Cu(Ala)]+ and Cu(Ala)2 species (no errors are reported), 
respectively, compared to 8.17(3) and 14.94(5) using potentiometric methods.91 Singh’s 
[Cu(Val)]+ and Cu(Val)2 electrophoresis determinations
84 are consistent with or slightly 
lower than potentiometrically determined values (8.02 and 14.62, respectively, compared 
to 8.05(2) and 14.91(2), respectively).95 Separately, Tewari101 reported paper 
electrophoresis stability constants for the Cu(II)-isoleucine system: 8.41(7) for [Cu(Ile)]+  
and 14.84(3) for Cu(Ile)2, values consistent with or slightly lower than the potentiometric 
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results of 8.50(6) and 15.79(8), respectively.93 While this is not a comprehensive list of 
paper electrophoresis determinations, these representative data demonstrate method 
viability. Indications of the charge of species due to electrophoretic movement is an 
advantage of electrophoresis. If the detection limits are suitable, electrophoresis may be a 
method worth exploring for establishing existence of minor species.  
Spectrophotometric analyses also are an option for spectrophotometrically active 
metals such as Cu(II) or ligands with aromatic groups that absorb or fluoresce in the UV 
or visible spectrum. However, concentrations required for species detection in the UV-
visible range can be a factor of ten higher for spectrophotometric analyses compared to the 
precision determination of protons in potentiometric analyses. Effects of metal-
coordinating solvents or supporting electrolyte can also contribute to error in 
spectrophotometric methods. For example, a spectrophotometric analysis of the Cu(II)-
leucine system by Bretton102 with no supporting electrolyte results in considerably higher 
stability constants than those obtained by potentiometric analyses with a supporting 
electrolyte of 0.1 M NaNO3 by Ivicic (Table 1.1).
93  Other optical methods such as 
circular dichroism and optical rotary dispersion have also been used to determine stability 
constants with Cu(II), with results similar to those from potentiometric analyses, but it can 
be difficult to identify minor species using these methods.82,83 Perhaps the most compelling 
use of spectrophotometric methods to determine stability constants is in conjunction with 
potentiometric methods, since species identification can be supported by two independent 
methods. This combination is demonstrated by Davis103 in determining the stability 
constants for Cu(II)-valine-pyridoxal complexes.  
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Stability constants of Cu(II) with aliphatic amino acids are one of the most widely 
studied of all metal-amino-acid combinations. The relative stability of this metal ion with 
non-redox active ligands makes the resulting data easy to interpret, as long as the method 
is reliable in collecting quantifiable changes to the system, whether the release of protons 
or spectral changes. As a result, these systems provide the best arena for development of 
methods to examine metal coordination with weakly binding ligands.  
 
Cu(II) Complexes of Potentially Tridentate Amino Acids  
Amino acids with polar side chains, including serine, histidine, threonine, tyrosine, 
aspartic acid, glutamic acid, asparagine, and glutamine, may coordinate not only through 
the carboxylate oxygen and amine nitrogen atoms, but also through the polar side chain 
atoms. Although polar, the side chains of lysine and arginine are typically positively 
charged in aqueous solution with pKa values of 10.54 and 12.48,
55 respectively, and 
therefore are not expected to coordinate positively charged Cu(II). Methionine and cysteine 
also have electronegative side chains with the potential for binding Cu(II), but these sulfur-
containing amino acids have unique redox properties that present potential complications 
for stability constant determination and are discussed separately.  
Due to the thermodynamic nature of stability constants, tridentate binding to Cu(II) 
should be reflected in considerably higher stability constants compared to bidentate 
binding. With Cu(II), stability constants for asparagine, glutamine, serine, threonine, and 
tyrosine (Table 1.3) are not significantly different from those for the bidentate amino acids 
(Table 1.2), suggesting only carboxylate and amine binding. Not surprisingly, the lowest 
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stability constants for Cu(II) binding are observed for Lys and Arg (Table 1.3), likely 
indicating electrostatic repulsion between the positively charged amino acid and Cu(II). In 
contrast, Cu(II) stability constants of histidine (ML = 9.75, ML2 = 17.49) and aspartic acid 
(ML = 8.83, ML2 = 15.93) are considerably higher than the other tridentate amino acids 
(Table 1.3), indicating side chain coordination.  
Tridentate coordination to Cu(II) by aspartic acid104 and histidine are supported by 
solid-state structures (Figure 1.5).105-108 Stability constants for glutamic acid (ML = 8.30, 
ML2 = 15.03) are slightly elevated compared to the other potentially tridentate amino acids, 
suggesting weaker side-chain coordination than for His or Asp. However, the only solid-
state structure to support this tridentate binding mode is the glutamate complex with 
cadmium, [Cd(Glu)(H2O)]H2O.
109 In general, most of the stability constants for the 
potentially tridentate ligands with Cu(II) do not indicate tridentate binding, and it is 
reasonable to assume that Cu(II) coordination by these amino acids is 
 
Figure 1.5. Crystal structure diagram for the Cu(His)2 complex, showing both tri- and bidentate binding of 
histidine to the Cu(II) center. The Cu(II) ion is shown in orange, oxygen atoms are red, carbon atoms are 
grey, and nitrogen atoms are blue. Hydrogens are omitted for clarity. 
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Table 1.3. Stability constants for Cu(II) and Cu(I) with potentially tridentate amino acids  
Stability Constants for Cu(II) 
Ligand ML 
(log βML)a 
ML2 
(log βML2)b 
    MLOH 
(log βMLOH )c 
Other  
Species 
Temp 
(°C) 
Ionic 
Strength 
(M) 
Method  
 
Ref. 
Arginine 7.555(4) 14.007(5)   25 0.1 KNO3 Potentiometry 62 
Asparagine 7.788(3) 14.142(4) 4.17(2) MLH 10.08(3) 
ML2H 17.44(3) 
37 0.15 NaClO4 Potentiometry 110 
Aspartic acid 8.83(3) 15.93(2) 24.0(1) MLH 12.52(2) 
ML2H 19.8(3) 
M2L  10.34(6) 
M2L2 19.5(1) 
25 0.1 KNO3 Potentiometry 111 
Glutamine 7.71(1) 14.12(1)   25 0.1 KNO3 Potentiometry 98 
Glutamic acid 8.30(4) 15.03(3)  MLH 12.52(2) 
ML2H 19.6(3) 
M2L  10.41(5) 
M2L2 18.6(2) 
25 0.1 KNO3 Potentiometry 111 
Histidined 9.75(1) 17.49(1) 2.2(2) MLH 13.78(1) 
ML2H 23.05(1) 
ML2H2  26.29(6) 
ML2OH 6.3(1) 
37 0.15 NaCl Potentiometry 112 
Lysine 7.62(2) 13.94(2)  MLH  10.361(5) 
ML2H  10.84(1) 
25 0.1 KNO3 Potentiometry 62 
Serine 7.748(2) 14.083(5) 4.285(13) MLH 10.030(16) 37 0.15 NaClO4 Potentiometry 110 
Threonine 7.98(4) 14.66(5) 4.81(3) ML2H-2 -6.0(1) 25 0.1 KNO3 Potentiometry 107,113,62,11
1,114 
Tyrosine 7.90(2) 15.17(3)   25 0.1 KNO3 Potentiometry 115 
Stability Constants for Cu(I) 
Histidine 12.80d 25.20d   25 0.2 KNO3 Redox 116 
a log βML = [M][L]/[ML]    b log βML2 = [M][L2]/[ML2]    c log βMLOH = [ML][OH]/[MLOH]    d The protonation state for His in the ML and ML2 species 
assumes the histidine has one ionizable proton.  
  
2
6
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very similar to the bidentate amino acids. Changes in side-chain protonation state, however, 
can complicate stability constant determination and make identifying minor species more 
difficult. 
 
Challenges in Determining Cu(II)-Amino Acid Stability Constants 
Determining the speciation of metal complexes with potentially tridentate amino 
acids is especially troublesome for modeling stability constants. These difficulties are 
primarily caused by reported potential minor species due to 1) inconsistency of identified 
species, 2) failure to independently characterize these species, and 3) absence of 
meaningful discussion about the relative importance or implications of the reported minor 
species. Thus, researchers may be adding minor species solely to optimize their model 
fitting to titration data, a particular issue given the unreliability of Cu(II)-amino acid 
titration data at pH > 9 due to precipitation. Collection of titration data is usually limited 
to the pH range over which all complexes remain in solution, but these pH limits are not 
always explained, and precipitation is rarely mentioned.  
As an example, most studies describing binding constants for Cu(II)-serine 
complexes report only two species, ML and ML2.
50 More recent work reports two 
additional species, ML2OH and MLH.
110 The difficulties surrounding identification of 
additional, minor species is demonstrated by comparing the simulated titration data based 
on reported constants110,117 for 1) a titration that incorporates just two primary species, 
Cu(Ser)2 and [Cu(Ser)]
+, and 2) a titration that incorporates the additional minor species 
[Cu(HSer)]2+ and Cu(Ser)(OH), for a total of four species (Figure 1.6). Under typical 
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titration conditions with a 1:2 Cu(II)-to-serine ratio, [Cu(SerH)]2+ is present at less than 
2% of total Cu and only present below pH ~4, as modeled in Figure 1.6B. Including this 
minor species results in no differences between the modeled two-species and four-species 
titration data at these concentrations at pH 4-8 (Figure 1.6A). In contrast, adding the  
 
 
 
Figure 1.6. A) Simulated titration with a strong base of Cu(II) and Ser with a 1:2 metal to ligand ratio. The 
“two-species” (red) line shows the modeled titration with only the Cu(Ser) (log β = 7.92(1)) and Cu(Ser)2 
(log β2 = 14.57(1)) species.118 The “four-species” (black) line shows the modeled titration with four species, 
Cu(Ser) (log β = 7.57), Cu(Ser)2 (log β = 14.02), Cu(Ser)2OH (log β = 4.29), and Cu(Ser)H (log β = 10.03).110 
B) A speciation diagram for the Cu(II) and Ser titration over the pH range 3-10.5 fit with two (red line) and 
four (black line) species. 
 
A 
B 
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[Cu(Ser)2OH]
- species significantly affects titration buffering above pH 8. Including this 
additional species may improve the model fit to experimental data; however, many Cu(II)-
amino-acid complexes precipitate above neutral pH as the concentration of the ML2 species 
increases, although this precipitation is often unreported, resulting in significant  
electrode drift and data inaccuracy. Under these conditions, the limited accuracy of the  
experimental data may not support including minor species to increase modeling accuracy, 
and in the absence of independent characterization, these species may even be artefactual. 
The Cu(II) to amino ratio used in stability constant determinations also has a 
significant effect on complex speciation, as demonstrated with the four-species Cu(II)-Ser 
model titration (Figure 1.6; modeled at a 1:2 ratio) at metal-to-ligand ratios of 1:1 (Figure 
1.7A) and 1:10 (Figure 1.7B). Concentrations of the two minor, potentially disputed, MLH 
and ML2OH species are amplified by at least two-fold in the 1:10 simulation. These MLH 
and ML2OH species are only present under very acidic or basic conditions, respectively, 
minimizing their impact in biological systems.  
To emphasize the inconsistency in identifying minor species, one can consider the 
example of Cu(II)-threonine titrations. From the wide range of data available, the primary 
ML and ML2 species are confirmed, and no MLH species is reported. Multiple studies 
identify the minor dihydroxide species, ML2(OH)2,
62,107,111,114 but the presence and 
contribution of this hydroxide species is disputed given the conflicting data and lack of 
independent characterization. 
Despite their uncertainties, the Cu(II)-Ser and Cu(II)-Thr systems are 
straightforward compared to Cu(II)-His titration modeling, where anywhere from four to 
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thirteen species are identified (Table 1.2).112,119-121 Understanding histidine-copper binding 
is of primary importance, since it is the most common amino acid in the binding pockets 
of copper metalloproteins and is the predominant non-protein-bound copper complex in 
blood plasma.48,122,123 Reports of so many species, including dinuclear complexes, is 
indicative of inherent variability in His-Cu(II) coordination. The major species at pH 6-8 
 
 
Figure 1.7. A) Modeled speciation diagrams for the Cu(II)-Ser four-species system from Figure 1.6 A) at a 
1:1 Cu(II):Ser ratio and B) at a 1:10 Cu(II):Ser ratio.  
are [Cu(His)2H]
+ and Cu(His)2; however, minor species, such as [CuHis]
+, are present that 
could influence cellular speciation.56 Kamyabi and coworkers provided independent 
confirmation of [Cu(His)]+, Cu(His)H, Cu(His)2, [Cu(His)2H]
+, and Cu(His)(OH) 
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complexes using spectroscopic methods.124 The complexity and difficulties of determining 
Cu(II)-histidine speciation highlight core issues for stability constant determination. Even 
when the metal-ligand interaction is well-behaved and a variety of methods are available 
for analysis, confirmation of relevant species must be achieved for the data to be useful in 
large-scale modeling projects. 
 
1.7  Stability Constants of Non-Sulfur and -Selenium-Containing Amino Acids  
with Cu(I)  
 Cu(I) is the least studied and the most poorly understood of the common copper 
and iron oxidation states in biological systems. In humans, cellular copper intake is tightly 
controlled through the membrane transport protein hCTR1,125-127 which has methionine-, 
cysteine-, and histidine-rich amino acid sequences in the Cu(I) binding site.6,128 Although 
hCTR1 and other copper transport proteins preferentially bind Cu(I) over Cu(II), Cu(I) 
stability constants are vastly underexamined due to the difficulties of working with this ion.  
Cu(I) is highly unstable in aqueous systems and disproportionates to Cu(II) and Cu0 
in the presence of dioxygen. Cu(I) is also spectrophotometrically inactive, limiting 
spectrophotometric titrations to ligands that have absorbances in the UV or visible 
spectrum. In addition, the most commonly used Cu(I) salt, CuCl, is only sparingly soluble 
in aqueous systems, narrowly defining the parameters for which potentiometric methods 
can be utilized. Sharma and coworkers129 used potentiometric methods to determine that 
Cu(I) is stabilized in aqueous systems with sufficient Cl- support (1.0 M). Using 
potentiometric methods, they identified three species: CuCl, [CuCl2]
-, and [CuCl3]
2-, with 
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step-wise stability constants of 2.68, 5.07, and 4.78, respectively.129 Given these difficulties 
with Cu(I) instability and solubility, reliable data for Cu(I) stability constants with amino 
acids lags far behind that of Cu(II) despite its biological importance. 
 Due to the significant limitations of potentiometric methods with Cu(I), stability 
constants have been primarily determined using redox methods. Since Cu(I) is unstable in 
aqueous solution, redox methods are preferred because metal oxidation state is controlled 
at the electrode surface. This method is dependent on predicting the potential at which half 
of the concentration is Cu(I) and half is Cu(II), and activity due to ionic strength is 
sometimes ignored in the calculations. Stability constants for Cu(I) with only three non-
sulfur or -selenium amino acids are reported; Cu(I) stability constants with sulfur- and 
selenium-containing amino acids will be discussed separately in the Stability constants of 
Cu(I) and Cu(II) with sulfur and selenium amino acids section.  
 Using redox analyses, stability constants of 9.6, 10.0, and 10.4 were found for 
Cu(Ala), Cu(Gly), and Cu(His), respectively.96 Since alanine and glycine have non-
coordinating side chains, and stability constants for all three complexes are very similar, 
these data suggest that all three amino acids are binding in bidentate fashion to Cu(I).  It is 
surprising that His would show such weak Cu(I) binding, considering the role that histidine 
plays in stabilizing copper in metalloproteins.130 The only other Cu(I)-His determination 
identifies formation of Cu(HHis) and [Cu(HHis)2]
- species with stability constants of 12.80 
and 25.20, respectively (Table 1.3),116 where “HHis” indicates protonation of the amine or 
imidazole nitrogen atom, implying only bidentate binding. These Cu(I)-His results seem 
contradictory not only because the identified species are not the same, but because the 
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Cu(I) species with a potentially tridentate-binding His ligand has a significantly lower 
stability constant than the Cu(I) species with only a bidentate-binding His ligand. 
Considering the importance of Cu(I) in biological systems, the fact that methods and 
stability constant data for Cu(I)-amino-acid complexes are not reliable enough to compare 
with similar Cu(II) data highlights the extreme difficulties inherent in studying this ion. To 
add these difficulties, even if reliable titration methods are identified, the propensity of 
Cu(I) to form multinuclear species131-133 will provide an additional challenge for these 
measurements.  
 
1.8  Stability Constants of Sulfur- and Selenium-Containing Amino Acids  
with Copper   
 Similar to histidine, sulfur-containing amino acids have been credited for the 
stability and redox activity of a wide variety of copper metalloproteins. Both methionine 
and cysteine are recognized for the structural and electronic stability that they contribute 
to blue copper proteins.134,135 Thiols have such a high stability with copper, that the drug 
penicillamine is administered in the treatment of Wilson’s disease as a copper chelator.16,17 
Selenium compounds, such as selenocysteine, are crucial to the function of 
selenoproteins.136-138 Selenocysteine coordinates nickel in NiFeSe hydrogenases,139 and 
selenomethionine is non-specifically incorporated into proteins in place of methionine.51 
In addition, many sulfur and selenium species have been identified and extensively studied 
as antioxidants by in vitro, in vivo, and epidemiological studies,135,140-144 in part due to their 
copper-binding properties.  Selenium-containing supplements have been the subject of 
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human studies for their potential as antioxidants, although results are limited and 
conflicting.53,145-148 
 All of the sulfur- and selenium-containing amino acids have the potential for 
tridentate binding through the carboxylate oxygen, the amine nitrogen, and the S/Se atom  
in the side chain.  Table 1.4 summarizes the available data for stability constants of Cu(II) 
and Cu(I) with these amino acids; unsurprisingly, data for Cu(II) are much more complete 
than for Cu(I).  
 
Cu(II) Complexes of Sulfur- and Selenium-Containing Amino Acids 
 Thiol-containing cysteine, homocysteine, and penicillamine are redox-active in the 
presence of Cu(II), forming the respective disulfides and reducing Cu(II) to Cu(I).149,150 
This redox activity impacts the validity of stability constant determinations with these 
amino acids.  Although Cu(II)-Cys stability constants have been errantly reported,54 
previous reviewers50 have explained the misidentification of species present in these 
analyses, and Pinto151 suggested that these complexes are stable at ligand:metal ratios 
below one. The potential for redox reactions casts a shadow over the reliability of  
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Table 1.4. Stability constants of Cu(II) and Cu(I) with sulfur- and selenium-containing amino acids 
 
alog βML = [M][L]/[ML]    b log βML2 = [M][L2]/[ML2]    c Error not reported  
  
Cu(II) Stability Constants 
Ligand ML 
(log βML)a 
ML2 
(log βML2)b 
Other Species Temp 
(°C) 
Ionic Strength 
(M) 
Method Ref. 
Homocysteine 11.92(1) 13.54(2)  7.57(1) (MLOH) 25 0.1 KNO3 Potentiometry 151 
Methionine 7.85(2) 14.52(1)  25 0.1 KNO3 Potentiometry 
62,152,153 
Methylcysteine 7.65c 14.13c  25 0.2 KCl Potentiometry 154 
Methylselenocysteine 8.2(1) 14.5(2)  25 0.1 NaClO4 Potentiometry 155 
Penicillamine 16.5c 21.7c  25 0.15 KNO3 Potentiometry 156 
Selenomethionine 7.77c 14.50c  25 0.1 NaNO3 Potentiometry 157 
Cu(I) Stability Constants  
Cysteine 10.164(6) 18.36(1) 20.34(2) (ML3) 25 1.0 NaCl Potentiometry 158 
Methionine 9.1c   20 0.1 NaClO4 Potentiometry 12,159 
Penicillamine 12.41(5)  18.72(1) (MLH) 
22.29(2) (M2LH) 
34.44(1) (M2L2H) 
25 1.0 NaCl Potentiometry 158 
3
5
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Cu(II)-thiol stability constant data and emphasizes the need for proof of speciation in these 
systems. 
Pencillamine has the highest Cu(II) stability constants of the amino acids in Table 
1.4, forming Cu(Pen) (log β = 16.5) and [Cu(Pen)2]2- (log β2 = 21.7) species.156  The high 
affinity of penicillamine for Cu(II) is not surprising, since a primary use of penicillamine  
is as a copper chelator. Of the other sulfur and selenium amino acids examined, the thiol-
containing homocysteine has a higher MLspecies stability constant (11.92(1))151 than the 
others (~7.8), but the ML2 species is slightly less stable at 13.54(2) than the ML2 species 
of methionine, methylcysteine, and selenomethionine. Pinto151 suggested that the amine 
and the soft thiolate of homocysteine binds borderline Cu(II) in the ML species, either in 
addition to the hard carboxylate oxygen or in place of it. This is reasonable, since EPR 
analysis of [Cu(hCys)2]
2- indicates tetrahedral geometry around Cu(II), with the thiolate 
sulfur replacing carboxylate oxygen binding.151 The [Cu(HhCys)] species has a 
significantly higher stability constant than the thio- or selenoethers, potentially indicating 
stability afforded by tridentate binding. When sterically hindered by a second ligand 
coordinating in the ML2 species, the carboxylate oxygen coordination may be lost, and the 
two ligands likely coordinate in a bidentate fashion through the amine nitrogen and thiolate 
sulfur atoms. 151 
The presence of a thioether or selenoether group does not contribute to 
thermodynamic stability of Cu(II) complexes, since stability constants for Cu(II) with 
methionine, methylcysteine, and selenomethionine are similar to those of the bidentate-
coordinating Cu(II)-amino acids in Table 1.2. Solid-state structures also show no thioether 
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or selenoether coordination in the ML2 complexes, including Cu(Met)2,
160,161 
Cu(SeMet)2,
155 and Cu(MCys)2,
162 but tridentate binding to Co(III)163,164 and softer metal 
ions such as rhenium165 and ruthenium166,167 is observed.  
 
Cu(II) Complexes of Sulfur- and Selenium-Containing Amino Acids 
 Stability constants for Cu(I) with sulfur and selenium amino acids are limited to 
two thiolates (Cys and Pen), only one thioether (Met), and no selenium-containing species 
(Table 1.4). This paucity of data makes evaluation difficult, as does the fact that the Cu(I)-
Met results159 have not been replicated in sixty years, and no other Cu(I) stability constants 
have been reported under these conditions. If these results are valid, only the CuI(Met) 
species has a higher stability constant (log  = 9.1) than the analogous Cu(II) species, 
[CuII(Met)]+ (log  = 7.85(1)).62 The higher stability of the Cu(I) complex may suggest 
tridentate binding, or at least a different binding mode than the glycine-like coordination 
of the [CuII(Met)]+ species. No X-ray diffraction structures are reported for CuI(Met), but 
X-ray absorption spectroscopy studies supported by NMR results in aqueous solution 
indicate Cu(I) coordination by the thioether sulfur and the amine nitrogen atoms in a 
bidentate fashion.168  
Cu(I)-Cys is one of the most thoroughly investigated Cu(I) systems, with stability 
constant determination attempted using at least four different methods with vastly different 
results. Using polargraphic methods, only the ML species was identified with a stability 
constant of 19.19.169 By spectrophotometry, the stability constant for the same ML species 
was reported as 11.38.170 In a review, Berthon50 highlighted the inconsistencies between 
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these two reports, attributing the difference to interference by NH3 or redox issues in the 
polargraphic determinations. More recently, Konigsberger158 attempted to determine 
Cu(I)-Cys stability constants in a ternary system using potentiometric analyses with 
penicillamine. Although penacillamine addition may expand the solubility range of the 
system beyond pH 5.2, it adds multiple species into an already complicated model.  Four 
different species were reported to form throughout the full pH range, including species with 
multiple cysteine protonation states and three dinuclear species. Polynuclear copper-
thiolate complexes are well known, but suggesting the formation of multiple dinuclear 
species based on model fit alone is insufficient support. Adding to this complexity, kinetics 
analyses suggest a dinuclear, mixed-valent Cu(II)/+-cysteine complex also may form as an 
intermediate between the ML and ML2 species.
171  
 Similar to Cys coordination, the Cu(I)-penicillamine system has also been 
extensively studied,158,171-173 with no agreement on either the stability constants or species 
present (Table 1.5). Again, the tendency of Cu(I) to form dinuclear and polynuclear 
complexes significantly complicates species determination. Most notably, Persson and 
coworkers172 determined stability constants of 39.18 and 101.5 for the [Cu(PenH)2]
- and 
[Cu5Pen4]
3- species, respectively, high values that indicate penicillamine strongly stabilizes 
Cu(I).  
To explore differences in speciation between Cu(I) and Cu(II) in the presence of 
penicillamine, a model of the speciation of copper (100 μM) with penicillamine (1000 mM) 
was calculated using Geochemist’s Workbench174 using the stability constants and species 
reported by Persson.172 Below pH 5, Cu(I) hydrolysis species predominate  
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Table 1.5. Speciation and stability constants for Cu(I) with penicillamine (Pen) 
Species log β Ionic Strength Temp(˚C) Method Ref. 
Cu(Pen) 10.470(6) 1 M NaCl 25 Potentiometry 158 
Cu(PenH) 18.46(1)     
Cu2(PenH) 20.48(1)     
Cu(Pen) 12.25(2) 1 M NaCl 25 Potentiometry 173 
Cu(PenH) 18.34(1)     
Cu(Pen)2 15.44(3)     
Cu4(Pen)3 49.15(7)     
Cu(Pen)2H2 39.18 0.5 M NaClO4 25 Potentiometry 172 
Cu5(Pen)4 101.5     
 
(Figure 1.8A). As the pH increases and the thiolate of penicillamine deprotonates, 
formation of Cu(II)- and Cu(I)-Pen species increases, but the Cu(II) species are the more 
prevalent species, by a factor of 100. As the electrochemical potential decreases, Cu(I)-Pen 
species are stabilized (Figure 1.8B). 
 Copper binding to selenium-containing amino acids is vastly understudied 
compared to their sulfur analogs. Data for the Cu(II)-SeMet system are reported, with 
stability constants of 7.77 and 14.50 for the ML and ML2 species, respectively. The Cu(II)- 
MeSeCys stability constants have been recently determined,155 and are consistent with the 
other thio- and selenoether amino acids with stability constants of 8.2(1) and 14.5(2) for 
the ML and ML2 species, respectively. Because these stability constants are similar to those 
of Cu(II) with methionine and to those for the bidentate-binding amino acids in Table 1.2, 
Cu(II) likely binds selenomethionine and methylselenocysteine in a glycine-like manner. 
No data could be found for other selenoamino acids such as selenocysteine. Selenocysteine 
is highly redox sensitive,175 but stability constants with  
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Figure 1.8. A) Speciation comparison between Cu(II) and Cu(I) complexes of penicillamine at a 10:1 ligand-
to-metal ratio, showing the favorable stability of Cu(II) over Cu(I) complexes. B) As the electrochemical 
potential decreases, Cu(I) complexes increase in stability. 
 
copper would contribute to the greater body of knowledge regarding selenium species 
incorporated into metalloproteins.   
 
Challenges in Determining Copper Stability Constants with Sulfur- and Selenium-
Containing Amino Acids   
 For the vast majority of Cu(II)-amino acid complexes, potentiometric analyses 
indicate formation of ML and ML2 species with stability constants of approximately 8 and 
14, respectively. Only histidine, glutamic acid, and penicillamine stability constants are 
high enough to suggest tridentate or partially tridentate Cu(II) coordination in the ML 
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species. In general, stability of glycine-like amino acid binding to Cu(II) is greater than to 
Cu(I), although increased stability constants suggest that thiols, thioethers, and 
selenoethers coordinate Cu(I) through the sulfur or selenium, either in addition to or in 
place of the carboxylate oxygen. The difficulties in controlling the redox chemistry of Cu(I) 
with thiols and selenols has discouraged researchers from pursuing the determination of 
these stability constants with Cu(I). For both Cu(I) and Cu(II), formation of a variety of 
multinuclear species with sulfur and selenium amino acids also significantly hinders 
stability constant analysis and interpretation. 
 
1.9  Stability Constants of Non-Sulfur and -Selenium-Containing Amino Acids  
with Fe(II) 
 Labile Fe(II) pools contribute to reactive oxygen species formation and cellular 
oxidative stress,176 and iron interactions with low-molecular-weight species such as amino 
acids may alter this behavior. Although not as robust as Cu(II) due to its tendency to form 
Fe(III) in the presence of oxygen, Fe(II) is fairly well-behaved in closed reaction vessels 
or under an inert atmosphere of nitrogen or argon. Hydrolysis constants of Fe(II) ([FeOH]+ 
log  = -9.5 and Fe(OH)2 log  = -20.5)177 are low enough to be a factor only at high pH 
and/or high metal-to-ligand ratios. Since Fe(II) is spectrophotometrically inactive, similar 
to Cu(I), most stability constant measurements with this ion are performed using 
potentiometric methods.  
 Stability constants have been determined for most amino acids with Fe(II); 
however, a majority of these data are individual analyses, making accuracy evaluation 
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difficult. For some amino acids, only one stability constant for either the ML or ML2 
species is reported, with little analysis or attempts to identify minor species. Because all 
the Fe(II)-amino-acid stability constants were determined using potentiometric analysis, 
comparisons to other methods are not possible.  
 
Fe(II) Complexes of Potentially Bidentate Amino Acids 
 Similar to Cu(II), Fe(II) stability constants with bidentate-coordinating amino acids 
all fall within one log unit of each other (3.39 to 4.13 for the ML species, and 7.1 to 8.3 for 
the ML2 species; Table 1.6). Glycine, with the relatively low log β values of 4.13 and 7.65 
for the ML and ML2 species, respectively, forms the most stable Fe(II)-amino acid 
species.66 Proof of speciation and details about coordination environment are scarce for 
these potentially bidentate Fe(II)-amino-acid complexes, since Fe(Pro)2(phenanthroline) 
(Figure 1.9) is the only reported Fe(II) structure with any single amino acid ligand.178 In 
this complex, Fe(II) is coordinated in distorted octahedral geometry, with both bidentate 
Pro ligands coordinating through the amine nitrogen and carboxylate oxygen atoms.  Given 
the similarity of ML2 stability constants for Fe(II) binding to all the potentially bidentate 
amino acids, it is reasonable to assume similar amine and carboxylate coordination for all 
the amino acids in Table 1.6.  
 A single study identifies ML3 species for phenylalanine and tryptophan with log β 
values of 10.7(2) and ~9.5, respectively.179 Fe(II) binding to a third amino acid must out-
compete formation of the [FeOH]+ and Fe(OH)2 species, the latter of which has limited 
solubility. If all three ligands of the ML3 species bind in a bidentate fashion, they are almost 
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certainly arranged in octahedral geometry around the Fe(II) center. Both Phe and Trp have 
aromatic side chains that would result in considerable steric encumbrance to the complex. 
The predictable stepwise formation constants (log K1 = 3.74, log K2 = 3.45, and log K3 = 
3.5) suggests there is no enthalpic penalty due to increasing coordination, and the reported 
potentiometric results are supported by calorimetry measurements.179 In all cases, the 
stability constants for the [FeL]+ and FeL2 species are extremely weak and indicate that 
high ligand-to-metal concentrations are required for complex formation. 
 
Table 1.6. Stability constants of Fe(II) and Fe(III) with potentially bidentate amino acids 
Stability Constants of Fe(II) 
Ligand ML 
(log β)a 
ML2 
(log 
β2)b 
ML3 
(log 
β3)c 
Temp 
(°C) 
Ionic 
Strength 
(M) 
Method Ref. 
Alanine 3.54d   20 1.0 KCl Potentiometry 180 
Glycine 4.13d 7.65d  25 0.1 KNO3 Potentiometry 66 
Leucine 3.42d   20 1.0 KCl Potentiometry 180 
Phenylalanine 3.74(1) 7.19(3) 10.7(2) 25 3.0 NaClO4 Potentiometry 179 
Proline  8.3d  20 0.01e Potentiometry 181 
Tryptophan 3.92d 7.39d ~9.5d 25 3.0 NaClO4 Potentiometry 179 
Valine 3.39d   20 1.0 KCl Potentiometry 180 
Stability Constants of Fe(III) 
Alanine 10.98d   30 1.0 KCl Polarography 182 
Glycine 10d   25 1.0 NaClO4 Redox 159 
Leucine 9.9d   20 1.0 NaClO4 Redox 159 
Phenylalanine 10.39(4) 19.1(1) 26.0(7) 25 3.0 NaClO4 Potentiometryf 179 
Proline 10.0(3)   20 1.0 NaClO4 Potentiometry  
Tryptophan 9.0d   20 1.0 NaClO4 Redox 159 
Valine 9.6d   20 1.0 NaClO4 Redox 159 
a log β = [M][L]/[ML]    b log β2 = [M][L2]/[ML2]    c log β3 = [M][L3]/[ML3]    d No error reported by 
author. e The identity of the electrolyte was not reported; titrations were run at approximately 0.01 M ligand. 
f Data also supported by calorimetry.   
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Figure 1.9. Solid-state structure of Fe(Pro)2(phenanthroline),178 showing bidentate Pro coordination through 
the carboxylate oxygen and the amine nitrogen atoms. Fe(II) is shown in orange, oxygen atoms are red, 
carbon atoms are grey, and nitrogen atoms are blue.   
Fe(II) Complexes of Potentially Tridentate Amino Acids 
 As for the bidentate amino acids, stability constant data for potentially tridentate 
amino acids binding Fe(II) are incomplete. Most of the stability constants for ML (3.20-
4.37) and ML2 complexes of these amino acids are similar to those for the bidentate amino 
acids, consistent with glycine-like binding to Fe(II) without significant stability contributed 
by the polar side chain. Many of the reported constants have not been replicated or 
independently confirmed by other methods. 
Histidine and aspartic acid have somewhat higher stability constants (5.88 and 5.34 
for the ML species and 10.43 and 8.57 for the ML2 species, respectively) than the majority 
of the other potentially tridentate amino acids, suggesting possible tridentate binding or 
Fe(II) stabilization through bridging ligands. ML3 stability constants are determined for 
asparagine183 and serine,184 further supporting bidentate coordination of these amino acids, 
at a maximum. It is surprising that minor species have not been  
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Table 1.7. Stability constants of Fe(II) and Fe(III) with potentially tridentate amino acids 
 
 
 
 
 
 
 
 
 
 
 
a log β = [M][L]/[ML]    b log β2 = [M][L2]/[ML2]    c log β3 = [M][L3]/[ML3]    dNo error reported by author. e No supporting  
electrolyte was reported. Titrations were run at approximately 0.01 M ligand.   
Stability Constants of Fe(II) 
Ligand ML 
(log βML )a 
ML2 
(log βML2)b 
ML3 
(log βML3)c 
Temp 
(°C) 
Ionic Strength 
(M) 
Method Ref. 
Arginine 3.20d   20 0.01e Potentiometry 99 
Asparagine 4.37(3) 7.57(3) 10.26(5) 25 3.0 NaClO4 Potentiometry 183 
Aspartic acid 5.34d 8.57d  25 0.1e Potentiometry 185 
Glutamic acid 3.50d   20 1.0 KCl Potentiometry 180 
Histidine 5.88d 10.43d  25 3.0 NaClO4 Potentiometry 186 
Lysine 4.5d   20 0.01e Potentiometry 99 
Serine 4.299d 7.377d 10.299d 20 3.0 NaClO4 Potentiometry 184 
Threonine 3.69d 6.50d  40 0.2 KNO3 Potentiometry 187 
Tyrosine  7.1d  20 0.01e Potentiometry  181 
Stability Constants of Fe(III) 
Arginine 8.7(3)   20 1.0 NaClO4 Potentiometry 159 
Asparagine 8.6(1)   20 1.0 NaClO4 Potentiometry 159 
Aspartic acid 11.4(3)   20 1.0 NaClO4 Potentiometry 159 
Glutamic acid 13.39d   20 1.0 NaClO4 Potentiometry 188 
Histidine 4.7(4)   20 1.0 NaClO4 Potentiometry 159 
Serine 9.2(4)   20 1.0 NaClO4 Potentiometry 159 
Threonine 8.6(3)   20 1.0  NaClO4 Potentiometry 159 
4
5
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identified in the low pH range for these iron-amino acid systems, but the stability of iron 
hydrolysis species above pH 7 outcompetes weakly binding amino acid ligands. Fe(II) 
stability constants with the majority of the potentially bidentate and tridentate amino acids 
are fairly consistent: ML stability constants are approximately 3-4; ML2 stability constants 
are approximately 7; and the few ML3 stability constants reported are approximately 10. 
Extrapolating from scarce structural and supporting speciation data, it is likely that most 
amino acids coordinate Fe(II) in a bidentate fashion through the carboxylate oxygen and 
amine nitrogen atoms.  Aspartic acid and histidine have somewhat higher stability 
constants for the ML (5.88 and 5.32, respectively) and ML2 (10.43 and 8.57, respectively) 
species, suggesting that the His and Asp side chains participate significantly in 
coordination. 
 
Challenges in Determining Fe(II)-Amino Acid Stability Constants 
  Although stability constants of divalent metals with amino acids have been the 
focus of a few comprehensive studies,99,180,181,187 most Fe(II) amino acid stability constants 
are limited to these few studies with little speciation analysis. The majority of the published 
data were obtained using potentiometric titrations. Although Fe(II) salts are water soluble, 
Fe(II) oxidizes to Fe(III) in air, so oxygen-free conditions must be employed. This air 
sensitivity limits analysis techniques to methods that can be performed in a glove box or in 
closed cells. Fe(II) also forms hydrolysis compounds above pH 7. Although these 
complexes are not as stable as Fe(III) hydrolysis products, they do compete with amino 
acids for metal binding in the upper pH range. Fe(II) is also spectrochemically inactive, 
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like Cu(I), and therefore not an option for spectrophotometric techniques with non-UV-
active amino acids. As a whole, these issues have limited the data availability for Fe(II) 
with amino acids. 
 
Comparison of Cu(II) and Fe(II) Stability Constants of Non-Sulfur and-Selenium-
Containing Amino Acids 
 Cu(II) and Fe(II) have the same valency and are both considered borderline Lewis 
acids; both also have the potential to coordinate ligands in octahedral geometry. However, 
stability constants of Cu(II) and Fe(II) with amino acids are significantly different, with 
Cu(II)-amino acid complexes significantly more stable than analogous Fe(II)-complexes. 
With ML constants of approximately 9 for [CuL]+ species (Table 1.3) and between 3 and 
4 for most of the [FeL]+ complexes (Table 1.7), all of the non-sulfur- and non-selenium-
containing amino acids show a higher affinity for the Cu(II) ion. A similar comparison can 
be made for CuL2 and FeL2 species with stability constants of ~14 and 7-8, respectively. 
With Cu(II), only His (ML log  = 9.75(1), ML2 log  = 17.49(1)) Asp (ML log  = 8.83, 
ML2 log  =15.93(2)), and Glu (ML log  = 8.30(4), ML2 log  = 15.03(3)) have large 
enough stability constants to suggest the potential for tridentate coordination. With Fe(II), 
stability constants with His (ML log  = 5.88, ML2 log  = 10.43) and Asp (ML log  = 
5.34, ML2 log  = 8.57) are somewhat elevated compared to bidentate-binding amino acids 
but are still considerably lower than stability constants with Cu(II).  
 Although solid-state structural data supports tridentate His coordination in Cu(His)2 
(Figure 1.5), no comparable Fe(II) structures exist to show tridentate amino acid 
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coordination. His and Asp may be tridentate ligands binding Fe(II) through the amine, 
carboxylate, and side-chain N or O atoms or, alternatively, adopt bidentate coordination 
through the N or O atom of the side chain and either the amine nitrogen or carboxylate 
oxygen atom.  Regardless of coordination mode, the stability of Fe(II) with non-sulfur- or 
selenium amino acids is significantly weaker than Cu(II) and therefore less biologically 
significant. 
 
1.10  Stability Constants of Non-Sulfur and –Selenium-Containing Amino Acids with 
Fe(III) 
 Most Fe(III) in the cell is sequestered in ferritin storage as ferrihydrite,189 although 
Fe(III) also exists in the mitochondria.32 Fe(III) does not generate hydroxyl radical as does 
Fe(II), and it is poorly soluble and therefore not readily available in the aqueous 
environment of a cell. Poor Fe(III) solubility, due to the stability of the hydrolysis species, 
also contributes to a deficit of Fe(III) stability constants with amino acids, since it restricts 
the use of potentiometric titrations to a very narrow pH range. The Fe(III) stability 
constants reported in Table 1.7 were measured below pH 5.159  
 
Fe(III) Complexes of Potentially Bidentate and Tridentate Amino Acids 
 For most amino acids, regardless of potential denticity, Fe(III) stability constants 
for only the ML species have been quantified (Table 1.7) with the exception of a single 
study by Williams.184 Many of these constants were determined using redox measurements 
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in one 1958 report by Perrin,159 and the lack of precision inherent to the redox method is 
reflected in the reported values. 
 Stability constants for the ML species of Fe(III) and a majority of the amino acids 
are consistently in the 8-10 range (Tables 1.6 and 1.7). Notable exceptions to this trend are 
glutamic acid, with a higher ML stability constant of 13.39, and histidine, with a lower ML 
stability constant of 4.7(4), respectively. The considerably higher Fe(III)-Glu stability 
constant was determined under different experimental conditions188 compared to most of 
the other amino acids, but these experimental differences would not explain such a 
significant disparity. The considerably lower stability constant for the [FeIII(His)]+ seems 
to indicate that His coordination does not greatly stabilize Fe(III). In contrast, the only 
solid-state structure of Fe(III) with an amino acid incorporates histidine in a tridentate 
coordination mode: an oxo-bridged, binuclear complex, Fe2(His)2(biphenyl)2(μ-O) (Figure 
1.10). Although this complex was not crystallized out of aqueous solution, it indicates that 
histidine is certainly capable of tridentate coordination to Fe(III).  
 
Determining Fe(III) Stability Constants Using the Solubility Method 
One method that has not been discussed thus far but has been used in environmental 
chemistry for determining Fe(III) stability constants is the solubility method. With this 
technique, insoluble metal ions are slowly dissolved by complex formation with an 
aqueous-phase ligand. The concentration of the soluble complex can then be determined 
through methods such as inductively-coupled-plasma mass spectrometry or scintillation  
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Figure 1.10. Solid-state structure of Fe2(His)2(biphenyl)2(μ-O), showing tridentate coordination of histidine 
through a nitrogen atom of the imidazole side chain as well as the carboxylate oxygen and amine nitrogen 
atoms. The Fe(III) ion is shown in orange, oxygen atoms are red, carbon atoms are grey, and nitrogen atoms 
are blue.   
 
techniques with radioisotopes. By varying the ratio of ligand to metal, a continuous plot 
can be derived to track mass transfer from solid state to aqueous solution. Due to the 
extreme insolubility and stability of Fe(III) hydrolysis products, the solubility method is an 
optimal tool for stability constant determination in this system. In this method, competition 
for the Fe(III) is measured through the addition of increasing concentration of ligand to a 
suspension of Fe(OH)3. The amount of complex is then determined by the measurement of 
pH and Fe(III) in solution. This method is by no means the easiest or the fastest, but it may 
overcome the difficulties inherent in using most other methods for Fe(III) stability constant 
determination due to the highly insoluble Fe(III) hydrolysis species.  
A model Fe(III) solubility experiment was calculated using Geochemist 
Workbench using low, moderate, and high amino acid stability constant values with Fe(III) 
as exemplified by Met, Glu, and Phe.159,179,188 In this model, amino acid concentrations are 
increased until the Fe(III)-amino-acid species out-compete the insoluble iron-hydrolysis 
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species. In Figure 1.11A, a complex forming with a stability constant of  9.1, the same as 
for [Fe(Met)]2+ and comparable to most of the other ML species reported by Perrin,159,180 
has very little ability to dissolve the solid ferric hydrolysis species to form [Fe(Met)]2+ in 
aqueous solution. Increasing the stability constant by four log units to 13.39, as reported 
for [Fe(Glu)]+,188 significantly increases the amount of Fe(III) dissolved in solution (Figure 
1.11B).  
Utilizing the only multi-species data reported for Fe(III) complexes with non-sulfur 
or selenoamino acids, [Fe(Phe)]2+, [Fe(Phe)2]
+, and Fe(Phe)3 species with stability 
constants of 10.39(4), 19.1(1), and 26.0(7), respectively,179 results in a significantly higher 
amount of dissolved Fe(III) (Figure 1.11C) compared to that in the Fe(III)-Met and Fe(III)-
Glu systems (Figures 11A and 11B). It is entirely possible that multiple species form in all 
of the Fe(III)-amino acid systems, but identification of these species may be hindered by 
low-pH precipitation of iron hydrolysis species in the potentiometric and redox titrations. 
Solubility titrations could provide insight into formation of additional species in these 
systems, although this method is limited by the aqueous solubility of the resulting Fe(III)-
amino acid complexes. It is reasonable to expect, however, that even low-solubility 
complexes would remain in solution at the extremely low total iron concentrations found 
in these modeled systems (pM to nM range). Thus, solubility titrations represent a viable 
but almost unexplored method for Fe(III) stability constant determination. 
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1.11  Stability Constants of Sulfur- and Selenium-Containing Amino Acids  
with Iron 
 Sulfur-containing metalloproteins such as rubredoxins, ferredoxins, and 
hemerythrin  play a crucial role in electron transfer through iron-sulfur interactions.130 
Despite their biological importance, Fe(II) and Fe(III) stability constant determinations 
with sulfur- and selenium containing amino acids are so limited, it is difficult to assess the 
viability of the experimental results or to identify trends.  
 
 
Figure 1.11. Modeled solubility method data for Fe(III) complexes with A) methionine (ML log  = 9.1),180 
B) glutamate (ML log  = 13.39),190 and C) phenylalanine (ML log  = 10.39, ML2 log  = 19.11, and ML3 
log  = 26).179 Comparing graphs A and B shows the effect a change in log β by 4 log units has on ferrihydrite 
solubility. Comparing graphs B and C shows the significant effects of higher stability constants and multiple 
species on aqueous Fe(III) solubility 
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Fe(II) Complexes of Sulfur- and Selenium-Containing Amino Acids 
 In contrast to Cu(II), stability constants of thioether- and selenoether-containing 
amino acids with Fe(II) are extremely low: 3.2 to 3.9 for the [FeL]+ species (Table 1.8). 
These constants are consistent with those of Fe(II)-amino-acid species with bidentate 
binding (Table 1.6), suggesting at most bidentate coordination and perhaps only amine or 
carboxylate binding. Thus, it is unlikely that the thio- or selenoether S or Se atom plays a 
significant role in Fe(II) coordination. Based on limited data, the selenoether-containing 
amino acids have slightly higher stability constants with Fe(II) than analogous thioether 
amino acids, although two data points (Met/SeMet and MeCys/MeSeCys) do not 
necessarily make a trend.  
 In contrast, Fe(II) stability constants with the thiol-containing amino acids Cys and 
Pen are significantly higher. Interestingly, these Cys and Pen stability constants are similar 
to those of bidentate Cu(II)-amino acid complexes (Table 1.2), potentially indicating a 
different coordination mode, possibly through the thiolate and amine groups, rather than 
tridentate binding. Studies to confirm coordination modes for these amino acids have not 
been performed, and there are no reported Fe(II) stability constants for selenol-containing 
amino acids. The lack of independent characterization of the species identified in these 
stability constant studies provides only a very indirect understanding of these coordination 
complexes.  
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Fe(III) Complexes of Sulfur- and Selenium-Containing Amino Acids 
 Only a handful of stability constant determinations with Fe(III) and sulfur amino 
acids have been reported, and none are reported for selenoamino acids. A variety of 
methods have been used for the few reported analyses, including potentiometric 
titrations,181,191 paper electrophoresis,192 and redox methods.180 Where comparisons can be 
made, the data conflict. For the Fe(III)-Met system, Tewari85 used paper electrophoresis to 
identify two different species [Fe(Met)]2+ and [Fe(Met)2]
+ with stability constants of 
7.95(7) and 12.65(6), respectively (Table 1.8). In contrast, a 1958 study by Perrin and 
coworkers159 reported a stability constant of 9.1 for the [Fe(Met)]2+ species using 
potentiometric methods. Due to the limited competition of methionine binding with 
formation of Fe(III) hydrolysis products (Figure 1.11), it is not surprising that a ML2 
stability constant was not determined using this method. While paper electrophoresis is 
limited to low pH (1-4) to maintain solubility, this method promotes separation of species 
through electrophoresis, directly establishing the number of species formed. 
 The thiol-containing amino acids cysteine and penicillamine have Fe(III) stability 
constants in the 10.8-11.3 range for the [ML]+ species, significantly higher than those with 
thioether-containing amino acids.  Thus, it is reasonable to assume that in aqueous solution, 
Cys and Pen interact with Fe(III) through tridentate coordination of the thiolate sulfur, 
amine nitrogen, and carboxylate oxygen atoms. This binding mode is supported by the 
solid-state structure of Th[Fe(Pen)2], an [Fe
III(Pen)2]
- complex with a Th+ counterion  
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Table 1.8. Stability constants of Fe(II) and Fe(III) with sulfur- and selenium-containing amino acids 
Fe(II) Stability Constants 
Ligand ML 
(log β)a 
ML2 
(log β2)b 
Temp 
(°C) 
Ionic Strength 
(M) 
Method Ref. 
Cysteine 6.69(2) 11.90(3) 20 0.1 NaClO4 Potentiometry 191 
Methionine 3.24c  20 1.0 KCl Potentiometry 159 
Methylcysteine 3.49(4)  25 0.1 NaCl Potentiometry 155 
Methylselenocysteine 3.84(1)  25 0.1 NaCl Potentiometry 155 
Penicillamine 7.58(1) 13.74(2) 20 0.1 NaClO4 Potentiometry 191 
Selenomethionine 3.51(7)  25 0.1 NaCl Potentiometry 155 
Fe(III) Stability Constants 
Cysteine 10.85c 14.49c 20 0.15 KNO3 Potentiometry 193 
Methionine 9.1c  20 1.0 NaClO4 Redox 159 
Methylcysteine 8.37(5) 13.92(1) 25 0.1 M KNO3 Electrophoresis 192 
Penicillamine 11.27c 16.25c 20 0.15 KNO3 Potentiometry 193 
a log β = [M][L]/[ML]    b log β2 = [M][L2]/[ML2]    cNo error reported. 55
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Figure 1.12. Solid-state structure for Th[Fe(Pen)2]. Hydrogen atoms are omitted for clarity. The Fe(II) ion 
is shown in orange, oxygen atoms are red, carbon atoms are grey, nitrogen atoms are blue, and the sulfur 
atoms are yellow.  Counterion and hydrogen atoms are omitted for clarity. 
 
(Figure 1.12).194 Both Pen ligands bind in tridentate fashion to Fe(III), with bond angles 
closer to trigonal bipyrimidal than octahedral geometry. 
 
Challenges in Determining Iron Stability Constants with Sulfur- and Selenium-Containing 
Amino Acids 
 Determination of iron stability constants with sulfur- and selenium-containing 
amino acids is plagued by issues common to Fe(II) and Fe(III) titrations with any amino 
acid. With Fe(II), experiments must be conducted in oxygen-controlled environments, UV-
visible analyses are limited to spectrochemically active ligands, and potentiometric 
analyses are limited above pH 7. Fe(III) stability constant determinations with weakly 
binding ligands are even more limited due to the high stability of Fe(III) hydroxide species.  
 In addition to these problems, cysteine and pencilliamine are also redox-active with 
Fe(III).195,196 Although Fe(III) stability constants are reported for these amino acids, 
conditions must be tightly controlled and data misinterpretation is not uncommon. 
Sisley’s196 kinetic analysis of the interaction of redox-active metals, including iron, with 
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these thiol-containing amino acids is detailed and specific. Due to these significant 
limitations, few analyses are reported and stability constant values can vary depending on 
experimental methods and conditions for these sensitive systems. 
 
Comparison of Copper and Iron Stability Constant Determinations with Sulfur- and 
Selenium-Containing Amino Acids 
 The most complete stability constant data with Cu(II), Cu(I), Fe(II), and Fe(III) 
exists for the thiol-containing amino acids cysteine and penicillamine. Cu(II)-penicillamine 
complexes are extremely stable with log β values of 16.5 and 21.7 for the ML and ML2 
species, respectively156 (Table 1.4). The stepwise log K values for these constants, 16.5 for 
ML and 5.2 for ML2, suggest that Pen may coordinate Cu(II) as a tridentate ligand in the 
ML species. The significantly lower stability increase upon adding a second Pen ligand 
suggests that the second ligand may have only mono- or bidentate binding. Mixed 
tridentate and bidentate amino acid-Cu(II) complexes are structurally characterized,105-107 
and rhenium-bound penicillamine adopts a structure where the two Pen ligands coordinate 
in tridentate and bidentate fashion simultaneously.197 Fe(II)-Pen stability constants are 
significantly lower than the analogous Cu(II) species (7.58(1) and 13.74(2) for the ML and 
ML2 species, respectively;
191 Table 1.8) but significantly higher than stability constants of 
other Fe(II)-amino acid complexes (except Cys).  These lower stability constants are most 
consistent with bidentate coordination. 
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 A comparison of stability constants for Cu(I), Fe(II), and Fe(III) with cysteine is 
somewhat surprising (Tables 4 and 8). Cu(I) and Fe(III) have similar ML stability constants 
of 10.164(6) and 10.85, respectively, but similar Fe(II) values are lower at 6.69(2).158,191,193 
This trend is slightly surprising since Cu(I) is significantly softer than Fe(III), with Fe(II) 
and Cu(II) falling in between. Comparing the ML2 stability constants, the Cu(I)-Cys 
species has a considerably higher stability of 18.36(1), as compared to 14.49 with Fe(III) 
and 11.90(3) with Fe(II). Perhaps this unexpected trend can be attributed to cysteine 
binding all of the metal ions in a tridentate fashion, but the relative Lewis acidity of the 
coordinating ligand atoms is also mixed, with hard carboxylate and amine group and a 
relatively soft thiolate group. It should be noted that Pen stability constants exhibit the same 
trends, with the Cu(II) species having the greatest stability compared to the other ions. 
 The thioether-containing methionine is the only other sulfur- or selenium-
containing amino acid with analyses reported for Cu(II), Cu(I), Fe(II), and Fe(III). Cu(II)-
Met stability constants of 7.82(2) and 14.52(1)  for the ML and ML2 species, respectively, 
are well-supported by a variety of authors62,152,153 and are consistent with results obtained 
for other amino acids with aliphatic side chains (Table 1.1). Methionine stability constants 
with Cu(I), Fe(II), and Fe(III) were reported in a single 1958 study by Perrin,159 making 
comparisons questionable. Met binding does not provide added stability compared to 
amino acids with non-coordinating side chains, suggesting that the thioether sulfur atom 
does not bind in the ML or ML2 species, a result supported by solid-state structures.
160,161 
Assuming Perrin’s results are accurate, the same trend is observed for Met as for Cys and 
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Pen. Methionine binding to both Cu(I) and Fe(III) has higher stability for the ML species 
(log  = 9.1 for both) than for the Fe(II) species (log  = 3.24).  
Although Met and SeMet are also bidentate chelators of Cu(I), the soft sulfur or 
selenium atom coordinates Cu(I) in addition to the amine nitrogen, with no bonding of the 
carboxylate group. The best characterization has been obtained for the Cu(II)-Met and -
SeMet complexes, where IR and X-ray diffraction data support the bidentate coordination 
of the amine and carboxylate groups. Differing amino acid coordination modes likely 
change the measured stability constants, so evaluating trends across metals is not possible.  
 
1.12 Iron and Copper Coordination to Weakly Binding Ligands: Biological 
Relevance, Methods Development, and Outlook 
 With their similar structures and diversity of side-chain functional groups, amino 
acids are an ideal system for developing more accurate methods to determine metal stability 
constants with weakly binding ligands.  The four metal ions treated in this review, Cu(II), 
Cu(I), Fe(II), and Fe(III) also span the range between easy to examine (Cu(II)) and 
extremely difficult to study due to redox activity and insoluble hydrolysis products (Cu(I) 
and Fe(III)). Developing methods specifically designed to work around these issues, such 
as solubility titrations for Fe(III) stability constant measurements, would provide a 
substantial advance in this field and provide a foundation for stability constant 
determination for metal complexes with any weakly binding ligands. In addition, accurate 
determination of metal-amino-acid stability constants can then be used to model  
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Figure 1.13. Percent complex formation of the ML species for aqueous solutions containing 10 μM metal 
ion and 0-100 μM amino acid. Formation constants for the amino acid (AA) of 9.2 for HAA and 11.28 for 
H2AA were included to model a representative amino acid with amine and carboxylate protons. 
 
complex biological systems and predict competition concentrations that may be relevant 
for maintaining metal homeostasis or in instances of metal mis-regulation.67,79,139,158,198  
 Taking into account the biological concentrations of metals and amino acids, we 
can use established stability constants to predict the likelihood of complex formation in 
binary systems. For this model, only ML species were considered with static protonation 
constants of 9.2 and 11.2, corresponding to the approximate stability constants for the 
amine and carboxylate groups of amino acids with non-protonating side chains. Figure 
1.13A shows the percentage of complex formation as the amino acid ligand concentration 
varies from 1 M to 500 M, the typical range of blood amino acid concentrations (as 
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discussed in the Cellular Redox-Active Metal Ions and Amino Acids section), assuming 10 
M of available metal ion. Figure 1.13B shows complex formation for the amino acid range 
from 1-10 M, where the metal (10 M) is in excess of the ligand. Percent complex 
formation for these binary systems is predicted, depending on stability constants for the 
metal-amino-acid complexes.  
Most of the Cu(II)-amino-acid complexes have [ML] stability constants of at least 
7, indicating bidentate binding and resulting in approximately 40% to 70% of metal bound 
within a 1:1 to 1:10 ligand-to-metal ratio. For thiol-containing amino acids and histidine 
that have Cu(II) [ML] stability constants upward of 10, it would be expected that 90-100% 
of the metal ion would be coordinated to the amino acid, assuming a 1:1 or greater metal-
to-amino-acid ratio.  Ten-fold higher metal ion concentrations (100 M) with the same 
amino acid concentration range result in decreased complex formation compared to 10 M 
metal over the same stability constant range (Figure S1 in Supplementary Data). All of the 
limited number of Cu(I)-amino-acid stability constants are higher than the Cu(II) stability 
constants with the same amino acid, even for amino acids such as alanine and glycine that 
are only bidentate chelators. Thus, in the reducing cellular environment, it is reasonable to 
expect that available Cu(I) ions would likely be coordinated by free amino acids.  
On the other end of the spectrum, the Fe(II)-amino-acid stability constants for the 
[ML] species are very low, approximately 3-4. With these low stability constants, even at 
a 10:1 ligand-to-metal ratio, less than 10% of Fe(II) would be bound (Figure 1.13). With 
Fe(II), only cysteine and penicillamine with stability constants of 6.69 and 7.58, 
respectively, would form an appreciable amount of complex. Although Fe(III)-amino-acid 
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complexes have high enough stability constants (8-13) to expect amino acid coordination 
at the modeled concentrations, amino acids could not outcompete formation of Fe(III) 
hydrolysis products at reasonable biological pH ranges.  
From these simple models, it is evident that amino acids with higher stability 
constants will dominate complexation with labile metal ions. For Cu(I) and Cu(II), 
histidine, aspartic acid, cysteine, and penicillamine would out-compete other amino acid 
binding, as long as amino acid concentrations were relatively similar. For Fe(II) and 
Fe(III), cysteine and penicillamine coordination would dominate, neglecting Fe(III) 
hydrolysis. 
From this overview, it is evident that there is a need for more complete analyses of 
the redox active metals with sulfur- and selenium-containing amino acids. Although Cu(II) 
has been extensively studied, the other metal ions, Cu(I), Fe(II), and Fe(III) are just as 
biologically relevant and data are poor. Before beginning an amino acid stability constant 
study, it is important to understand the advantages and disadvantages of not just the 
methods used, but of the metal and ligands to be studied. Cu(II) is a robust ion with high 
solubility in aqueous systems and its stability constants with a wide variety of amino acids 
and other ligands have already been thoroughly examined. Using Cu(II) is ideal for new 
methods development, since the breadth of data available would provide dependable 
comparisons. Because it is a redox-active metal, the redox activity of the ligand must be 
considered when selecting experimental parameters. 
Cu(I) binds a variety of amino acids in metalloenzymes and also contributes to 
oxidative damage within the cell, if not controlled through cellular mechanisms and 
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complexation. Determining Cu(I) complex stabilities with available small molecules is a 
wide-open field with significant biological implications. Cu(I) is extremely difficult to 
work with due to redox activity, oxygen sensitivity, limited solubility, tendency for 
disproportiation, and lack of spectrochemical activity. There is much need for methods 
development for stability constant determination with this ion. Measuring stability in high 
ionic strength media may provide the best path forward for potentiometric analysis. Other 
methods, such as zero-current potentiometry and electrophoresis, under atmosphere-
controlled conditions, are worth developing and validating.  
Fe(II)- and Fe(III)-amino-acid stability constant data is also lacking. Since 
potentiometric analysis is not ideal due to low solubility of iron hydrolysis products, other 
methods need to be explored. The solubility method has the potential to open up the Fe(III) 
determinations, especially with mass spectrometry techniques capable of detecting and 
quantifying individual species.   
 Determining stability constants for copper and iron binding to sulfur and selenium 
amino acids is also critical for understanding biological systems.  Sulfur amino acids are 
required for maintaining cellular redox balance, and modeling studies indicate that these 
amino acids may bind both iron and copper. Selenoamino acids and related species have 
been implicated in cancer prevention and as antioxidants to prevent metal-mediated 
oxidative damage, yet selenium speciation and interaction with biometals is thoroughly 
underexplored and requires more dedicated study.  
 “The difficulty lies not so much in developing new ideas as in escaping from old 
ones” (John Maynard Keynes). One of the primary difficulties with this field is that the 
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easiest systems have been thoroughly studied, but the more problematic ones only have 
single analyses or no data at all. Revisiting some of the analyses that were performed 50 
years ago and using and/or developing new methods to confirm these results and continue 
the study of weakly binding ligands is worth exploring. Understanding and predicting the 
interface between metal ions and small molecules can have far reaching effects into the 
efficacy of drug development and oxidative-damage prevention in biological systems. 
 Chapter 1 reviews amino acid stability constants with the redox-active metal ions 
Cu(I), Cu(II), Fe(II), and Fe(III). Although reviews of metal-amino-acid complexes have 
been published previously, they tend to be data-heavy and make it difficult to identify the 
most pertinent data. In addition, few reviews have focused significant attention on sulfur- 
and selenium-containing amino acids.  Chapter 1 is also intended to help elucidate the best 
methods to determine stability constants for each metal ion, based on solubility limitations 
and redox sensitivities.  
 The work in Chapter 2 focuses on the determination of stability constants for Cu(II) 
and Fe(II) with sulfur and selenium amino acids and identifies the species and most likely 
coordination modes for the complexes formed in these potentiometric titrations. [CuL]+ 
and CuL2 species, with stability constants of approximately 9 and 14, respectively, were 
determined for the amino acids glycine, methylcysteine, methionine, 
selenomethylcysteine, and selenomethionine. In all cases, only the amine nitrogen and the 
carboxylate oxygen atoms, but not the sulfur or selenium atom, are coordinated to Cu(II). 
For the same amino acids, the Fe(II) species [FeL]+ and FeLOH  were identified, with 
significantly lower stability constants of approximately 3 and -5, respectively. 
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Penicillamine, a thiol-containing amino acid, has significantly higher stability constants of 
approximately 7.5 and 14 for the FePen and [Fe(Pen)]2- species, due to direct coordination 
of the thiolate sulfur.  
 Reactions between copper and the thione methimazole, both redox-active species, 
are explored in Chapter 3. Cu(II) is reduced by methimazole to form Cu(I) and 
methimazole disulfide, and a wide variety of mono-, di-, and polynuclear copper complexes 
are formed with these two ligands. The effects of oxygen availability, oxidation states of 
the metal ion and ligand, and solvent on the reaction products is investigated. Under 
anaerobic conditions, the products favor direct coordination of Cu(I) with bridging and 
terminal methimazole ligands. In the presence of oxygen and water or methanol, sulfur 
extrusion from the oxidized methimazole ligand is favored.   Direct coordination of 
methimazole disulfide to Cu(I) without sulfur extrusion occurs under air-free conditions, 
but this product is produced in low yield. Based on these results, a mechanism for sulfur 
extrusion is proposed that incorporates copper coordination, oxidation by O2, and solvent 
reactivity. 
 In Chapter 4, the interactions of copper and methimazole explored in Chapter 3 are 
expanded to include the interactions of methimazole disulfides and diselenides with Cu(I). 
Dinuclear, mixed ligand Cu(I) complexes containing both reduced and oxidized 
methimazole or selenomethimazole ligands can be isolated, suggesting Cu(I)-mediated 
reversibility of disulfide or diselenide bond formation. When Cu(I) was treated with 
methimazole diselenide in air, two unusual products were crystallized from the same 
reaction solution. Selenium migration is observed in one complex, and reaction with the 
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dichloromethane solvent is observed in the other product. Methimazole and 
selenomethimazole show reversible redox reactivity and unique elimination and insertion 
reactions in the presence of copper. Sulfur- and selenium-containing amino acids and 
imidazole thiones and selones coordinate to softer metal ions, such as Cu(I), Cu(II), and 
Fe(II), and may have the potential to influence metal homeostasis, redox behavior, and 
biological activity of these ions.  
 
1.13  Supplementary Data   
 
 
Table 1.9. Parameters added to the visual Mintec database for Use with Geochemist Workbench  
to Generate the Fe(III) Solubility Models (Figure 1.11) and the Cu-penicillamine models (Figure 1.8) 
Species Reaction log β Reference 
[Fe(Met)]2+ Fe(III) + Met- ↔ [Fe(Met)]2+ 9.1 159 
[Fe(Glu)]+ Fe(III) + Glu2- ↔ [Fe(Glu)]+ 13.39 188 
[Fe(Phe)]2+ Fe(III) + Phe- ↔ [Fe(Phe)]2+ 10.39 179 
[Fe(Phe)2]+ Fe(III) + 2 Phe- ↔ [Fe(Phe)2]+ 19.11 179 
Fe(Phe)3 Fe(III) + 3 Phe- ↔ Fe(Phe)3 26 179 
[Cu(HPen)2]3- Cu(I) + 2 HPen2- ↔ [Cu(HPen)2]3- 39.18 172 
[Cu5Pen4]3- 5 Cu(I) + 4 Pen3- ↔ [Cu5Pen4]3- 101.5 172 
   
 
 
Figure 1.14. Percent complex formation for solutions containing 100 μM metal ion and 100-500 μM amino 
acid for the formation of the ML species. Formation constants for the amino acid (AA) of 9.2 for HAA and 
11.28 for H2AA were included in the modeling as a representative amino acid with amine and carboxylate 
protons. 
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CHAPTER TWO 
STABILITY CONSTANT DETERMINATION OF SULFUR AND SELENIUM 
AMINO ACIDS WITH Cu(II) AND Fe(II) 
 
2.1  Introduction 
Despite the ubiquity and importance of amino acids in biological systems, very 
little is understood about coordination of labile (non-protein-bound) metal ions by free 
amino acids. Determining aqueous stability constants for metal ions with biologically 
relevant ligands, including amino acids, is one way in which more complex systems such 
as biological fluids or ocean water can be modeled. Fifty years ago, Hallman and coworkers 
simulated plasma speciation of Cu(II) and Zn2+ with seventeen amino acids,1 but 
subsequent reviews and analysis of this plasma speciation model revealed deficiencies in 
the underlying stability constant data, since the importance of minor species and redox 
interactions were neglected.2,3 More recently, amino acid stability constant data and 
speciation modeling have been used to help explain copper and zinc deficiencies that occur 
with total parenternal nutrition,4 trace element speciation in phloem sap5 and xylem fluid,6 
and copper speciation in the eye.7 Developing more accurate Cu(I) speciation models with 
penicillamine, cysteine, and glutathione resulted in a better understanding of metallic 
copper precipitation in the lens and cornea in patients with Wilson’s disease.7 Development 
of these complex models relies heavily on the accuracy of measured metal-amino-acid 
stability constants, a particular issue with potentially redox-active sulfur- and selenium-
containing amino acids. 
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Amino acid interactions with copper and iron may also play a crucial role in 
preventing oxidative damage and diseases that arise due to oxidative stress. Loss of metal 
homeostasis, mitochondrial malfunction, and the resulting oxidative stress is linked to 
neurodegenerative disease development, but the mechanistic details that cause this 
oxidative damage is poorly understood.8-10 Labile copper and iron produce reactive oxygen 
species (ROS) such as hydroxyl radical that can damage nucleic acids, proteins, and lipids, 
and this oxidative damage is catalytic in cells (Figure 2.1).11-13 Antioxidants capable of 
disrupting catalytic ROS generation through metal chelation may lessen the oxidative 
damage leading to Alzheimer’s, Parkinson’s, Huntington’s, and Wilson’s diseases.14 To 
ascertain whether amino acid binding to copper and iron may affect their ability to generate 
ROS, several factors must be determined: the amino acids and other small molecules most 
likely to interact with labile metal ions, metal ion and amino acid concentrations in the 
system, and stability constants for the metal-amino-acid complexes. 
 
 
Figure 2.1. Catalytic hydroxyl radical generation by iron and copper in cells. 
 Naturally occurring and biomimetic sulfur and selenium amino acids with 
thioether/selenoether and thiol/selenol groups are of significant interest due to their 
abundance in the active sites of metalloenzymes, their presence in biofluids, and their 
affinity for binding softer metal ions, such as Cu(I), Cu(II), and Fe(II). A variety of sulfur 
and selenium amino acids are present naturally (Figure 2.2), including methionine (Met), 
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cysteine (Cys), methylcysteine (MeCys), homocysteine (hCys), selenomethionine 
(SeMet), selenocysteine (SeCys), and methylselenocysteine (MeSeCys). One of the most 
prevalent sulfur amino acids,15 cysteine, has reported concentrations of 256 ± 15 μM in 
human plasma16 and 180 ± 20 μM in muscle tissue.17 Methionine has somewhat lower 
concentrations of 69 ± 15 μM16 and 110 ± 20 μM17 in plasma and muscle tissue, 
respectively. Normal levels of homocysteine (hCys) in plasma are in the 5 – 18 μM range,18 
and elevated hCys levels are an established risk factor for cardiovascular diseases, 
cognitive impairment, and chronic renal failure.19-22  Methylcysteine is not typically used 
for protein synthesis, but is occasionally incorporated into proteins.23 MeCys 
concentrations are not quantified in plasma or cells, but are found at concentrations of 0.2-
5 μM in human urine.24  Although not a natural amino acid, penicillamine (Pen; Figure 2.2) 
is structurally similar to cysteine and is used to chelate and remove excess copper in 
Wilson’s disease.25,26 When supplemented at 750 mg/day, penicillamine levels can reach 
100 μM in human serum.27 
 
Figure 2.2. Structures of common sulfur- and selenium-containing amino acids. 
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 Biological concentrations of selenium-containing amino acids are not determined, 
although total selenium concentration in human plasma averages 1.5-1.6 μM with 90% 
incorporated into selenoproteins as SeCys or SeMet.28  In humans, total selenium 
concentration is unlikely to exceed 10 μM due to selenium toxicity.29 SeCys is the most 
prevalent selenium amino acid in mammalian selenoproteins,30 but it is difficult to study 
in solution because its low pKa (~5) results in dimerization to form the oxidized diselenide 
species, selenocystine, at physiological pH.31 In contrast, MeSeCys is the most abundant 
selenium metabolite in plants.32 Although selenoamino acids are required for selenoprotein 
activity33,34 and can prevent ROS damage,35-37 their interaction with metal ions is not as 
widely studied as their sulfur-containing analogs. 
Labile iron is typically found in low concentrations but increases when the cell is 
under oxidative stress.38 In Escherichia coli, the concentration can rise from 20 µM under 
normal conditions up to 320 µM when stressed,39 increasing cellular damage. Labile iron 
pools of up to 10 M are present in human lymphocytes.40 Iron accumulation in certain 
regions of the brain41-43 is implicated in the pathology of Parkinson’s disease.44,45 Cellular 
labile copper pools have been identified but not precisely measured,46,47 and total copper 
has been reported as high as 100 μM in brain tissue.48,49  Labile copper causes increased 
protein aggregation in Alzheimer’s disease, which may be a direct result of oxidative 
protein damage.9,49,50  
Many researchers have examined the antioxidant activity of sulfur- and selenium-
amino acids,51-56 and Brumaghim, et al.37,57 established metal binding as a primary 
antioxidant mechanism for sulfur- and selenium-amino acid prevention of in vitro metal-
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mediated oxidative DNA damage. Structural analyses and density functional theory 
determinations established that the HOMO orbital energies of copper-amino-acid 
complexes predict the observed antioxidant activity.58,59 However, it is not clear if the 
stabilities of these amino-acid-metal complexes also correlate with DNA damage 
prevention ability. Such an analysis is critically hampered by the lack of stability constants 
for these amino acids with Cu(II) and Fe(II). To test this hypothesis, we determined 
stability constants for Cu(II) and Fe(II) with sulfur- and selenium-amino acids by 
potentiometric titration. In addition, metal binding modes of these amino acids with Cu(II) 
a predicted based on speciation trends, infrared (IR) spectroscopy, mass spectrometry, and 
solid-state structural determination. We use these measured stability constants and reported 
metal ion and amino acid concentrations, to discuss the likelihood of metal-amino-acid 
complex formation in biological systems. This work was a collaborative work. Andrea 
Gaertner completed the IC50 gel electrophoresis analysis of copper and iron with 
penicillamine. Tyler Williams performed the ESI-MS analyses of Cu(II) and Fe(II) with 
methionine in solution.  Colin D. McMillen determined the XRD determination of 
Cu(SeMet)2. Brian A. Powell provided expertise in the advisement of potentiometric 
titrations and stability constant determination. 
 
2.2  Results and Discussion 
Stability constants measure the thermodynamic likelihood of metal complex 
formation (Equations 1 and 2) and are directly related to the Gibbs free energy of a system 
(Equation 3). A positive log β indicates favorable thermodynamic stability for complex 
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formation. In this study, potentiometric titrations for multiple metal:ligand molar ratios at 
25 °C and pH 3-9 were used to determine stability constants of sulfur and selenium amino 
acids (L) with Cu(II) and Fe(II) (M), where x is the stoichiometric number of complexing 
ligands. 
M  +  x L    MLx  
 βML=    
[MLx]
[M][L]x
   
ΔG= -2.30RTlogβML 
 
 
Amino Acid Protonation Constant Determination 
 Protonation constants for Gly, Met, SeMet, MeCys, and MeSeCys were determined 
prior to titrations with metal ions. Although several of these amino acids have established 
protonation constants, precise determinations of these values under the exact conditions of 
temperature, ionic strength, and ionic salt used for the Cu(II) and Fe(II) titrations were 
required to ensure consistency and accuracy across all measurements (Table 2.1). The data 
agree well with previously reported values, with minor variations due slightly different 
analysis conditions, such as the solution composition or concentration. Speciation diagrams 
for glycine and the thio- and selenoether amino acids, such as the example speciation 
diagram for Met (Figure 2.3), indicate that three separate species (L-, LH, and LH2
+) form 
from pH 3 to 11, with the zwitterionic LH species as the primary species at pH 7. 
 
 
(2) 
(3) 
(1) 
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Table 2.1. Amino acid protonation constants; amine protonation is represented by K1 and carboxylate 
protonation by K2. 
Amino 
Acid 
log K1a log K2b Temp (˚C) Ionic Strength Reference 
Gly 9.67(2) 2.28(5) 25 0.1 M NaClO4 This work 
Gly 9.62 2.43 25 0.2 M NaClO4 60 
Met 9.196(5) 2.09(1) 25 0.1 M NaClO4 This work 
Met 9.12 2.22 25 0.2 M KCl 61 
SeMet 9.29(2) 2.05(1) 25 0.1 M NaClO4 This work 
SeMet 9.15 2.37 25 0.1 M NaNO3 62 
MeCys 8.79(2) 2.02(5) 25 0.1 M NaClO4 This work 
MeCys 8.72 2.2 25 0.2 M KCl 61 
MeSeCys 8.86(2) 2.3(2) 25 0.1 M NaClO4 This work 
a log K1= [L-][H+]/[HL]  b log K2 = [HL][H+]/[H2L+] 
 
 
 
 
 
 
Figure 2.3. Representative titration  and speciation diagrams for the potentiometric titration of the fully 
protonated amino acids (LH2 with Met shown in this example; 0.1 M NaOH, I = 0.1 M NaClO4, 25˚C). The 
solid blue line represents the modeled titration data with points indicating measured data (pH on the right y-
axis); formation of Met-, MetH, and MetH2+ species are indicated as shown in the legend. 
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Glycine has the highest log K1 values compared to the thio- and selenoether amino 
acids, indicating the amine proton is less likely to dissociate. These data represent the first 
reported protonation constants for methylselenocysteine. Structurally similar MeCys and 
MeSeCys have the lowest log K1 values, indicating amine deprotonation at lower pH. 
MeCys and MeSeCys protonation constants are also in close agreement, 8.79(2) and 
2.02(5) for log K1 and 8.86(2) and 2.3(2) for log K2, respectively, indicating that selenium 
substitution for sulfur has no significant effect on amine or carboxylate protonation. The 
carboxylate dissociation constant (log K2) is similar for all amino acids (2.02 to 2.3), and 
thus the carboxylate group is deprotonated at biologically relevant pH values. 
Cu(II)-Amino Acid Stability Constants 
 Cu(II) stability constants with the sulfur-containing amino acids have been widely 
studied,1,3,4,61,63-74 due to their bioavailability and their role in metal coordination in 
metalloproteins. Two species are identified, [CuL]+ and CuL2, where L
- represents the 
amino acid with both amine and carboxylate groups deprotonated. For Met, SeMet, MeCys, 
and MeSeCys, the S/Se atom in the side chain can potentially bind Cu(II) in addition to the 
amine N and carboxylate O atoms, resulting in a tridentate species.  Such tridentate binding 
occurs for Cu(II)-amino acid complexes such as Cu(His)2 (His = L-histidine),
75 and 
[Cu(Asp)(phen)(H2O)] (Asp = aspartic acid; phen = 1,10-phenanthroline).
76 Glycine is well 
known to bind Cu(II) in a bidentate fashion77 but cannot bind through the side chain to 
become a tridentate chelator; therefore, it was included in this study as a bidentate-binding 
control. If the thio- or selenoether S/Se atom participates in tridentate binding to Cu(II), 
higher stability constants are expected compared to those of the Cu(II)-glycine system. 
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 Cu(II) stability constants were determined for Gly, Met, SeMet, MeCys, and 
MeSeCys at 25˚C with a constant ionic strength of 0.1 M NaClO4 to provide a self-
consistent data set. Titrations were performed in triplicate at metal-to-ligand ratios of 1:2 
and 1:5, and stability constants describing metal-ligand binding are provided in Table 2.2. 
For all the Cu(II) titrations, precipitation occurred above pH 8, except for the Cu(II)-SeMet 
system in which precipitation began at pH 5. A representative speciation graph for the 
Cu(II)-Met titrations at a 1:2 Cu:amino acid ratio is provided in Figure 2.4.  
 Only two species are present at pH 7, [CuMet]+ and Cu(Met)2 (Figure 2.4), and  the 
Cu(Met)2 species reaches a maximum concentration around pH 8, approximately the pH 
that precipitation occurs. When the full data set (pH 2-10) was included in the modeling, 
incorporation of a third species, Cu(Met)(OH), produced a better fit (Figure 2.9); however, 
this species was excluded from the analysis because its log β value was extremely low. 
Since this putative Cu(Met)(OH) species forms at pH 8 and above, it is more likely that 
deviation in the fit reflects the instability of the system as Cu(II) and Met- are depleted due 
to precipitation, rather than the presence of a new species. The precipitate was confirmed 
as Cu(Met)2 by IR analysis (see Proof of Speciation for Cu(II) Complexes section). All the 
thio- and selenoether amino acids as well as glycine form the same [CuL]+ and CuL2 
species.  
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Table 2.2. Stability constants for Cu(II)- amino acid complexes determined by potentiometric titration 
 Cu(II) Stability Constants 
Amino Acid ML 
(log β)a 
ML2 
(log β2)b 
MLOH 
(log β-1)c 
Temp 
(°C) 
Ionic Strength 
(M) 
Reference 
Gly 8.11 14.96  25 0.1  78 
 8.26(1) 15.10(5)  25 0.1 NaClO4 This work 
Met 7.85(2) 14.52(1)  25 0.1 KNO3 67,69,79  
 7.96(5) 14.65(7)  25 0.1 NaClO4 This work 
MeCys 7.65d 14.13d  25 0.2 KCl 80 
 8.05(5) 14.47(5)  25 0.1 NaClO4 This work 
SeMet 7.77d 14.50d  25 0.1 NaNO3 62 
 8.02(2) 14.63(2)  25 0.1 NaClO4 This work 
MeSeCys 8.2(1) 14.5(2)  25 0.1 NaClO4 This work 
hCys 11.92(1) 13.54(2)e 7.57(1) 25 0.1 KNO3 81 
Pen 16.5d 21.7d  25 0.15 KNO3 82 
Fe(II) Stability Constants 
Gly 4.13d 7.65d  25 0.1 KNO3 83 
 4.04(5)  -4.24(2) 25 0.1 NaClO4 This work 
Met 3.24d   20 1.0 KCl 84 
 3.51(3)  -4.9(1) 25 0.1 NaClO4 This work 
MeCys 3.49(4)  -5.7(1) 25 0.1 NaClO4 This work 
SeMet 3.51(7)  -5.3(3) 25 0.1 NaClO4 This work 
MeSeCys 3.84(1)  -5.08(2) 25 0.1 NaClO4 This work 
Cys 6.69(2) 11.90(3)  20 0.1 NaClO4 85 
Pen 7.58(1) 13.74(2)  20 0.1 NaClO4 85 
 7.48(7) 13.91(7)  25 0.1 NaClO4 This work 
a log β = [M][L]/[ML]   b log β2 = [M][L2]/[ML2]   c log β-1 = [ML][OH]/[MLOH]   d No error reported.   
 e Reported as the [MHL] species, not the [ML2] species. 
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 Figure 2.4. Representative titration and speciation diagram for the potentiometric titration of Cu(II) and 
methionine in a 1:2 metal-to-ligand ratio (0.1 M NaOH, I = 0.1 M NaClO4, 25°C. The solid blue line 
represents the modeled titration and points represent the measured data. Formation of [Cu(Met)]+ and 
Cu(Met)2 species are indicated as shown in the legend. 
 
Proof of Speciation for Cu(II) Complexes 
 Speciation in the Cu(II)-thio- and selenoether amino acid systems was confirmed 
using a variety of solution and solid-state analyses. For the soluble Cu(II)-Met species, 
electrospray ionization mass spectrometry (ESI-MS) confirmed the presence of [Cu(Met)]+ 
(212 m/z). The Cu(Met)(OH) (230 m/z) species was also identified; however, the samples 
were prepared at pH 5, well below the pH where modelling indicates possible formation of 
this species. Thus, this species is most likely arises from water coordination of the 
[Cu(Met)]+ species.  Since Gly, Met, SeMet, MeCys, and MeSeCys all have Cu(II) stability 
constants within 0.5 log units, the resulting species are assumed to bind Cu(II) similarly.  
Above pH 8, the Cu(II)-amino-acid complexes precipitated, and IR spectroscopy 
was used to confirm CuL2 formation of the species and to compare with reported spectra 
(Table 2.3).62,86-88 For Cu(Met)2 and Cu(SeMet)2, broad N-H stretching absorption bands 
at 3077 and 3080 cm-1 for Met and SeMet, respectively, split into three distinct stretching 
92 
vibrations for the corresponding Cu(II) complexes: 3300, 3241, and 3120 cm-1 for the Met 
complex and 3281, 3233, and 3132 cm-1 for the SeMet analog. This N-H splitting confirms 
participation of the amine nitrogen in Cu(II) binding, since the environment of the amine 
protons change slightly to compensate for the loss of freedom due to the proximity of the 
copper ion.62 Amine binding is further supported by a N-H deformation band that appears 
at 1569 cm-1 for Met and 1570 cm-1 for SeMet. Carboxylate oxygen binding is also 
indicated by the shift of the asymmetric C-O stretch from approximately 1610 cm-1 to 1622 
and 1616 cm-1 for the Met and SeMet complexes, respectively.62,87 M-N and/or M-O bond 
formation is also indicated by the presence of one or two absorbances in the 440-600 cm-1 
region.  
 IR results for MeCys and MeSeCys are consistent with the trends observed with 
the aforementioned Met and SeMet, although the C=O stretch observed at approximately 
1620 cm-1 for the other complexes was shifted to 1640 cm-1 for the MeSeCys and no 
discernible NH2 deformation was observed. Trends observed in the IR spectrum of 
Cu(MeSeCys)2 can help confirm that the same structural confirmations are being formed 
in the binding of the [MeSeCys]- ligand to the Cu(II) as has been shown with the other 
thio- and selenoether amino acids. The stability constants indicate similar coordination for 
all of the thio- and seleno-ether amino acids. 
 
 
93 
Table 2.3. IR data for metal-amino-acid complex precipitates in potentiometric titrations (pH > 8; NR = not reported) 
Vibration Cu(Met)286 
(cm-1) 
Cu(Met)2a 
(cm-1) 
Cu(MeCys)287 
(cm-1) 
Cu(MeCys)2a
(cm-1) 
Cu(SeMet)2a 
(cm-1) 
Cu(MeSeCys)2a 
(cm-1) 
Fe(Met)2a 
(cm-1) 
NH2 stretching 3390 
3230 
3130 
3300 
3241 
3120 
3300 
3230 
2990 
3299 
3232 
3110 
3281 
3233 
3132 
3322 
3221 
3130 
3410 
3360 
3289 
C=O stretch 1620 1622 1620 1618 1616 1640 1598 
NH2 deformation 1580 1569 1570 1571 1570 1571 1562 
C-N vibration NR 1337 NR 1340 1399 1335 1330 
M-N and/or M-O 
stretch 
NR 578 NR 576 497 521 568 
a This work 
9
3
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 Amine nitrogen and carboxylate oxygen coordination to Cu(II) is strongly 
supported by the solid-state structure of Cu(SeMet)2 (Figure 2.5 and Table 2.4), the first 
structure for a Cu(II)-seleno amino acid complex. In Cu(SeMet)2, each SeMet ligand 
coordinates the copper ion through bidentate binding of nitrogen and oxygen atoms in the 
equatorial position, resulting in an overall distorted square planar geometry (τ4 = 0.043) 
around Cu(II) (Cu-N = 1.980(6) and 1.992(6) Å; Cu-O = 1.950(5) and 1.954(5) Å). This is 
similar to the thioether complexes Cu(Met)2 (Cu-N = 1.97(1) and 2.01(1) Å; Cu-O = 
1.944(8) and 1.970(8) Å)86,89 and Cu(MeCys)2 (Cu-N = 1.994 and 2.000 Å; Cu-O = 
1.936(1) and 1.951(1) Å).
87 All other bond lengths and angles are comparable to those in 
the Cu(Met)2 structure reported by Ou and coworkers,
86 with the exception of a slight 
lengthening in the carbon-chalcogen bonds, averaging 1.950(9) for the C-Se bonds in the 
present study compared to 1.80(2) Å for the C-S bonds in Cu(Met)2. This lengthening also 
results in a slightly longer c-axis of the selenoether complex (16.082(1) Å) compared to 
the thioether complex (15.563(8) Å). 
 
 
Figure 2.5. Structure of Cu(SeMet)2 shown with 70% probability ellipsoids for Cu(SeMet)2. Hydrogen atoms 
are omitted for clarity.  
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Table 2.4. Selected bond lengths (Å) and angles (˚) for Cu(SeMet)2 
Cu(L-SMet)2 Bond lengths (Å)  Angles (˚) 
Cu1-N1 1.992(6) O2-Cu1-O1 178.3(2) 
Cu1-N2 1.980(6) O2-Cu1-N2 84.4(2) 
Cu1-O1 1.954(5) O1-Cu1-N2 94.8(2) 
Cu1-O2 1.950(5) O2-Cu1-N1 96.2(2) 
Cu1-O4a 2.640(4) O1-Cu1-N1 84.4(2) 
Cu1-O3 a  2.687(4) N2-Cu1-N1 175.5(2) 
C4-Se1 1.952(7) C4-Se1-C5 98.4(3) 
C5-Se1 1.953(9) C10-Se2-C9 98.5(4) 
C9-Se2 1.958(7)   
C10-Se2 1.939(9)   
a Cu1-O3 and Cu1-O4 represent the carboxylate-bridged, apical bond distances in  
the packing diagram (Figure 2.8). 
 
 
Carboxylate oxygen atoms from neighboring molecules form axial bonds to the Cu 
centers with extended copper-oxygen bond lengths of 2.640(4) and 2.687(4) Å, 
significantly longer than the equatorial carbon-oxygen bonds of 1.950(5) and 1.954(5) Å. 
These apical interactions result in the formation of sheets in the ab-plane (Figure 2.10). 
Hydrophobic intermolecular interactions of the Se-CH3 side chains isolate neighboring 
sheets from one another along the c-axis.  The structures of Cu(Met)2 and Cu(MeCys)2 also 
crystallize in space group P21 and feature similar long range motifs directed by the axial 
interactions of Cu(II) with carboxylate groups (though in the case of Cu(MeCys)2, the 
sheets occur in the bc-plane, and the  angle is expanded somewhat to 97.55(2)°.86,87,89 
 Similar elongated Cu-carboxylate axial interactions are observed in Cu(II)-glycine-
based structures;90,91 however, some Cu(II)-glycine structures instead incorporate one92-95 
or two77 water molecules in the axial positions. This water coordination in the solid state 
suggests that Cu(II) would likely be hydrated in solution, especially for [Cu(Met)]+ and 
similar amino acid species with open coordination sites around the central metal ion. Water 
coordination at pH < 7 also suggests formation of species with hydroxide ligands at pH > 
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7, although these species may not be readily identifiable in titrations due to complex 
precipitation. 
 
Structure-Stability Analysis for Cu(II)  
 Cu(II)-MeSeCys stability constants are reported for the first time as 8.2(1) 
and14.5(2) for the [Cu(MeSeCys)]+ and Cu(MeSeCys)2 species, respectively (Table 2.2). 
The higher error for these MeSeCys titrations relative to other thio- and selenoether amino 
acid values is likely due to interactions of the soft selenoether species with the electrode. 
To mitigate this issue, MeSeCys titrations were back-titrated to demonstrate reversibility. 
Cu(II)-MeSeCys stability constants are within 0.5 log units of those for the other thioether 
and selenoether amino acids, suggesting similar binding modes.  
 Stability constants of Cu(II) with Met, SeMet, and MeCys are within 0.2 log units  
for the [ML]+ species (7.96(5) to 8.05(5) and ML2 species (14.47(5) to 14.65(7)), although 
they are slightly higher than other reported results (Table 2.2), indicating little difference 
in Gly, Met, MeCys, and SeMet thermodynamic stability upon Cu(II) binding. Small 
variations in these values are likely due to differences in supporting electrolyte or in time 
allowed for the titrations to reach equilibrium. The greater relative stability of Cu(II) 
binding to Gly compared to thioether and selenoether amino acids corroborates the solid-
state results that show no Cu(II)-S/Se interactions and suggests that the thio- and 
selenoether side chains slightly destabilize these complexes in solution. 
Cu(II) complexes of thiol-containing amino acids are more stable than their thio- 
and selenoether counterparts (Table 2.2). In contrast to the thio- and selenoether functional 
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groups, thiols have ionizable protons and thiol-containing amino acids have four possible 
protonation states: [H3L]
+, [H2L], [HL]
-, and L2-. To date, no selenol copper stability 
constants have been reported, likely due to the low pKa of selenols (~5) and the resulting 
tendency to form diselenide species.31 In potentiometric titrations with Cu(II), both 
homocysteine (hCys) and penicillamine (Pen) form CuL species (Table 2.2),81,82 and Rosen 
and Kuchinkas82 also identified a [Cu(Pen)2]
2- species.  
Other reported Cu(II) complexes of thiol-containing amino acids are not consistent; 
Pinto and coworkers81 identified [Cu(HhCys)]+ and [Cu(hCys)(OH)] species in a 
potentiometric titration of a 1:1 Cu(II) to hCys (to prevent Cu(II)oxidation of hCys) and 
identified Cu(hCys)2 as a precipitate at higher ligand-to-metal ratios. Based on our model 
simulations using the stability constant values reported by Pinto, et al.,81 the Cu(hCys)(OH) 
species is the dominant species above pH 4, with no evidence for formation of the 
[Cu(HhCys)]+ species under the given experimental conditions. Solid-state analysis of 
Cu(hCys)2 by IR and EPR spectroscopy indicated bidentate Cu(II) coordination of the 
amine and thiolate groups, with no binding of the carboxylate group. 
In contrast, tridentate Cu(II) coordination in the solid state is reported for 
penicillamine, and in a unique polymeric structure supported by a gold-
bis(diphenylphosphino)alkane linker, Cu(II) coordinates two penicillamine ligands, one in 
a tridentate fashion through the amine, carboxylate, and thiolate groups, and one in a 
bidentate fashion through only the amine and thiolate.96 Higher stability constants for the 
thiol-containing amino acids with Cu(II) indicate increased stability compared to thioether 
and selenoether amino acids and glycine, either due to increased stability of an amine and 
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side-chain thiolate coordination or tridentate chelation of the copper by the carboxylate, 
amine, and thiolate groups.  
 
Fe(II)-Amino Acid Stability Constants 
 Even though iron is the most abundant transition metal ion in the biological system, 
stability constant data for Fe(II) with sulfur and selenium amino acids is much more limited 
than for Cu(II). Since Fe(II) is more difficult to work with due to its tendency to oxidize in 
air, titrations must be performed under nitrogen or argon to exclude oxygen during analysis. 
In addition to oxygen sensitivity, Fe(II)-amino acid complexes precipitate above pH ~8, 
limiting the analysis window for potentiometric titrations. Likely because of these 
limitations, Met is the only thio- or selenoether amino acid with reported Fe(II) stability 
constants,63,97 and data from these 1950s papers are inconsistent. Perrin97 reports a stability 
constant of 3.42 for a [Fe(Met)]+ species; however, Albert63 reports formation of a Fe(Met)2 
species with a stability constant of 6.7. In neither study were the identified species 
investigated using alternative methods.  
To address the paucity of Fe(II) stability constant data with sulfur and selenium 
amino acids, potentiometric titrations of Fe(II) with Met, MeCys, SeMet, MeSeCys, and 
penicillamine (Pen) at a 1:2 and 1:5  metal to ligand ratio were performed in a nitrogen-
atmosphere glovebox. Similar to the Cu(II) studies, glycine titrations with Fe(II) were 
performed for comparison. Because precipitation is observed above pH 8, with the 
exception of the Fe(II)-Pen system that shows no precipitation up to pH 10, titrations were 
restricted to a maximum of pH 8. These titrations indicate formation of [FeL]+ and 
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Fe(L)(OH) complexes with Gly, Met, SeMet, MeCys, and MeSeCys (Figure 2.6A and 
Table 2.2). In contrast, Fe(II) titrations with thiol-containing Pen indicate formation of 
Fe(Pen) and [Fe(Pen)2]
2- species (Figure 2.6B) in excellent agreement with previous 
analyses.85 
Stability constants for the 1:1 [Fe(Gly)]+ and [Fe(Met)]+ agree with previously 
reported data (Table 2.2).83,84,97-99 For Gly titrations, Gergely83 also identifies a Fe(Gly)2 
 
 
Figure 2.6. Representative titrations (0.1 M NaOH, I = 0.1 M NaCl, 25˚C) and speciation diagrams for the 
titration of A) Fe(II) and methionine in a 1:2 ratio and B) Fe(II) and penicillamine in a 1:2 ratio. The solid 
blue line represents the modeled titration, and points represent the measured data. Formation of Fe(II)-amino-
acid species are indicated as shown in the legend. 
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species with a log β of 7.65, whereas Micskei99 identifies two additional species, Fe(Gly)2 
with a log β of 6.65(1) and [Fe(Gly)3]- with a log β of 8.87(1). Under our titration 
conditions, these Fe(Gly)2 and [Fe(Gly)3]
- species are not present; instead, a Fe(Gly)(OH) 
species is observed with a stability constant of -4.24(2). In Met titrations, a similar 
Fe(Met)(OH) species is also identified, but the Fe(Met)2 species reported by Albert is not.
63  
Due to a lack of reported detail, it is unclear how these titrations differ from the analysis 
by Albert, although the authors of these studies included data above the pH at which 
precipitation begins to occur, perhaps skewing the fit of their models. 
Stability constants for the 1:1 species of Fe(II) with MeCys, SeMet, and MeSeCys 
were determined to be 3.49(4), 3.51(7), and 3.84(1), respectively (Table 2.2), representing 
the first stability constant determinations for Fe(II) with these amino acids. These [FeL]+ 
stability constants are similar to those for [Fe(Gly)]+ (3.73(1)) and [Fe(Met)]+ (4.13).83,84 
As noted for the Cu(II) titrations, the [Fe(Gly)]+ stability constant is slightly higher than 
those for any of the thio- or selenoether amino acids, likely indicating no Fe(II)-S/Se 
binding. In contrast to previous reports, presence of the Fe(L)(OH) species (L = Met, 
SeMet, MeCys, MeSeCys) is identified in the best fit model for these systems, with this 
species growing in above pH 4 as hydroxide becomes more readily available. 
For Fe(II) titrations with the thiol-containing penicillamine, the [FePen] and 
[Fe(Pen)2]
2- species are present, with stability constants of 7.48(7) and 13.91(7), 
respectively, closely matching results reported by Doornbas85 in 1964 (Table 2.2). The lack 
of precipitation in this system up to pH 10 is due to strong Fe(II)-thiolate interactions as 
well as the greater charge of [Fe(Pen)2]
2- that makes it more soluble in aqueous solution 
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than the [Fe(L)]+ species formed with the thio- and selenoether amino acids. These 
speciation differences in the Fe(II)-Pen and Fe(II)-Met systems are obvious when 
comparing their respective titration data (Figure 2.6) . In fact, Fe(II)-Pen complexes are 
slightly more stable than Fe(II)-Cys complexes (Table 2.2).  
  
Proof of Speciation for Fe(II) Complexes  
Proof of speciation using mass spectrometry was more difficult for the 
representative Fe(II)-Met system than for the analogous Cu(II)-Met system, likely due to 
the weaker stability constants determined for the Fe(II) species. By ESI-MS only the Fe(III) 
species, [Fe(Met)2]
+ (m/z = 353), is observed due to Fe(II) oxidation during injection and 
analysis. Precipitate formed during Fe(II)-Met titrations was analyzed using IR 
spectroscopy to determine amino acid binding modes as a representative sample of the 
Fe(II)-thioether and –selenoether interactions. As discussed in detail for the Cu(II)-amino 
acid complexes, shifts in both the N-H and C=O stretches for Fe(Met)2 (Table 2.3) 
compared to unbound Met indicate Fe(II) coordination through both the amine nitrogen 
and the carboxylate oxygen atoms, similar to the IR spectrum of the fully characterized 
Cu(Met)2.  In addition, the absence of a broad absorption in the 3500-3700 cm
-1 range 
indicates that no hydroxide or water is coordinated. The Fe(II)-Pen species were not 
confirmed by IR, because they do not precipitate in aqueous solution. The formation of the 
complex as the thiol is deprotonated is consistent with coordination via the amine and the 
thiol, as discussed by Doornbos and Faber.85 
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The only single crystal structure for Fe(II) with any amino acid is Fe(Pro)2(phen) 
(Pro = L-proline; phen = 1,10-phenanthroline,100) which binds Fe(II) through the amine N 
and carboxylate O atoms. The only stability constant reported for the Fe(II)-Pro system is 
for the ML2 complex (log β = 8.3), determined by Albert63 in 1950. This low stability 
constant indicates extremely weak Fe(II) coordination, similar to those observed for the 
thio- and seleno-ethers, but does indicate that bidentate binding of thio- and selenoether 
amino acids is likely. As all of the FeL2 stability constants with the thio- and selenoether 
amino acids were similarly low and approximately the same as the Fe(Pro)2 stability 
constant, it is reasonable to assume that the coordination environments are similar. The 
lack of reported solid-state structures for Fe(II)-amino-acid complexes is indicative of 
weak coordination and difficulty in working with oxygen-sensitive Fe(II) complexes.  
 
Structure-Stability Analysis for Fe(II)  
 Fe(II)-amino acid stability constants for the [FeL]+ species with the thio- and 
selenoether amino acids are within 0.5 pH units of each other (3.49(4) to 3.84(1); Table 
2.2), and stability constants for the Fe(L)(OH) complexes are in the range -4.9(1) to -5.7(1), 
slightly less accurate due to precipitation at pH 8. The [Fe(Gly)]+ stability constant is 
slightly higher (4.04(5)) than those of the thio- and selenoether amino acids, indicating that 
the sulfur and selenium atoms of these amino acids do not contribute to complex stability.  
 In contrast, the thiol-containing Pen exhibits stronger binding to Fe(II), with 
Fe(Pen) and [Fe(Pen)2]
2- stability constants of 7.48(7) and 13.91(7), respectively, similar 
to Cu(II) stability constants with the thio- and selenoether amino acids, but much higher 
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than the stability constant for [Fe(Gly)]+ (Table 2.2). Similarities in the stability constants 
for the Fe(II)-Pen and Cu(II)-Met systems suggest bidentate coordination, although Pen 
likely binds through the thiolate sulfur, replacing either the amine nitrogen or the 
carboxylate oxygen. Stability constants for Cu(II) with penicillamine have been reported 
as 16.5 and 21.7 for the Cu(Pen) and [Cu(Pen)2]
2- species, respectively (Table 2.2). This 
significant increase in stability compared to Fe(II)-Pen complexes strongly suggests 
tridentate Cu(II) coordination of the thiolate, amine, and carboxylate groups, a trait critical 
for its use as a biological Cu(II) chelator to treat Wilson’s disease.  
Greater binding stability for Cu(II) over Fe(II) coordination was determined for all 
the sulfur and selenium amino acids in Table 2.2.  Stability constants of approximately 8 
for the [CuL]+ species and approximately 4 for the [FeL]+ species, indicates a much lower 
affinity of the amino acid for Fe(II) in comparison to Cu(II). This may be due to differences 
in electronic environment and/or preferred coordination geometries around these two 
divalent metal ions. The extremely low [FeL]+ stability constants indicate unlikely complex 
formation in a competitive environment of other biomolecules with much higher stability 
constants.   
 
Cu(II)/Fe(II) Competition for Sulfur- and Selenium-Containing Amino Acids at Biological 
Concentrations 
The sulfur- and selenium- containing amino acids form significantly more stable 
complexes with Cu(II) than with Fe(II), as discussed previously. However, iron is 
considered to be the most abundant transition metal ion in the biological system, with labile 
104 
pools believed to be as high as 10 μM.40 Copper is the third most abundant transition metal 
ion, although discrete determination of copper pools has not been accurately 
determined.47,101 Although the stability of the Fe(II) complexes is considerably weaker, the 
higher concentrations available may allow Fe(II) to compete for the available amino acids, 
especially with the thiol amino acids. 
 Penicillamine is routinely used as a chelating agent in the treatment of Wilson’s 
disease25,26 and has been used in the treatment of copper and lead poisoning.102 As such, it 
is not surprising that the stability constants for Cu(II) and penicillamine are significantly 
higher (ML=16.5 and ML2=21.7, Table 2.2) than those reported for the thio- and 
selenoether amino acids (ML=7.6-8.1 and ML2=14.5-14.7). The stability constants for the 
Fe(Pen) (7.6) and [Fe(Pen)2]
2- (13.7) also indicate much weaker coordination than those 
for Cu(II), but if more Fe(II) is available, these complexes may form in significant 
quantities. The penicillamine may be effective for removing excess copper, but may also 
interfere with iron homeostasis. 
 
Figure 2.7. The simulated speciation graph for the modeled solution of 1 μM Cu(II), 10 μM Fe(II), and 1-
100 μM Pen incorporating the stability constants for Cu(Pen), Fe(Pen), [Cu(Pen)2]2-, and [Fe(Pen)2]2- species, 
with less than 1% formation was observed for the [Cu(Pen)2]2-, and [Fe(Pen)2]2- species. 
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 To demonstrate the preference of penicillamine for the Cu(II) ion over the Fe(II) 
ion, a model solution was studied that incorporated 1 μM Cu(II), 10 μM Fe(II), and 1-100 
μM Pen at pH=7. These concentrations were chosen based on approximate labile 
concentrations for iron40 and reported concentrations for penicillamine for patients being 
treated for Wilson’s disease.27 Although exact labile concentrations for Cu(II) have not 
been reported,47,101 the concentration of 1 μM was chosen to examine the effect of a ten-
fold difference between copper and iron. The model can be seen in Figure 2.7.  
From the model seen in Figure 2.7 at pH 7, the formation of the Cu(Pen) species is 
unaffected by the availability of excess Fe(II). If the total concentrations are considered, 
the Pen ligand is initially equimolar to the Cu(II) and ten times less concentrated than the 
Fe(II). From these ratios, 99.8% of the Cu(II) (or 0.998 μM) is coordinated to the 
penicillamine. As the penicillamine concentration rises with excess available for 
coordination, limited Fe(II) coordination is observed, even when the pencillamine is ten 
times more concentrated than the Fe(II). A maximum of 3.93% of the Fe(II) (or 0.393 μM) 
is coordinated by penicillamine in this simulation. The [Cu(Pen)2]
2- and [Fe(Pen)2]
2- 
species are only observed in trace amounts (<0.1 μM, not seen in Figure 2.7) at pH 7 and 
do not seem to be a contributing species in this model. From this model, limited 
coordination of labile Fe(II) is observed when the penicillamine is in 10x excess which 
may affect iron homeostasis, but the Fe(II) would not outcompete or inhibit Cu(II) 
complexation. 
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Correlation of Stability Constants with Amino Acid Antioxidant Ability and Biological 
Speciation 
 Iron- and copper-mediated DNA damage can lead to oxidative stress and cell death, 
and sulfur and selenium compounds have been widely examined for their ability to inhibit 
DNA damage by Fe(II) or Cu(II)-mediated hydroxyl radical generation (Figure 2.1). In vitro 
gel electrophoresis studies quantified the concentration of thio- and selenoether amino 
acids required to inhibit 50% of the DNA damage (IC50 values) caused by Fe(II)
 or Cu(I) 
and hydrogen peroxide (Table 2.5). Brumaghim and coworkers37,57,103 established that this 
antioxidant behavior was due to metal-amino-acid coordination, although they did not 
attempt to correlate DNA damage prevention with stability constants. 
Table 2.5. Inhibitory concentrations for metal-mediated DNA damage prevention by amino 
acids.  
Amino Acid Cu(I) IC50 
(µM) 
Fe(II) IC50 
(µM) 
Reference 
Gly 22.4 ± 0.1 None 48 
Met 11.8 ± 1.3 None 57 
SeMet 25.1 ± 0.1 None 37 
MeCys 9.6 ± 1.0 None 57 
MeSeCys 8.64 ± 0.02 None 37 
Pen 26.9 ± 0.1 591±1 This work 
 
 To investigate potential correlations between metal-amino-acid binding and DNA 
damage prevention, we examined the relationship between the IC50 data (Table 2.5) and 
stability constants for the [CuL]+ and CuL2 species with Gly, Met, SeMet, MeCys, and 
MeSeCys. Data for the Cu(II)-Pen system were excluded from this analysis due to the 
differences in metal binding modes. Although stability of the ML species and inhibition of 
metal-mediated DNA damage are not correlated (R2 = 0.045; Figure 2.8B), a weak 
correlation exists between stability constants for the ML2 species and DNA damage 
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prevention (R2 = 0.4742; Figure 2.8A). This limited correlation indicates that the stronger 
the Cu(II)-amino-acid binding, the less effective the amino acid is at preventing metal-
mediated DNA damage.  
 These DNA damage inhibition assays use Cu(I)/H2O2 to generate damaging 
hydroxyl radical, and Cu(I) complexes are not expected to have the same stability constants 
as Cu(II). A comparison of Cu(I) stability constants with IC50 values would be ideal, but 
only Cu(I) stability constants with and Cys,7 Pen,7 and Met84 are reported, due to the 
difficulty of working with Cu(I) in aqueous systems. CuI(Met) has a higher log β than 
[CuII(Met)]+ species, 9.1 vs. 7.65, respectively, so Met is more stable binding Cu(I) than 
Cu(II), but data are too limited to establish trends. 
 Perhaps the most relevant general trend of complex stability with DNA damage 
prevention can be elucidated from the poor stability of the Fe(II)-thioether and -selenoether 
complexes. Thio- and selenoether amino acids do not inhibit DNA damage by Fe(II) (Table 
2.5), but the more strongly binding Pen does. Although quantifiable trends cannot be 
determined due to lack of IC50 values with Fe(II), it is possible that thio- and selenoether 
ligands do not coordinate Fe(II) strongly enough to prevent iron-mediated DNA damage.  
 Based on the stability constants of Cu(II) with Met, SeMet, MeCys, MeSeCys, and 
Gly, the models indicate approximately 100% coordination by at least one ligand at 
biological pH (Figure 2.3). For the Fe(II) stability determinations with the same amino 
acids, only the Fe(II)-Pen system shows appreciable coordination at biological pH (Figure 
2.6). These low stability constants reflect the fact that very little Fe(II) is coordinated up to 
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Figure 2.8. Graphs of A) stability constants of the CuL2 species and B) stability constants of the CuL 
species vs. 50% inhibitory concentrations for oxidative DNA damage (IC50 values) for the amino acid 
antioxidants (L) in Table 2.5. Solid lines show the best-fit linear trend line for the data with the 
equations given.  
 
pH 7, although a small change in pH to 8 results in >80% coordination of Fe(II) as [ML]+ 
or MLOH species. The Fe-penicillamine system indicates a much higher stability with 
>90% coordination at pH 7, indicating probable coordination of the thiolate group to Fe(II). 
Thus, sulfur and selenium amino acid binding may affect the biological chemistry of Cu(II) 
significantly more than Fe(II).  
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2.3  Conclusions 
 Stability constants were determined for Cu(II) with the thio- and selenoamino acids, 
methylcysteine, methionine, methylselenocysteine, and selenomethionine, and stability 
constants for the [Cu(MeSeCys)]+ and Cu(MeSeCys)2 species were reported for the first 
time. Identity of these Cu(II)-amino acid species were independently confirmed by IR 
spectroscopy, ESI-MS, and/or solid-state structural analysis, including the first Cu(II) 
structure with a selenium-containing amino acid, Cu(SeMet)2. Cu(II) binds these amino 
acids through the amine nitrogen and carboxylate oxygen atoms, and the thioether or 
selenoether moiety does not coordinate or increase complex stability. Based on the Cu(II) 
stability constants with these amino acids (log  = 8.0 to 8.2 for the [ML]+ species), all of 
the available Cu(II) is coordinated at pH 7 in as the [ML]+ and [ML2] species, suggesting 
that these complexes may potentially form in biological systems.   
 Stability constants of Fe(II) with methylcysteine, methylselenocysteine, and 
selenomethionine also were determined for the first time. Fe(II) stability constants are 
consistently lower than the Cu(II) constants for all sulfur and selenium amino acids tested, 
including penicillamine.  The [FeL]+ species was identified for all of the thio- and seleno-
ether amino acids, consistent with previous reports for the Fe(II)-methionine system; 
however, including a secondary [FeLOH] species provided a better match of the model to 
the collected data. The low stability constants for the [FeL]+ species of the thioether and 
selenoether amino acids (log  = 3-4) indicate much weaker binding than with Cu(II). As 
with Cu(II), the similarity of the stability constants for Fe(II) with glycine and all of the 
thio- and selenoamino acids indicates that the sulfur and selenium atoms do not interact 
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with the metal ion. Of the sulfur- and selenoamino acids, only penicillamine is likely to 
form complexes with the Fe(II) at pH 7. 
 In general, the higher stability constants of Cu(II) with the thio- and selenoether 
amino acids indicates that amino acid binding to Cu(II) at pH 7 may inhibit copper 
generation of hydroxyl radical, resulting in the weak correlation identified between Cu(II) 
stability constant and DNA damage prevention abilities of these amino acids. With the 
thio- and seleno-ether amino acids, the very weakly coordinated Fe(II) is more available 
than the stronger-binding Cu(II) for redox cycling to generate hydroxyl radical. Although 
sulfur- and selenium-containing amino acids are considered relatively weakly binding 
ligands, they may have large-scale implications for the biological availability and reactivity 
of redox-active metals such as Cu(II) and Fe(II). 
 
2.4  Experimental Methods 
Materials and Instrumentation  
 Concentrations of stock solutions of copper(II) nitrate trihydrate solutions and 
iron(II) sulfate heptahydrate were confirmed by ICP-OES. Infrared spectra were recorded 
using a Magna 550 IR spectrometer in the range 4000-450 cm-1 as Nujol mulls on KBr 
plates. IR absorption abbreviations are vs, very strong; s, strong; m, medium; w, weak; sh, 
shoulder.  
 ESI-MS analysis was carried out with a Thermo Scientific (San Jose, CA) TSQ 
Quantum Access MAX triple quadrupole mass spectrometer. Sample solutions were 
prepared in 50/50 mixture by volume of MeOH/H2O and NaClO4 (10 mM) at pH of 5. 
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Samples were prepared by mixing Cu(II) or Fe(II) (2 mM) with of the amino acid (4 mM) 
and introduced to the ESI source by direct infusion. A scan containing 5 micro scans was 
taken every 0.5 seconds across a 10 to 1000 Da range. For each sample, 100 scans were 
collected and averaged to obtain a final spectrum. TSQ Tune software (Thermo Scientific) 
was used for data acquisition. ESI-MS data are shown in Figures 2.11-2.12, and both 
mass/charge ratio and isotopic distribution match simulated envelope intensities.  
 
Potentiometric Titrations  
 Titrations were performed using an 836 Titrando equipped with a 800 Dosino 
autotitrater. A Thermo Sure-flow Ag/AgCl electrode with 0.1 M NaCl filling solution was 
used to monitor potential of the solution during titration. Amino acid protonation constants 
were determined by direct titration of 30 mL of a 2.0 mM solution of each amino acid in 
NaClO4 (0.1 M ) to maintain a constant ionic strength. After bubbling with CO2-scrubbed 
Ar, the solutions were titrated with CO2-free, NIST standardized 0.1002 M NaOH using 
the 836 Titrando equipped with the 800 Dosino to autotitrate.  
Cu(II) stability constants with the indicated amino acids were determined using 
aqueous solutions of Cu(NO3)2·3H2O (1.0 mM) and each amino acid (2.0 mM or 3.0 mM) 
in 1:2 and 1:3 ratios of Cu:ligand and a constant ionic strength of 0.1 M NaClO4. The 
electrode was calibrated for the system utilizing NIST-standarized 0.1001 M HCl and 
NIST-standarized 0.1002 M NaOH and the GLEE program104 to determine standard 
reduction potentials in 0.1 M NaClO4. For all titrations, 0.1001 M HCl was added to the 
metal-amino acid solution to bring the solution pH down to 2-3. Copper solutions were 
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bubbled with argon for 15 min and maintained at a constant temperature of 25.0˚C with a 
jacketed cell under a constant stream of argon to minimize CO2 contamination of the 
reaction solutions. The solutions were then titrated as described above for the pure amino 
acid system. Potentials were measured at 25˚C until precipitation was visible.  
Fe(II) stability constants were determined by titrating aqueous solutions of 
FeSO4·7H2O (1.0 mM) in 1:2 and 1:3 metal to ligand ratios with solutions of each amino 
acid (2.0 mM or 3.0 mM) at a constant ionic strength of 0.1 M NaCl in a dry, nitrogen-
atmosphere glovebox. All solutions were prepared and titrations were performed in the 
glovebox. Temperature was maintained at 25.0˚C with a jacketed cell and water circulator.  
Iron solutions were then titrated with NIST standardized 0.0100 M NaOH utilizing the 836 
Titrando and 800 Dosino autotitrator. Precipitation was observed above pH 8 during iron 
titrations, except with penicillamine. The iron titrations were back-titrated from pH 10 to 
3 to demonstrate reversibility and to improve stability of the electrode over multiple 
analyses.  For all amino acid, Cu(II), and Fe(II) titrations, data were collected in triplicate 
with reported standard deviations. Potentiometric titration data were analyzed and model-
matched using HYPERQUAD2013.104  
 
Synthesis of Cu(SeMet)2  
 A solution of L-selenomethionine (117.7 mg, 0.6 mmol) in water was added to a 
solution of Cu(NO3)2·3H2O (72.5 mg, 0.3 mmol) in water. NaOH (0.1 M) was added 
dropwise until the solution reached pH 6.0. The solution was evaporated in air over three 
weeks, resulting in light-blue crystals as well as powder precipitate. Yield:106 mg, 78%. 
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IR (cm-1): 3299 w, 3232 w, 3110 s, 1618 vs, 1571 sh, 1462 w, 1340 w, 1304 w, 1138 s, 
1083 w, 1246 w, 1160 s, 818 w, 722 w, 671 s, 638 w, 576 s. ESI-MS (m/z): 251 
[Cu(C5H11NO2Se)]
+, 274 [Cu(C5H11NO2Se)(OH)]
+, 456 [Cu(C5H11NO2Se)2H]
+. Anal. 
Calc. for C10H20CuN2Se2O4: C, 26.47; H, 4.44; N, 6.17. Found: C, 26.03; H, 4.66; N, 6.86. 
 
X-ray crystallography 
 Single crystals for X-ray diffraction were obtained through slow evaporation of a 
1:2 metal to ligand solution in water at pH 6, yielding blue, plate-like crystals.  A single 
crystal was mounted on a low background loop and quenched to 100 K in a cold nitrogen 
stream.  Data were collected at this temperature using a Bruker D8 Venture diffractometer 
with Mo Kα radiation (λ = 0.71073 Å) and a Photon 100 CMOS detector; crystallographic 
data are summarized in Table 2.6.  A total of 10345 reflections were collected (3012 
independent) using phi and omega scans.  Data collection, processing (SAINT), and scaling 
(SADABS) were performed using the Apex 3 software package.105 The monoclinic space 
group P21 was determined from the systematic absences.  The structure was solved using 
intrinsic phasing (SHELXT) and refined using full matrix least squares techniques 
(SHELXL) using the SHELXTL software suite.106 All non-hydrogen atoms were refined 
anisotropically, and hydrogen atoms were then placed in geometrically optimized positions 
using appropriate riding models.  The presence of two hydrogen atoms on the amine 
nitrogen atoms was confirmed on the difference electron density map prior to hydrogen 
atom assignment at these positions.  The proper absolute structure was confirmed by a 
Flack parameter of 0.06(2). 
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Table 2.6. Summary of crystallographic data for Cu(SeMet)2. 
 Cu(SeMet)2 
Chemical formula C10H20CuN2O4Se2 
F.W. (g mol-1) 453.74 
Temperature, K 100(2)  
Wavelength, Å 0.71073 
Crystal system Monoclinic 
Space group P21 
a, Å 9.4131(7) 
b, Å 4.9660(4) 
c, Å 16.0824(11) 
β, ˚ 90.897(2) 
V, Å3 751.7(1) 
Z 2 
D, g cm-3 2.005 
Absorption coefficient, mm-1 6.305 
Crystal size, mm3 0.021 × 0.124 × 0.268 
F(000) 446 
2θ range, ˚ 2.16 to 26.38 
Collected reflections 10345 
Unique reflections 3012 
Rint 0.0542 
Final R (obs. data)α, R1; wR2 0.0382; 0.0700 
Final R (all data)α, R1; wR2 0.0497; 0.0733 
Flack parameter 0.06(2) 
Largest diff. peak/hole (e/Å3) 0.506/-0.575 
 
Plasmid DNA transfection, amplification, and purification.  
Plasmid DNA (pBSSK) was purified from DH1 E. coli competent cells using a 
ZyppyTM Plasmid Miniprep Kit (400 preps, Fisher). Plasmid was dialyzed against 130 
mM NaCl for 24 h at 4°C to ensure all Tris-EDTA buffer and metal contaminates were 
removed, and plasmid concentration was determined by UV-vis spectroscopy at a 
wavelength of 260 nm. Absorbance ratios of A250/A260  0.95 and A260/A280  1.8 were 
determined for DNA used in all experiments. Plasmid purity was determined through 
digestion of plasmid (0.1 pmol) with Sac 1 and KpN1 in a 10x Fast Digest Buffer (Thermo 
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Scientific) at 37°C for 90 minutes. Digested plasmids were compared to an undigested 
plasmid sample and a 1 kb molecular weight marker using gel electrophoresis. 
 
DNA damage gel electrophoresis experiments  
 For the DNA damage assays with copper, deionized water, MOPS buffer (10 mM, 
pH 7.0), NaCl (130 mM), ethanol (100%), 10 mM), CuSO4∙5H2O, ascorbic acid (7.5 µM, 
to reduce Cu(II) to Cu(I)), and penicillamine were combined in an acid-washed (1 M HCl 
for ~ 1 h) and dried microcentrifuge tube and allowed to stand for 5 min at room 
temperature. Plasmid (pBSSK, 0.1 pmol in 130 mmol NaCl) was then added to the reaction 
mixture and allowed to stand for 5 min at room temperature. H2O2 (50 µM) was added and 
allowed to react at room temperature for 30 min. EDTA (50 µM) was added after 30 min 
to quench the reaction. For the Fe(II) DNA damage experiments, the 2 µM FeSO4∙7H2O 
and MES buffer (10 mM, pH 6.0) were used. All concentrations are final concentrations in 
a 10 µM volume. Samples were loaded into a 1% agarose gel in a TAE running buffer 
(50); damaged and undamaged plasmid was separated by electrophoresis (140 V for 60 
min). Gels were stained using ethidium bromide and imaged using UV light. The amounts 
of nicked (damaged) and circular (undamaged) were analyzed using UViProMW software 
(Jencons Scientific Inc.). Intensity of circular plasmid was multiplied by 1.24, due to the 
lower binding affinity of ethidium bromide to supercoiled plasmid.107,108  Intensities of the 
nicked and supercoiled DNA bands were normalized for each lane so that % nicked + % 
supercoiled = 100%. Plots of percent inhibition of DNA damage versus log concentration 
of amino acid were fit to a variable-slope, sigmoidal dose-response curve using SigmaPlot 
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(v. 9.01, Systat Software, Inc., San Jose, CA). IC50 value errors represent standard 
deviations of the values obtained from fits of three separate experiments. Data and IC50 
plots for all gel electrophoresis experiments are provided in Tables 2.7-2.8 and Figures 
2.11-2.12. 
 
 
 
2.5  Supplementary Data 
 
 
Figure 2.9 Representative titration (0.1 M NaOH, I = 0.1 M NaClO4, 25˚C) and speciation diagram for the 
potentiometric titration of Cu(II) and methionine in a 1:2 ratio. The solid blue line represents the modeled 
titration with the measured data points overlayed; formation of [Cu(Met)]+, Cu(Met)2, and Cu(Met)(OH) 
species are indicated as shown in the legend. 
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Figure 2.10 Crystal packing diagram for Cu(SeMet)2. The long range intermolecular interactions of the 
carboxylate oxygens (red) with the copper ions (turquoise) in the axial positions are designated by dashed 
bonds. 
 
 
 
Figure 2.11ESI-MS data for  Cu(NO3)2 (2 mM) and methionine (4 mM) with 0.01 M NaClO4 in 
methanol/water at pH 5. The inset shows the isotopic distribution that confirms the identify of [Cu(Met)]+ 
and [Cu(Met)(OH)]+ species. 
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Figure 2.12 ESI-MS of FeSO4 (2 mM) and methionine (4 mM) in 0.01 M NaClO4 in methanol/water at pH 
5. The inset shows the isotopic distribution that confirms the identity of the [Fe(Met)2]+ species. 
 
 
 
Figure 2.13 A) Gel electrophoresis image showing copper-mediated DNA damage inhibition by 
penicillamine. MW: 1 kb molecular weight marker; lane 1: plasmid DNA (p); lane 2: p + H2O2. lane 3: p + 
penicillamine (100 μM) + H2O2; lane 4: p + CuSO4 (6 μM) + ascorbate (7.5 μM) H2O2; lanes 5-11: p + H2O2 
+ Cu(II) + AA + 0.1, 1, 5, 10, 25, 50, 100 μM, respectively. B) A graph of log penicillamine concentration 
vs. DNA damage inhibition showing the best-fit sigmoidal dose-response curve; IC50 value = 26.94 ± 0.07 
M). 
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Table 2.7 Gel electrophoresis results for DNA damage inhibition by penicillamine (Pen) with Cu(II), ascorbate, and 
H2O2.a 
Gel 
lane 
Contents 
[Pen] 
(µM) 
% Supercoiled 
DNA 
% 
Nicked 
DNA 
% DNA 
Damage 
Inhibition 
p Value 
1 plasmid DNA (p) 0 99.58 ± 0.73 0.42 - - 
2 p + H2O2 (50 µM) 0 100 ± 0 0.00 - - 
3 p + penicillamine + H2O2 100 99.86 ± 0.25 0.14 - - 
4 
p + Cu(II) (6 µM) + ascorbate (7.5 µM) + 
H2O2 
0 11.37 ± 4.91 
88.63 
- - 
5 p + Cu(II) + AA + H2O2 + Pen 0.1 11.40 ± 2.03 88.60 0.03 ± 2.03 0.982 
6  1 16.61 ± 6.97 83.39 5.90 ± 6.94 0.279 
7  5 25.01 ± 7.55 74.99 15.38 ± 7.52 0.071 
8  10 33.93 ± 5.55 66.07 25.42 ± 5.57 0.016 
9  25 50.66 ± 3.13 49.34 44.30 ± 3.11 0.002 
10  50 73.02 ± 2.84 26.98 69.57 ± 2.84 <0.001 
11  100 73.71 ± 4.11 26.29 70.33 ± 4.13 <0.001 
aData are reported as the average of three trials with calculated standard deviations shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
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Figure 2.14 Gel electrophoresis image showing iron-mediated DNA damage inhibition by penicillamine. 
MW: 1 kb molecular weight marker; lane 1: plasmid DNA (p); lane 2: p + H2O2. lane 3: p + penicillamine 
(2000 μM) + H2O2; lane 4: p + FeSO4 (2 μM) + H2O2; lanes 5-11: p + H2O2 + Fe(II) + 10, 100, 250, 500, 
750, 1000, 2000 μM, respectively. B) A graph of log penicillamine concentration vs. DNA damage 
inhibition showing the best-fit sigmoidal dose-response curve; IC50 value = 591 ± 1 M). 
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Table 2.8 Gel electrophoresis results for DNA damage inhibition by penicillamine (Pen) with Fe(II), ascorbate, and H2O2.a 
Gel 
lane 
Contents 
[Pen] 
(µM) 
% 
Supercoiled 
DNA 
% Nicked 
DNA 
% DNA 
Damage 
Inhibition 
p Value 
1 plasmid 0 100.0 ± 0 0.0 - - 
2 p + H2O2 (50 µM) 0 100 ± 0 0.0 - - 
3 p + penicillamine + H2O2 2000 100 ± 0 0.0 - - 
4 p + Fe(II) (2 µM) + H2O2 0 5.85 ±  94.15 - - 
5 p + Fe(II) + H2O2 + penicillamine 10 0.70 ± 0.7 99.30 - 5.47 ± 0.70 0.005 
6  100 0.35 ± 0.35 99.65 -5.84 ± 3.61 0.107 
7  250 4.53 ± 7.77 95.47 -1.40 ± 7.77 0.785 
8  500 37.10 ± 4.40 62.90 33.19 ± 4.40 0.006 
9  750 71.45 ± 4.45 28.55 69.68 ± 4.45 0.001 
10  1000 82.10 ± 0.60 17.90 80.99 ± 0.60 < 0.001 
11  2000 89.90 ± 2.95 10.10 89.27 ± 2.95 < 0.001 
aData are reported as the average of three trials with calculated standard deviations shown. 
 
1
2
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CHAPTER THREE 
COORDINATION COMPLEXES OF METHIMAZOLE WITH COPPER: 
CONTROLLING REDOX REACTIONS AND SULFUR EXTRUSION 
 
3.1  Introduction 
Immense diversity in stoichiometry and redox activity has been demonstrated for 
the coordination of N-heterocyclic thioamides with softer metal centers such as Cu(I) and 
Fe(II).
1-4 This remarkable flexibility in redox activity has led to the exploration of 
thioamides in catalysis,5,6 radiopharmaceuticals,7 energy production,8 corrosion 
resistance,9,10 sensors,11 and organometallic and coordination chemistry.12,13 Although 
thioether- and thiol-containing amino acids have attracted considerable attention as ligands 
due to their bioavailability, imidazole thiones are of recent interest due to their sigma donor 
bonding ability,4,14 potential for multidentate binding, and redox activity.15 Methimazole 
(MMI), is the most widely prescribed hyperthyroid treatment in the U.S.16 and is believed 
to bind Fe(II) in the heme protein, thyroid peroxidase.17 The exact mechanism of action for 
MMI is poorly understood, and its biological redox activity and metal coordination has not 
been investigated fully. MMI is also structurally similar to ergothioneine, a known 
biological antioxidant.18 Upon oxidation, MMI forms the corresponding disulfide, MMIDS, 
a reaction reminiscent of cysteine oxidation to cystine.   
Under inert atmosphere conditions, Cu(I)-MMI coordination has been widely 
studied, and a wide variety of mono-,19,20 di-,21-24 tetra-,25 and polynuclear26,27 complexes 
are reported. The two mononuclear Cu(I) complexes [Cu(MMI)3][NO3]
28 and   
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Figure 1.1. N-heterocyclic thione and disulfide compounds discussed in this study: A) methimazole (MMI), 
B) methimazole disulfide (MMIDS), C) methimazole monosulfide (MMIMS), and D) 2-mercaptoimidazole 
(HMI). 
 
[Cu(MMI3)Cl]
29 have monodentate coordination through the MMI sulfur atom and 
coordinate trigonal planar geometry. The multinuclear and polymeric complexes include 
S-bridging methimazole ligands bound to Cu(I) in trigonal planar or tetrahedral geometry. 
The dinuclear species form Cu2S2 rhombohedral cores, distorting the tetrahedral 
coordination around Cu(I). The relatively short Cu-S bond lengths (2.3-2.5 Å) in these 
dinuclear complexes are similar to the Cu-S(Cys) bond lengths observed in blue copper 
proteins, and indicate high π-covalency.30  
In an unusual reaction illustrating the facile redox chemistry of methimazole and 
copper, copper promotes sulfur extrusion from methimazole disulfide (MMIDS) to form a 
methimazole monosulfide ligand (MMIMS; Figure 3.1).  In the first step, Cu(II) oxidizes 
methimazole to its disulfide with and is reduced to Cu(I) (Scheme 3.1, reaction A).15 In the 
presence of O2 from air, Lobana and coworkers
31 established that Cu(I) was oxidized to 
Cu(II) and the disulfide was oxidized to a sulfone, resulting in sulfur elimination (Scheme 
3.1, reaction B) and formation of MMIMS, with mass spectroscopy data supporting the 
formation of the disulfide, the sulfone, and the monosulfide. The in-situ-generated  
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Scheme 3.1. Reduction of Cu(II) by methimazole (A) and subsequent oxidation of Cu(I) with sulfur 
extrusion (B) in air. 
 
MMIMS ligand coordinates Cu(II) in a bidentate fashion through an N atom on each of the 
heterocycles.27,32-37 To date, no Cu(II) or Cu(I) complexes incorporating the intact MMIDS 
ligand are reported.  
To determine the effects of oxygen on the coordination chemistry of copper and 
methimazole, a series of reactions with Cu(II) or Cu(I) and MMI or MMIDS were performed 
air-free and in air, yielding several novel dinuclear and polynuclear Cu(I)-MMI complexes. 
Under aerobic conditions, a series of novel Cu(II) complexes with the sulfur-extruded 
MMIMS ligand were obtained, resulting in a greater mechanistic understanding of this 
unusual reaction. These goals were achieved through the contributions of Amanda Owen, 
for the development of the MMIDS synthesis and crystallization, Sam Struder, for her part 
in the synthesis of the 2-mercaptoimidazole polymer, {[CuI2(μ-HMI)3](NO3)2}n, and Colin 
D. McMillan for his expertise in X-ray crystallography. 
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3.2  Results and Discussion 
Synthesis 
 The disulfide MMIDS can be generated in situ by air oxidation of MMI to yield the 
Zn(MMIDS)Cl2 complex,
38 and single crystal structures of the charged [MMIDSH2][ClO4] 
species,39 where the imidazole nitrogen atoms are protonated or methylated,39 have been 
isolated. However, direct synthesis of the neutral MMIDS ligand has not been previously 
reported. By modifying a method for synthesis of the neutral t-butyl-substituted MMIDS40, 
MMIDS(1) can be successfully synthesized in 49% yield.  
Three variables were analyzed when exploring reactions between copper and 
methimazole: the oxidation state of the copper, the monomeric (MMI) or oxidized dimeric 
form of methimazole (MMIDS), and the presence of oxygen. To determine the effect of 
copper oxidation state in the reaction, separate reactions of [Cu(NCCH3)4][BF4] or 
Cu(BF4)2 was treated with methimazole in acetonitrile were performed (Scheme 3.2A and 
3.2B). After stirring both reactions for 18 h, the same dinuclear copper(I) complex [Cu2(μ-
MMI)2(MMI)4][BF4]2 (2) is the primary product. With the [Cu(NCCH3)4]
+ starting 
material, 2 forms in 68% yield and is air stable in the solid state for several weeks, although 
sulfur extrusion is reported when the reaction is stirred for 3-4 days.31 With Cu(BF4)2 as 
the copper source, the blue reaction solution becomes colorless, indicating reduction of 
Cu(II) to Cu(I), with concomitant formation of MMIDS (Scheme 3.2B), and 2 was isolated 
as a colorless solid in 36% yield. Formation of MMIDS in addition to 2 was verified by 
MALDI-MS of the reaction solution (m/z 229 for [MMIDSH]+), but no Cu(I)-coordinated 
MMIDS product was isolated. Raper23 previously synthesized complex 2  
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Scheme 3.2. Reaction conditions used to evaluate the effects of copper oxidation state and counterions on 
product formation.  
 
from Cu(BF4)2 using similar methods, but MMI
DS formation during the reaction was not 
examined. Although O2 was readily available during synthesis, there was no indication of 
sulfur elimination with acetonitrile as the solvent and tetrafluoroborate as the counterion, 
either in analysis of the reaction mixture by MALDI-MS or in the isolated products. 
Sulfur extrusion to form copper-coordinated MMIMS ligands is typically observed 
for reactions performed in air with Cu(NO3)2 as the copper source.
31,34-36,41 To examine the 
oxygen dependence of MMIMS formation, Cu(NO3)2 and methimazole were combined 
under air-free conditions. Upon Cu(NO3)2 addition, the blue reaction mixture immediately 
becomes colorless, indicating  Cu(II) reduction to Cu(I) by methimazole. MMIDS formation 
was confirmed by mass spectrometry. The polymer, {[CuI(μ-MMI)(MMI)](NO3)}n (3; 
10% yield) was isolated under air-free conditions (Scheme 3.2C). Subsequent attempts to 
reproduce the synthesis of this product for further characterization were unsuccessful and 
resulted in isolation of the previously reported, mononuclear [Cu(MMI)3][NO3] complex.
28  
A parallel, air-free reaction was also examined by combining Cu(NO3)2 with 2-
mercaptoimidazole (HMI; Scheme 3.2D), the structurally similar but unmethylated 
135 
imidazole thione (Figure 3.1). This reaction also resulted in formation of a novel polymeric 
Cu(I) complex, {[CuI2(μ-HMI)3](NO3)2}n (4) in 21% yield. No evidence for sulfur 
extrusion was observed under air-free conditions, supporting the key role of oxygen in the 
elimination of the sulfur from the disulfide.   
A similar reaction was performed under aerobic conditions (Scheme 3.2B). When 
MMI in acetonitrile is added to Cu(NO3)2 in methanol in a 4:1 ligand-to-metal ratio, the 
blue Cu(II) solution turns light yellow, indicating the reduction of the copper ion to Cu(I). 
After stirring for 12 hours, the solution turns back to light blue, due to oxidation of Cu(I) 
back to Cu(II) in air. After stirring for 3 days, products were isolated under a variety of 
conditions, using several different solvents (Scheme 3.3). One previously reported product, 
[CuII(η2-MMIMS)2(H2O)2][NO3]2 (5),31 was obtained through ether diffusion into the 
reaction mixture, and previously reported, CuII(η2-MMIMS)2(H2O)2][CH3SO4]2 (6) 42 as 
well as the novel [CuII(η2-MMIMS)2(H2O)][CH3SO4][HSO4]·H2O (7) were obtained by 
solvent evaporation. [CuII(η2-MMIMS)2(H2O)][CH3SO4]2 (8) was obtained by slow 
evaporation after a reaction time of only 18 hours. The sulfate-bound [CuII(η2-MMIMS)(η2-
SO4)(CH3OH)] (9) and [Cu(η2-MMIMS)(η2-SO4)(DMSO)]·0.5 DMSO (10) complexes 
were obtained when the ligand-to-metal ratio was reduced to 2:1. Mass spectrometry results 
of the reaction solutions confirm the presence of a number of Cu-MMI and Cu-MMIDS 
fragments with no evidence of MMIMS formation.  
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Scheme 3.3. Treating methimazole (MMI) with Cu(NO3)2 under aerobic conditions results in a variety of 
sulfur-extruded (MMIMS) products 5, 6, 7, 8, 9, and 10 that are dependent on MMI stoichiometry, reaction 
duration, and crystallization conditions. 
 
 Although sulfate or methylsulfate ions were not present in the starting materials of 
the reactions that yielded complexes 6-10, sulfate and methylsulfate counterions are 
observed in the isolated products. This suggests that these counterions were formed from 
oxidation of the extruded sulfur during the course of the reaction.  In cases where only two 
equivalents of MMI were used in this reaction, one of the two Cu(II)-coordinated MMIMS 
ligands observed in complexes 5-8 is replaced with Cu(II)-coordinated sulfate in 
complexes 9 and 10.  In the reported synthesis of 6, copper(II) sulfate was used as a 
reactant, so the source of the sulfate could not be positively identified.  
 To determine whether sulfur elimination to form complexes 5-10 is dependent on 
copper oxidation state, MMIDS was treated with [Cu(NCCH3)4]
+ under air-free conditions 
(Scheme 3.4). After 3 h stirring, [CuI2(μ-MMIDS)(MMIDS)2](BF4)2 (11) was isolated in 22% 
yield. In subsequent attempts to reproduce this synthesis, only the [Cu(NCCH3)4][BF4] 
starting material was recovered. This suggests that [Cu(NCCH3)4][BF4] may be more  
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Scheme 3.4. Treating MMIDS with Cu(I) under air-free conditions yields the novel, dinuclear Cu(I) 
complex [Cu2(MMIDS)3][BF4]2 (11). 
stable than 11, perhaps due to the strain on the disulfide bond induced in crystallization, as 
discussed in the Structural analysis of Cu-methimazole complexes section. 
From the reactions shown in Schemes 3.1, 3.2, and 3.3, it is evident that oxygen 
availability, copper ionization state, and counter ion and solvent effects all influence the 
products formed with these relatively straightforward reactants. Cu(I) forms complexes 
with both the thione sulfur of MMI, as seen in complexes 1 and 2, as well as the nitrogens 
of MMIDS, as seen in complex 11, but control of oxygen is crucial. Sulfur extrusion is only 
observed under aerobic conditions, as exemplified by complexes 5-10. Although disulfide 
oxidation to sulfinates or sulfonates is fairly common,43-46 sulfur elimination has only been 
reported for MMI reactions. The identity of the metal also plays a critical role. Complexes 
with imidazole disulfide ligands are reported with a variety of metals: Co(t-butyl-
MMIDS)2Cl2,
47 Zn(t-butyl-MMIDS)2Cl2,
40
 Fe(t-butyl-MMI
DS)2Cl2,
40  Ni(t-butyl-
MMIDS)2Cl2,
40
 and Zn(MMI
DS)Cl2
38 All of these complexes are synthesized under aerobic 
conditions with no evidence of sulfur oxidation or elimination. Aside from the Cu(II) 
complexes mentioned above, no other metal complexes are reported with the MMIMS 
ligand, although sulfur extrusion to form MMIMS was observed when 
hydrotris(thioimdiazolyl) borate was treated with iodine.48  
After MMI coordination to redox-active Cu(I) and subsequent oxidation to the 
MMIDS, the formation of monosulfide methimazole-Cu(II) complexes were consistently 
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observed. Subsequent Cu(II) coordination of the monosulfide (MMIMS) is favored in a 
bidentate fashion in the equatorial position, with a variety of solvents coordinating in the 
axial positions. Disulfide oxidation to sulfinate is common,43,44,46 but this generally results 
in the breaking of the disulfide bond rather than complete oxidation and elimination of a 
sulfur atom. The presence of methylsulfate ions in 6-8 indicates that nucleophilic attack of 
methanol on a sulfur atom may occur prior to sulfur elimination.  
 
NMR spectroscopy  
1H NMR spectra were obtained only for Cu(I) complexes 2, 3, and 4 due to Cu(II) 
paramagnetic effects in complexes 5, 6, 7, 8, 9, and 10. The 1H NMR spectrum of 2 shows 
a small downfield shift for the MMI methyl resonance compared to unbound MMI (δ 3.53 
vs. 3.42; Table 1), whereas the olefinic protons shift slightly upfield by an average of δ 0.1 
compared to unbound methimazole. In contrast, similar dinuclear complexes, such as 
[Cu2(ebit)2(MMI)2][BF4] (ebit = ethylene bis-imidazole thione),
49 show a downfield shift 
of the MMI olefinic protons upon copper coordination, indicating an increase in the 
electron density of the heterocycle.  
For the Cu(I) polymeric complexes 3 and 4, opposing shifts in the olefinic 
resonances are observed. The MMI olefinic resonance shifts downfield upon complexation, 
but the HMI olefinic responances shift slightly upfield. The imidazole –NH peak at δ 12.06 
of the unbound methimazole is broad, indicating exchange. Upon complexation, this 
resonance is no longer observed for the polymeric 3, and is shifted significantly upfield for 
the dinuclear 2.  
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Table 3.1. 1H NMR resonances (in CD3CN) for ligands and their Cu(I) complexes. 
Compound 1H NMR Resonances 
 δ CH3 δ CH δ NH 
MMI 3.42 6.87,7.05 12.06 
2 3.54 6.83, 6.90 10.32 
3 3.66 7.06, 7.13 - 
HMI - 7.10 12.56 
4 - 6.85 11.98 
 
  
Infrared spectroscopy  
Compared to the C=S stretching band for unbound MMI in the infrared (IR) 
spectrum (1273 cm-1), Cu(I) complex 2 has three separate C=S stretching bands at similar 
energies (1267, 1279, and 1267 cm-1), consistent with IR data for 2 reported by Raper.23 
Although little change in energy of the δ C=S vibration is observed upon copper-MMI 
binding compared to MMI (674 vs, 673 cm-1, respectively), the π C-S band shifts to lower 
energy (515 cm-1 for 2 and 529 cm-1 for MMI). This shift indicates that the double bond 
character of the thione in the polymer is increased, which one would not expect as the 
copper coordination occurs and is not indicated in the bond length of the complex, which 
is significantly longer for 2 as compared to methimazole. Broadening in the 1020-1100 cm-
1 range typical of the tetrafluoroborate ion was observed in 2.  
   
Structural analysis of MMIDS and Cu-methimazole complexes 
 N-heterocyclic disulfides with t-butyl and benzyl substituents on one nitrogen atom 
have been reported by Figueroa and coworkers,40 and the ionic form of methimazole 
disulfide, with protons on one or both of the heterocyclic nitrogen atoms, has also been 
isolated.  However, the structure of neutral MMIDS (Figure 3.2 and Table 3.2), is reported 
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here for the first time. In contrast to [H(MMIDS)]+ and [H2(MMI
DS)]2+, 1 has no observable 
electron density around the unmethylated nitrogen of the imidazole ring, supporting the 
lack of protonation at N2 (Figure 3.2B). The MMIDS molecules form layers along the b-
axis with dihedral angles of 90.2˚ along the C-S-S-C bonds, as seen in the packing diagram 
in Figure 3.7.   
 Structures were also obtained for the Cu(I) complexes, [CuI2(μ-
MMI)2(MMI)4](BF4)2 (2), {[Cu
I(μ-MMI)(MMI)](NO3)}n (3), and {[CuI2(μ- 
HMI)3](NO3)2}n (4), (Figure 3.3 and Table 3.3). X-ray data for 2 is consistent with previous  
 
Figure 3.2. A) Crystal structure diagrams with 50% probability density ellipsoids for MMIDS (1). Hydrogen 
atoms are omitted for clarity in A. B) Structure diagram showing hydrogen atoms, emphasizing the lack of 
protonation at the N2 atom. 
 
 
 
Table 3.2. Selected bond lengths (Å) and angles (˚) for 1. 
 Bond length (Å)  Bond Angle (˚) 
S1-S2 2.1010(4) C1-S1-S1 101.72(3) 
C1-S1 1.7413(8) S1-C1-N2 123.81(6) 
C1-N1 1.3678(10)   
C1-N2 1.3295(11)   
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reports,23 although our unit cell dimensions are slightly smaller (Table 3.7), likely due to 
structural determination at a lower temperature (100 K). Since all other structures in the 
present study were collected at low temperature, data from this low temperature structure 
of 1 will be used for comparisons.  
 The two polymeric methimazole complexes 2 and 3 have distorted tetrahedral 
geometry (τ = 0.895) and trigonal planar geometry around Cu(I), respectively (Figure 3.3 
and Table 3.3). Complex 2 exhibits an alternating Cu-S-Cu-S backbone incorporating one 
terminal and two bridging MMI ligands. Cu-S bond lengths (2.2243(4) Å and 2.2620(4) Å 
for terminal and bridging MMI, respectively) are shorter than the Cu-S bond lengths of 2 
for both bridging (2.4394(4) Å) and terminal (2.3136(4) Å MMI ligands), due to the 
difference in Cu(I) coordination geometry. Similar to 3, the polymeric structure of 4 with 
HMI ligands also has trigonal planar geometry around Cu(I), but a double S-Cu-S-Cu  
backbone is formed in which all of the S atoms are bridging (Figure 3.3B). The structures 
of copper-methimazole coordination polymers with bridging halides, {Cu3Br3(MMI)3} and 
{Cu2I2(MMI)2}n,
41 are reported, but this is the first homoleptic Cu-methimazole polymer. 
In the polymeric structures of 3 and 4, π-π interactions resulting in alignment of the 
heterocyclic rings provides stability. Intermolecular and intramolecular π-π interactions are 
of particular interest in polymer research, and the 
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Figure 3.3. Crystal structure diagrams with 50% probability density ellipsoids for A) {[CuI(μ-
MMI)(MMI)](NO3)}n 3 (top) and B) {[CuI2(μ-HMI)3](NO3)2}n 4 (top). Hydrogen atoms and counterions are 
omitted for clarity. Diagrams showing the extended structures for A) 3 with a single Cu-S-Cu-S backbone 
(bottom) and B) 4 with the bridging sulfurs creating a double Cu-S-Cu-S backbone (bottom.) 
Table 3.3. Selected bond lengths (Å) and angles (˚) for 2, 3, and 4. Sb denotes a bridging sulfur and St 
denotes a terminal sulfur. 
 2 3 4 
Cu-Sb 2.3475(4) 
2.2620(4) 
2.2739(4) 
2.2374(12) 
2.2534(12) 
2.2773(11) 
Cu-St 2.4394(4) 2.2243(4) - 
C-Sb 1.7157(11) 1.7243(16) 
1.728(4) 
1.731(6) 
C-St 1.7055(11) 1.7143(15) - 
Sb-Cu-St 117.154(13) 125.94(2) - 
Sb-Cu-Sb 103.029(10) 118.79(2) 
135.13(5) 
118.45(5) 
105.56(5) 
C-Sb-Cu 99.40(4) 
108.24(6) 
104.11(5) 
109.56(15) 
103.49(14) 
106.22(12) 
C-St-Cu 107.75(4) 105.03(5) - 
Cu-Sb-Cu 76.972(10) 106.00(2) 
93.28(4) 
108.23(7) 
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incorporation of a redox active metal such as copper enhances both spectrochemical and 
electrochemical properties.50-53 
Six differentstructures incorporate the sulfur-extruded MMIMS ligand: [CuII(η2-
MMIMS)2(H2O)2][NO3]2 (5), ([Cu
II(η2-MMIMS)2(H2O)2][CH3SO4]2 (6), ([CuII(η2-
MMIMS)2(H2O)][CH3SO4][HSO4]·H2O (7), ([CuII(η2-MMIMS)2(H2O)][CH3SO4]2 (8),  
CuII(η2-MMIMS)(η2-SO4)(CH3OH) (9), and Cu(η2-MMIMS)(η2-SO4)(DMSO)·0.5 DMSO 
(10). These Cu(II) complexes can be grouped into three categories based on cationic 
structure: 1) octahedral geometry with two MMIMS ligands in the equatorial positions 
bound in a bidentate fashion through the nitrogen atoms and two waters in the axial 
positions (5 and 6, Figure 3.4B and Table 3.4), 2) distorted square pyramidal geometry 
with two MMIMS ligands in the equatorial positions and one water in the axial position (7 
and 8, Figure 3.4A and Table 3.4), and 3) distorted tetrahedral geometry with one MMIMS 
ligand in the equatorial position, one bidentate sulfate in the equatorial position, and a 
solvent molecule (methanol or DMSO) in the axial position (9 and 10). Since the structure 
of 5 is published,31 it will not be discussed in depth. Octahedral 6 is also reported,42 but it 
will be used as a representative octahedral cation, to compare to 7 and 8, and for general 
discussion of the fate of the extruded sulfur.  
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Figure 3.4. Crystal structure diagrams with 50% probability density ellipsoids for A) ([CuII(η2-
MMIMS)2(H2O)][CH3SO4][HSO4]·H2O (7), showing the distorted square pyramidal geometry with an axial 
water molecule, and B) ([CuII(η2-MMIMS)2(H2O)2][CH3SO4]2 (6), showing octahedral geometry with two 
coordinated water molecules. Hydrogen atoms and counterions are omitted for clarity. 
 
 
Table 3.4. Selected bond distances (Å) and angles (˚) for the [Cu(MMIMS)2(H2O)x]2+ complexes 5, 6, 7, and 
8, with x = 2 for 5 and 6  and x = 1 for 7 and 8. 
 5 6 7 8 
Cu-N1 2.0172(12) 2.000(2) 1.9969(17) 2.0034(18) 
Cu-N3 2.0172(12) 2.002(2) 1.9998(17) 1.9943(18) 
C1-S1 1.7474(15) 1.760(3) 1.746(2) 1.755(2) 
C5-S1 1.7520(15) 1.768(3) 1.751(2) 1.756(2) 
Cu-OW 2.4514(12) 2.4186(19) 2.1926(16) 2.1864(16) 
N3-Cu-N5 180 180 169.86(7) 169.20(7) 
N3-Cu-N7 91.58(5) 89.06(9) 91.97(7) 89.33(7) 
N5-Cu-N7 88.42(5) 90.94(9) 87.16(7) 88.41(7) 
N3-Cu-O1 88.61(5) 87.12(8) 100.09(7) 97.10(7) 
N3-Cu-O2 91.39(5) 90.79(8) -- -- 
  
Complexes 9 and 10 have distorted square pyramidal geometry about the copper 
ion and only one molecule of MMIMS is coordinated in an equatorial position, (Figure 3.5 
and Table 3.5). Equatorial coordination is completed by bidentate coordination of sulfate, 
although the equatorial plane is distorted due to the ring strain inherent in the 4-membered 
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chelate ring formed by the sulfate with copper. A solvent molecule coordinates in the axial 
position for both 9 (CH3OH) and 10 (DMSO), varying depending on the solvent present 
during crystallization. All of these products are solvent dependent, since H2O, CH3OH, and 
DMSO stabilize the axial positions of the five-coordinate or six-coordinate complexes.  
The coordinated water molecules are likely from the waters of hydration of the 
Cu(NO3)2∙3H2O starting material, since dry solvents were used in all the reactions. 
In the first copper structure with this ligand, the nitrogen atoms of one terminal, 
bidentate MMIDS ligand in [CuI2(μ-MMIDS)(MMIDS)2][BF4]2 (11) and one nitrogen atom 
of a bridging MMIDS ligand coordinate each Cu(I) center, resulting in trigonal planar 
 
 
Figure 3.5. Crystal structure diagrams with 50% probability density ellipsoids for A) 9 and B) 10. Both 
structures exhibit bidentate coordination of Cu(I) with in situ-generated sulfate and methanol (9) or DMSO 
(10) coordination. Hydrogen atoms and counter ions are omitted for clarity. 
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Table 3.5. Selected bond distances (Å) and angles (˚) for [Cu(MMIMS)(SO4)(L)]2+ complexes. For 9, L = 
CH3OH and for 10, L = DMSO). 
 9 10 
Cu-N1 1.9547(16) 1.959(3) 
Cu-N3 1.9587(16) 1.957(3) 
C1-S1 1.7473(19) 1.744(4) 
C5-S1 1.7493(18) 1.746(4) 
Cu-OW 2.2186(15) 2.259(3) 
Cu-O1 2.0083(13) 1.992(3) 
N3-Cu-O2 160.84(7) 160.00(12) 
N3-Cu-O1 95.41(6) 94.65(12) 
N1-Cu-N3 93.40(6) 93.95(13) 
N3-Cu-O5 100.82(6) 101.05(12) 
O2-Cu-O1 71.29(6) 71.73(11) 
 
 
geometry (Figure 3.6 and Table 3.6). Complex 11 is folded over with the bend in the 
molecule occurring through the C-S-S-C bond of the bridging molecule. The terminal 
MMIDS ligands form a 7-membered ring with each Cu(I). The Cu(I) trigonal planar 
geometry is distorted, with bond angles of 110.81(11)˚, 119.53(11)˚, and 129.64(12)˚. The 
N-Cu-N angle closest to 120˚ (119.53(11) of the N4-Cu1-N1) is the ring-incorporated 
angle, indicating that the distortion of the other two angles is due to the strain of the 
bridging MMIDS. The C-S-S angle (101.25˚) of the terminal MMIDS ligands does not 
change from unbound MMIDS (101.72(3)˚). However, the bridging MMIDS bond angle is 
slightly broadened to 105.55(12)˚, indicating strain on the disulfide bond. The 
intramolecular Cu-Cu distance is 3.521 Å in 11, and the intermolecular distance between 
Cu(I) of adjacent molecules is 3.705 Å (Figure 3.8).  
The S-S bond length for all three MMIDS ligands in 11 (2.0659(12)-2.0813(14) Å) 
is slightly smaller than that of unbound MMIDS (2.1010(4) Å), but the C-S bonds do not 
significantly change (1.7413(8) Å in unbound MMIDS (1) and 1.748(3) Å in 11). The C1-
N1 bond in the imidazole ring is 1.327(4) Å, compared to 1.470(4) Å for the N2-C4 bond  
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Figure 3.6. Crystal structure diagram with 50% probability density ellipsoids for 11. Hydrogen atoms and 
counterions are omitted for clarity. The side view of 11 is shown in B, showing the intramolecular stacking 
and the disulfide ligand bridging the Cu(I) ions. 
 
 
 
 
 
 
 
Table 3.6. Selected bond distances (Å) and angles (˚) for 11. 
 Bond length (Å)  Bond Angle (˚) 
Cu1-N4 1.960(3) N4-Cu1-N1 119.53(11) 
Cu1-N1 2.021(3) N4-Cu1-N5 129.64(12) 
Cu1-N5 1.976(3) N5-Cu1-N1 110.81(11) 
S1-S2 2.0659(12) C5-S2-S1 101.65(12) 
C5-S2 1.748(3) C1-S1-S2 101.25(11) 
Cu-Cu 3.705 C9-S3-S4 (br) 105.55(12) 
C1-N1 1.327(4)   
C4-N2 1.470(4)   
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to the methyl group. The shorter bond length is consistent with the aromaticity of the 
imidazole ring and is consistent with the imidazole C-N of the unbound ligand (1.3295(11) 
Å).   
For all of the structures, little change is observed in the C-S bond length (1.75 Å), whether 
the methimazole S is terminal, bridging, or in the monosulfide or disulfide ligands. This 
bond length is significantly longer than the C=S bond in uncoordinated methimazole (1.686 
Å54) or dimethylimidazole thione (1.698 Å55), and is shorter than the C-S single bonds of 
thiols (1.86 Å). This suggests that the C-S bond is an extension of the electron 
delocalization exhibited in the heterocycle. In addition, the bond length of the non-
methylated nitrogen of the imidazole ring and sulfur-bound carbon shortens upon 
complexation compared to the protonated, unbound ligands. This shortening in bond length 
suggests that electron density is shifted to the ring upon coordination for all complexes. 
The thione exhibits a remarkable capacity to bridge copper ions, as seen in 
complexes 1, 2, and 3. Even when MMIDS is formed in the reduction of Cu(II) (Scheme 
3.2B and 3.2C), the resulting Cu(I) ion shows preference for coordination of the thione of 
MMI over the imidazole nitrogen atoms in MMIDS. As seen in the Cu(I) polymers, the 
imidazole moiety also increases stability to the three-dimensional structure through π-
stacking.  
 
Revising the sulfur extrusion mechanism 
 Sulfur extrusion is observed for all reactions performed in air with the Cu(NO3)2 
starting material (Scheme 3.3). MMIDS initially forms as Cu(II) is reduced by MMI 
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(Scheme 3.1); however, in the reaction and/or crystallization process, a sulfur atom is 
eliminated from the disulfide, and the resulting MMIMS coordinates Cu(II). Previous 
groups have attributed oxidation of the disulfide bond to either water44 or dioxygen 
exposure.31 Subsequent sulfur elimination is only observed in the presence of strong 
oxidizers such as nitrate,56,57 or in the presence of electron-rich transition metals, such as 
copper.31,33-36,58,59 The most detailed mechanism for sulfur extrusion from MMIDS to form 
MMIMS is proposed by Lobana and coworkers,31 but this mechanism fails to 1) incorporate 
the critical role of copper coordination, 2) does not address stoichiometry in the oxidation 
of the sulfur, and 3) does not address the role of the solvent in formation of the methyl 
sulfate counterion.  
 A revised mechanism for this sulfur extrusion reaction is proposed in Scheme 3.5. 
As in the mechanism proposed by Lobana and coworkers,31 oxidation of MMI to MMIDS 
is facilitated by Cu(II) reduction to Cu(I). Cu(I) coordinates MMIDS, similar to the 
coordination we observe in complex 11. In the presence of oxygen, one of the MMIDS 
sulfur atoms is then oxidized to the sulfone, with concomitant oxidation of Cu(I) to Cu(II). 
Nucleophilic attack by water or methanol on the sulfone sulfur then initiates cleavage of 
the S-S bond to form an imidazole thiolate.  Cu(II) coordination is likely vital to keep the 
nucleophilic imidazole thiolate in proximity to the now-separated, second imidazole ring. 
Nucleophilic attack by the imidazole thiolate on the C=S carbon of the second imidazole 
ring eliminates the extruded sulfur as sulfite or methylsulfite. Sulfite oxidation to sulfate 
catalyzed by transition metals, including copper, is well known,60,61 and in this case, 
possible formation of superoxide from the oxidation of Cu(I) to Cu(II) by oxygen may also 
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contribute to sulfite oxidation.61 Incorporation of water or methanol to generate sulfate or 
methylsulfate ions from the extruded sulfur is consistent with the sulfate and methylsulfate 
ions present in complexes 6-10.  Overall, this nucleophilic aromatic substitution 
mechanism is similar to that observed for thiolate deprotection of nitrobenzenesulfonyl. 
 Oxidation of disulfide bonds has been extensively studied under a variety of 
conditions,62-66 and Cu(II) can oxidatively cleave disulfide bonds to form sulfinates.43,44 
Oxygen from air participates in the oxidation of the disulfide bond, but Cu(II) is shown to 
be crucial to disulfide oxidation, as opposed to other transition metals, such as Zn2+.37 Only 
aromatic, heterocyclic thiones have demonstrated the ability to eliminate one of the 
disulfide sulfur atoms by oxidation,31,33-36,59 giving support to the proposed nucleophilic 
aromatic substitution mechanism as well as the importance of copper coordination to keep 
the nucleophilic thiolate in proximity to the site of nucleophilic attack. 
3.3 Conclusions 
 Control of Cu(I) and Cu(II) reactions with methimazole was explored utilizing a 
variety of counterions, solvents, and the presence or absence of oxygen. In the absence of 
oxygen, Cu(I) reacts with MMI to form multinuclear complexes stabilized by bridging 
thiones and π-stacking, indicating an environment rich in electrons. In the presence of 
oxygen with tetrafluoroborate counterion, the dinuclear [Cu2(MMI)6][BF4]2 complex is the 
favored product with both Cu(I) and Cu(II) starting materials. In the presence of oxygen 
and nitrate, sulfur extrusion by oxidation of the MMIDS ligand results in the formation of a 
variety of Cu(II)-MMIMS complexes, with variation introduced by the solvent system and 
molar ratios of ligand available. To form MMIMS, sulfur oxidation and elimination of
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Scheme 3.5. New proposed mechanism for formation of MMIDS by Cu(II) reduction, formation of the sulfone by  
reaction with dioxygen, and eventual sulfur extrusion via nucleophilic aromatic substitution. 
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sulfite or methylsulfite likely occurs to generate sulfate and methylsulfate ions, 
catalytically oxidized by the available copper. Cu(II) coordination likely imposes entropic 
control to align the resulting thiolate for nucleophilic aromatic substitution.  
 MMIDS is a bridging ligand in the dinuclear Cu(I) complex [Cu2(MMI
DS)3][BF4], 
but poor reaction yields and high recovery of the starting material suggest that this is not a 
particularly stable complex. Based on the reaction conditions and complexes obtained, 
Cu(I) coordination favors the thione of MMI, whereas Cu(II) favors bidentate coordination 
of the MMIMS to form five-membered, almost planar, rings in the equatorial position.  
 The complexity of redox reactions between methimazole, copper, and other 
oxidative sources such as solvents and oxygen indicates a wide range of potential 
interactions within the cellular system. The propensity to coordinate copper ions in both 
the oxidized and reduced state, along with the sensitivity to oxidative species, has potential 
implications for biological MMI reactivity and catalysis with redox systems incorporating 
copper. 
 
3.4 Experimental Methods 
General Methods 
1-Methylimidazole thione (methimazole, MMI), copper(II) nitrate heptahydrate, 
and copper(II) tetrafluoroborate were purchased commercially. 
Tetrakis(acetonitrile)copper(I) tetrafluoroborate was prepared according to published 
procedures.67 Reactions were performed air-free where indicated, utilizing standard 
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Schlenk techniques under argon. IR spectra of the ligands and complexes were acquired in 
the range 4000-450 cm-1 as Nujol mulls on KBr plates or as KBr pressed pellets, as 
indicated, on a Magna 550 IR spectrometer. IR absorption abbreviations are vs, very 
strong; s, strong; m, medium; w, weak; b, broad; sh, shoulder. 1H and 13C{1H} NMR 
spectra were obtained using Bruker-AVANCE 300 and 500 MHz NMR spectrometers. 
Chemical shifts are reported in δ relative to tetramethylsilane (δ 0) and referenced to 
solvent. MALDI mass spectrometry experiments were performed using a Bruker Microflex 
MALDI-TOF mass spectrometer with trans-2-3-(4-tert-butylphenyl)-2-methyl-2-
propenyldiene (m/z 250.3) as the matrix. All peak envelopes matched calculated values.  
 
Synthesis of bis(1-methylimidazol)-2-yl-disulfide, MMIDS (1) 
  Synthesis of 1 was performed by adapting the published synthesis of the t-butyl-
methimazole disulfide.40 I2 (1.62 g, 6.4 mmol) was added in portions to a solution of 1-
methylimidazole thione (MMI; 1.46 g, 12.8 mmol) and NEt3 (1.86 mL, 13.4 mmol) in 
CH2Cl2 (100 mL). The resulting orange mixture was stirred for 30 min and H2O (100 mL) 
was added. The resulting layers were separated, and the CH2Cl2 layer was washed with 
H2O (2 × 50 mL), dried over Na2SO4 for an additional 45 min, and filtered. After filtration, 
the solvent was removed in vacuo to give MMIDS as a yellow powder (671 mg, 46 %). 
Crystals suitable for X-ray diffraction were grown from chloroform in diethyl ether.  1H 
NMR (300 MHz, d6-DMSO): δ 3.43 (s, 6H, CH3), 7.09 (s, 1H, CH), 7.46 (s, 1H, CH). 
13C{1H} NMR (d6-DMSO ):δ 33.4 (CH3), 126.0 (CH), 130.3 (CH), 138.1 (C=S). IR (Nujol, 
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cm-1): 3902 w, 2725 w, 1313 w, 1283 s, 1159 w, 1128 s,b, 919 s, 794 s, 724 s, 683 s, 500 
s.  
 
Synthesis of [Cu2(MMI)4(μ-MMI)2](BF4)2 (2) 
 Method 1. Under air-free conditions, a solution of (MMI; 137 mg, 1.20 mmol) in 
acetonitrile (10 mL) was transferred by cannula to a solution of Cu(BF4)2·6H2O (104 mg, 
0.30 mmol) in acetonitrile (5 mL). As MMI was added a light green precipitate formed that 
turned yellow-white upon filtration and drying under vacuum. The precipitate was washed 
with diethyl ether (10 mL). Crystals of 2 were obtained by ether diffusion into an 
acetonitrile solution. Yield: 566 mg, 57 %. IR (Nujol mull, cm
-1): 3161 w, 3116 w, 2727 s, 
1577 vs, 1517 w, 1462 vs, 1401 vs, 1350 s, 1289 s, 1279 s, 1267 s, 1246 w, 1160 s, 1108 
b, 1063 b, 992 b, 918 w, 850 w, 763 s, 728 vs, 695 w, 673 s, 599 w, 515 s. 1H NMR (500 
MHz, CD3CN): δ 3.54 (s, 18H, CH3), 6.83 and 6.90, (each, d, 6H, C-H), 10.32 (br s, 5.5 H, 
N-H). 13C{1H} NMR (CD3CN): 34.1 (CH3), 115.1 (CH), 120.9 (CH), 156.5 (C=S). Anal. 
Calc. for C24H36B2Cu2F8N12S6: C, 29.24; H, 3.68; N, 17.05. Found: C, 29.03; H, 3.66; N, 
16.86. 
 Method 2. Complex 2 was also synthesized using the procedure outlined in method 
1, except that [Cu(CH3CN)4]BF4 (94 mg, 0.30 mmol) was used in place of Cu(BF4)2·6H2O. 
Yield: 566 mg, 57 %.  
 Method 3. A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (10 mL) was 
transferred via cannula into a solution of [Cu(CH3CN)4]BF4 (94 mg, 0.30 mmol) in 
acetonitrile (10 mL) under argon. The solvent volume was reduced by half in vacuo, and 
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then diethyl ether was added to precipitate out the product. The resulting white precipitate 
was filtered, washed with diethyl ether, and dried in vacuo. This reaction was also 
performed in air, affording the same product with a similar yield. Yield: 663 mg, 67%. 
 
Synthesis of {[Cu(μ-MMI)(MMI)](NO3)}n (3) 
 Under argon, a solution of MMI (137 mg, 1.20 mmol) in acetonitrile (10 mL) was 
transferred via cannula into a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in 
acetonitrile (5 mL). The solution was stirred for 3 hours and an oil formed upon solvent 
removal in vacuo. Methanol (5 mL) was added to dissolve the oil, and diethyl ether was 
diffused into the solution to afford needle-like, colorless crystals. Yield: 39 mg, 10.%. 1H 
NMR (500 MHz, CD3CN): 3.66 (s, 6 H, CH3), 7.06 (s, 2H, CH), 7.13 (s, 2H, CH). 
13C{1H} 
NMR (CD3CN): 34.3 (CH3), 120.2 (CH), 122.6 (CH), 150.6 (C=S). 
 
Synthesis of {[Cu2(μ-HMI)3](NO3)2}n (4) 
 Under argon, a solution of HMI (120 mg, 1.20 mmol) in methanol (10 mL) was 
transferred via cannula into a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in methanol 
(10 mL). After stirring for 3 h, the blue solution became colorless, and a white precipitate 
formed. The precipitate was filtered, washed with diethyl ether (10 mL), and dried in 
vacuo. X-ray quality crystals were obtained by diffusion of diethyl ether into a methanolic 
solution of 4. Yield: 118 mg, 21%. MALDI-MS (m/z): [Cu(C3H4N2S)2]
+ 262.3, 
[Cu(C3H4N2S)]
+ 163.9. 1H NMR (500 MHz, CD3CN): 6.85 (s, 6H, CH), 11.98 (br s, 6H, 
NH). IR (Nujol mull, cm-1): 3095 b,s, 2974 b,s, 2862 b,s, 2683 b,s, 1595 s, 1583 vs, 1459 
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s, 1319 vs, 1288 s, 1251 w, 1231 w, 1223 w, 1084 w, 1041 w, 912 s, 873 b, 761 s, 727 s, 
680 s, 498 w. Anal. Calc. for C9H12Cu2N8O6S3: C, 19.60; H, 2.19; N, 20.32. Found: C, 
19.93; H, 2.25; N, 19.33. 
 
Synthesis of [Cu(η2-MMIMS)2(H2O)2](NO3)2 (5) 
 A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added 
to a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in acetonitrile (5 mL), and the reaction 
mixture slowly turned light green. After stirring in air for 3 d, the solution became bright 
blue. The reaction mixture was allowed to slowly evaporate over a week to form blue 
crystals of 5. Lighter blue crystals were also isolated and identified as CuSO4·5H2O. The 
product obtained was consistent with that reported by Lobana and coworkers. Yield of 5: 
110 mg, 18%. Anal. Calc. for C9H12Cu2N8O6S3: C, 19.60; H, 2.19; N, 20.32. Found: C, 
19.93; H, 2.25; N, 19.33. 
 
Synthesis of [Cu(η2-MMIMS)2(H2O)2](CH3SO4)2 (6)  
 A solution of MMI (228 mg, 2.00 mmol) in acetonitrile (10 mL) was added to a 
solution of Cu(NO3)2∙3H2O (120 mg, 0.50 mmol) in acetonitrile (10 mL). The colorless 
reaction mixture became blue after 1 h stirring, and a white precipitate formed. The 
precipitate was filtered and dried in vacuo. Methanol (5 mL) was added to dissolve the oil, 
and deep blue crystals of 6 formed upon solvent evaporation in air. The product obtained 
was consistent with the reported complex by Baldwin and coworkers. Yield: 369 mg, 52%. 
IR (Nujol mull, cm-1): 3435 b, 3139 w, 2728 w, 1634 s, 1588 sh, 1532 w, 1487 sh, 1254 s, 
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1218 s, 1062 w, 1032 w, 1007 w, 960 w, 760 b, 710 sh, 655 w, 619 s, 576 w, 561 sh. Anal. 
Calc. for C18H38CuN8O10S4: C, 30.10; H, 5.33; N, 15.60. Found: C, 29.32; H, 5.81; N, 
15.53. 
 
Synthesis of [Cu(η2-MMIMS)2(H2O)][CH3SO4][HSO4][H2O] (7) 
 A solution of MMI (137 mg, 1.20 mmol) in 10 mL of acetonitrile was slowly added 
to a solution of Cu(NO3)2 ∙3H2O (73 mg, 0.30 mmol) in acetonitrile (10 mL), and the 
reaction mixture initially turned a light green. Upon stirring for 7 d, the solution turned 
blue, and the solvent was removed in vacuo to yield a dark-blue oil. Methanol (5 mL) was 
added to dissolve the oil, and blue crystals of 7 formed upon evaporation in air. Yield: 334 
mg, 48%. IR, (Nujol mull, cm-1): 3430 b, 3152 w, 3130 w, 2725 w, 2669 w, 1634 s, 1530 
s, 1517 w, 1418 w, 1348 sh, 1307 w, 1286 w, 1234 s, 1147 b, 1059 s, 957 s, 867 sh, 849 s, 
755 s, 708 w, 694 w, 687 w, 617 w, 581 s, 599 s, 521 w, 508 w, 460 w, 442 w. Anal. Calc. 
for C17H28CuN8O10S4: C, 29.33; H, 4.05; N, 16.09. Found: C, 27.31; H, 3.82; N, 15.83. 
 
Synthesis of [Cu(η2-MMIMS)2(H2O)](CH3SO4)2 (8) 
 A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added 
to a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in dichloromethane (2 mL). As the 
MMI was added, a dark precipitate formed immediately and then redissolved with stirring, 
and the reaction mixture then turned light green. After stirring in air for 3 d, the reaction 
mixture turned bright blue, and a blue precipitate formed. The solution was filtered, and 
the isolated blue precipitate was highly hygroscopic, so the precipitate was quickly 
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dissolved in methanol (5 mL). Diethyl ether diffusion into the methanolic solution over the 
period of a week yielded crystals of 8. Yield: 123 mg, 32%. MALDI-MS (m/z): 
[Cu(C3H4N2S)2]
+ 262.3, [Cu(C3H4N2S)]
+ 163.9. IR (Nujol, cm-1) 3430 b, 2727 w, 1577 s, 
1517 w, 1481 w, 1401 sh, 1246 s, 1160 w, 1108 w, 885 sh, 850 s, 768 s, 728 w, 516 w.  
 
Synthesis of [Cu(η2-MMIMS)(SO4)(CH3OH)] (9) 
 A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added 
to a solution of Cu(NO3)2∙3H2O (146 mg, 0.60 mmol) in acetonitrile (5 mL). As MMI was 
added, the reaction mixture slowly turned light green. After stirring in air for 3 d, the 
solution turned a light blue, and the solvent was removed in vacuo. Methanol (5 mL) was 
added to dissolve the resulting oil, and crystals were obtained by slow evaporation of the 
methanolic solution in air. Yield: 90 mg, 13%. 
 
Synthesis of [Cu(η2-MMIMS)(SO4)(DMSO)]∙ 0.5 DMSO (10)  
 A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added 
to a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in acetonitrile (5 mL). As MMI was 
added, the reaction mixture slowly turned light green. After stirring in air for 3 d, the 
solution turned a light green, and the solvent was removed in vacuo. Dimethylsulfoxide (5 
mL) was added to dissolve the resulting oil, and crystals were obtained by tetrahydrofuran 
diffusion into the DMSO mixture. Yield: 76 mg, 16%. 
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Synthesis of [Cu2(η2-MMIDS)2(μ-MMIDS)](BF4)2 (11) 
 Under argon, a solution of bis(1-methylimidazol)-2-yl-disulfide (198 mg, 0.986 
mmol) in methanol (6 mL) was slowly added to a solution of [Cu(CH3CN)4](BF4)2 (173 
mg, 0.550 mmol) in dichloromethane (2 mL), and the resulting reaction mixture was 
allowed to stir for 3 h. The solvent volume was then reduced to ~3 mL in vacuo, and 
crystals of 11 were grown by ether diffusion. Yield: 223 mg, 22.3%. 
 
X-ray crystallography 
Single crystal X-ray diffraction measurements were performed at 100 K using Mo Kα 
(λ = 0.71073 Å radiation on a Bruker D8 Venture diffractometer with an Incoatec 
microfocus source and a Photon 100 CMOS detector. The Apex3 software suite was used 
for data collection,  processing, and scaling corrections.68,69 A summary of crystallographic 
data for 1-4 is available in Table 3.7, data for 5-7 are in Table 3.8, and data for 8-11 are in 
Table 3.9. Space group assignments were made based on systematic absences. Structures 
were solved by intrinsic phasing (SHELXT), and refined to convergence by full-matrix 
least squares using the SHELXTL software suite.70 All non-hydrogen atoms were refined 
anisotropically. Hydrogen atoms attached to carbon atoms were placed geometrically and 
treated using appropriate riding models.  Positions of hydrogen atoms attached to nitrogen 
and oxygen atoms were first verified using the difference electron density maps, and then 
placed in geometrically optimized positions using riding models.  The final positions of 
these hydrogen atoms did not differ significantly from where their position was first 
indicated on the difference electron density map. 
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Several structures in the present study required somewhat special treatment during the 
refinement process.  In the case of 3, the nitrate counterion and methanol solvent molecule 
were found to be disordered in several different orientations.  Thus, their electron density 
was best modeled using the SQUEEZE algorithm in the PLATON software package.71  For 
7, the methyl sulfate counterion was modeled in two disordered orientations.  In 10, the 
coordinated DMSO molecule was found to be disordered, with the sulfur and carbon atoms 
modeled over split positions and the occupancy values for the two disordered orientations 
refined as free variables. 
 
 
 
3.5 Supplementary Information 
 
 
Figure 3.7  Packing diagram along the b-axis for MMIDS (1). Yellow atoms: sulfur; blue atoms: nitrogen; 
grey atoms: carbon; white atoms: hydrogen. 
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Figure 3.8. Packing diagram for [Cu2(MMIDS)3][BF4]2. Yellow atoms: sulfur; dark blue atoms: nitrogen; grey 
atoms: carbon; white atoms: hydrogen; light blue atoms: copper; green atoms: fluorine; and dark grey atoms: 
boron. 
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Table 3.7. Summary of crystallographic data for MMIDS (1) and Cu(I) complexes 2, 3, and 4. 
 1 2 3 4 
Chemical formula C8H10N4S2 C24H36B2Cu2F8N12S6 C9H16CuN5O4S2 C9H12Cu2N8O6S3 
F.W. (g mol-1) 226.32 985.71 385.93 551.53 
Temperature, K 100(2) 100(2)  100(2) 100(2) 
Wavelength, Å 0.71073 0.71073 0.7103 0.71073 
Crystal system Monoclinic Monoclinic Monoclinic Orthorhombic 
Space group C2/c  P2/c P2/c Pnma 
a, Å 12.2875(8) 14.4704(17) 16.3614(8) 6.4334(4) 
b, Å 7.3836(5) 15.7849(17) 13.9033(7) 30.109(2) 
c, Å 11.2422(7) 8.3677(10) 6.9472(3) 9.1569(7) 
α, ˚ 90 90 90 90 
β, ˚ 98.514 (2) 94.269(3) 98.539(2) 90 
γ, ˚ 90 90 90 90 
V, Å3 1008.72(11) 1906.0(4) 1562.81(13) 1773.7(2) 
Z 4 2 4 4  
D, g cm-3 1.490 1.718 1.640 2.065  
Absorption coefficient, mm-1 0.492 1.523 1.686 2.801  
Crystal size, mm3 0.2040.2090.311 0.020.4010.416 0.1670.1740.566 0.0330.1780.335  
F(000) 472 1000 792 1104  
2θ range, ˚ 3.23 to 33.23 2.76 to 31.00 2.52 to 29.99 2.33 to 26.00  
Collected reflections 13154 58706 45916 13711  
Unique reflections 1919 6050 4546 1770  
Final R (obs. Data)α, R1 0.0256 0.0216 0.0282 0.0395  
wR2 0.0696 0.0593 0.0696 0.1140  
1
6
2
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Table 3.8. Summary of crystallographic data for complexes 5, 6, and 7. 
 5 6 7 
Chemical formula C16H24CuN10O8S2 C38H30CuN8O10S4 C17H28CuN8O10S4 
F.W. (g mol-1) 612.11 710.28 696.25 
Temperature, K 100(2) 140(2) 140(2) 
Wavelength, Å 0.71073 0.71073 0.71073 
Crystal system Monoclinic Monoclinic Triclinic 
Space group P 2/n P 2/n P-1 
a, Å 8.6291(9) 8.3452(4) 8.6675(13) 
b, Å 13.5838(16) 8.4167(5) 12.442(2) 
c, Å 10.3684(11) 20.3354(12) 13.658(2) 
α, ˚ 90 90 70.800(5) 
β, ˚ 100.436(4) 99.568(2) 79.904(5) 
γ, ˚ 90 90 78.593(5) 
V, Å3 1195.2(2) 1408.47(14) 1353.8(4) 
Z 2 2 2  
D, g cm-3 1.701 1.675 1.708  
Absorption coefficient, mm-1 1.154 1.138 1.182  
Crystal size, mm3 0.0560.0640.122 0.0440.1120.176 0.0870.1680.204  
F(000) 630 734 718  
2θ range, ˚ 2.83 to 27.50 2.62 to 25.50 2.70 to 26.50  
Collected reflections 26649 33742 57400  
Unique reflections 2734 2613 5596  
Final R (obs. Data)α, R1 0.0253 0.0346 0.0289  
wR2 0.0592 0.0825 0.0706  
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Table 3.9  Summary of crystallographic data for complexes 8, 9, 10 and 11. 
 8 9 10 11 
Chemical formula C9H14CuN4O5S2 C18H28CuN8O9S4 C11H19CuN4O5.56S3.50 C25H31.50B2Cu2F8N12.50S6 
F.W. (g mol-1) 385.90 692.26 471.05 1000.19 
Temperature, K 100(2)  100(2) 100(2) 100(2) 
Wavelength, Å 0.71073 0.71073 0.71073 0.7103 
Crystal system Triclinic Triclinic Monoclinic Monoclinic 
Space group P1 P1 P 2/c P 2/c 
a, Å 7.2792(7) 9.0467(8) 12.4725(4) 7.0458(4) 
b, Å 9.7671(9) 12.2650(11) 9.4873(3) 24.9693(16) 
c, Å 10.1282(9) 13.2201(2) 15.3776(5) 22.3144(15) 
α, ˚ 95.449(3) 72.176(3) 90 90 
β, ˚ 104.276(3) 81.140(3) 96.3480(10) 96.468(2) 
γ, ˚ 96.167(3) 74.176(3) 90 90 
V, Å3 688.27(11) 1341.492) 1808.48(10) 3900.8(4) 
Z 2 2 4 4  
D, g cm-3 1.862 1.714 1.730 1.703  
Absorption coefficient, mm-1 1.917 1.645 1.645 1.490  
Crystal size, mm3 0.0820.0860.088 0.0310.1330.461 0.0310.1330.461 0.0480.1120.387  
F(000) 394 968 968 2020  
2θ range, ˚ 2.09 to 30.57 2.67 to 25.25 2.67 to 25.25 2.46 to 25.50  
Collected reflections 33902 22581 22581 70149  
Unique reflections 4212 3276 3276 7276  
Final R (obs. Data) R1 0.0266 0.0427 0.0427 0.0418  
wR2 0.0886 0.0850 0.0850 0.0941  
 
1
6
4
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CHAPTER FOUR  
REACTIVITY OF NON-INNOCENT IMIDAZOLE DISULFIDE AND DISELENIDE 
LIGANDS WITH COPPER 
 
4.1  Introduction 
 Disulfide bonds play crucial roles in the structure, function, and catalytic activity 
of many proteins,1,2 and metal complexes with ligands that incorporate disulfide bonds have 
been used in polymers,3-8 switches,9,10 and photodetectors.11 Their high bond-dissociation 
energies contribute stability, and their redox properties can be tuned by steric strain, the 
nature of the local environment, and oxygen availability.12,13 In thioredoxin enzymes, thiol-
disulfide exchange reactions involve electron transfer from a higher-potential disulfide 
bond to redox-ready thiols, enabling a domino-effect of electron transfer using sulfur-sulfur 
bonds.9 Disregulation of disulfide bond formation is implicated in development of 
Creutzfeldt-Jakob disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and 
various cancers.14-19 
 Diselenide bonds are not as prevalent in biological systems or in biomimetic 
materials, although the diselenide bond has been identified in proteins20,21 and non-native 
diselenides have been used to drive oxidative folding of proteins.22  Selenocysteine is an 
essential component in a number of redox enzymes, including glutathione peroxidase, 
iodothyronine diodinases, and thioredoxin reductases,23 but the redox mechanism in these 
enzymes does not involve diselenide bond formation. Lower reduction potentials and 
broader reactivity limit the stability of diselenide bonds in biological systems,24,25 but 
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diselenides are promising antioxidants due to their ability to react with thiol groups in a 
glutathione peroxidase-like manner.26 
 Metals such as copper and iron serve as electron sinks for catalyzing disulfide-to-
thiol reductions in metalloproteins.9,27 Recently, heterocyclic thiones have attracted 
attention for the similarity of their redox properties to thiols, their ability to bond softer 
metals such as Cu(I) and Fe(II),28-30 and their ability to form disulfide bonds.31 Under 
anaerobic conditions, a wide variety of mono-,32,33 di-,32,34-36 tetra-,35 and polynuclear37,38 
complexes have been reported as products of reactions between Cu(I) and methimazole 
(MMI; Figure 4.1). With the exception of two mononuclear complexes 
[Cu(MMI)3][NO3]
32 and [Cu(MMI3)Cl],
34 the products are typically multinuclear 
complexes that include bridging MMI ligands. Reactions of Cu(I) and the oxidized form of 
methimazole, methimazole disulfide (MMIDS; Figure 4.1), have not been explored in depth. 
Only two metal complexes with coordinated MMIDS are reported, [Cu(MMIDS)3][BF4]
39 
and Zn(MMIDS)Cl2,
40 although Figueroa and coworkers41 synthesized complexes  of Zn2+, 
Fe(II), Cu(I), Co2+, and Ni2+ with t-butyl (tBu-MMIDS) and Co2+ with phenyl (Ph-MMIDS) 
substituents in place of the methyl group. Structures with Cu(II), Cd2+, Hg2+, and Zn2+ 
coordinated to the selenium-containing methimazole diselenide (MMIDSe; Figure 4.1) are 
also reported.42,43  
In reactions of MMI with Cu(II), MMI is typically oxidized to MMIDS and copper 
is reduced to Cu(I).31 It is believed that a similar reaction of MMISe with Cu(II) results in 
formation of MMIDSe, but upon treating Cu(ClO4)2 with MMI
Se in air, a selenium atom is 
eliminated from MMIDSe and the monoselenide complex [Cu(MMIMSe)2(H2O)2][ClO4]2 is 
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isolated.44 In these studies, reactions were performed with Cu(I) and MMIDS or MMIDSe 
under air-free conditions to explore the possibility of reversible disulfide/thione and 
diselenide/selone formation. A similar reaction of Cu(I) with MMIDSe was performed in 
air, resulting in three separate products isolated from the same reaction mixture and 
demonstrating the variable chemistry that can occur when combining a redox-active metal 
with a non-innocent ligand. The work in this chapter was performed in collaboration with 
Dr. Colin McMillen, Managing Director of the Molecular Structure Center at Clemson 
University.  
 
Figure 4.1. Sulfur- and selenium-containing imidazole ligands discussed in this work. 
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4.2  Results and Discussion 
Synthesis 
 Transition metal complexes with heterocyclic thiones have been extensively 
examined, but few complexes of the disulfide forms of these heterocycles exist.40,41,45 
Formation of MMIDS  in Zn(MMIDS)Cl2 was generated by air oxidation of MMI. Figueroa 
and coworkers demonstrated that electron-rich Ni0 reduces the structurally-similar, tBu-
MMIDS (Figure 4.1) to the corresponding thione.41 Cu(II) oxidizes MMI to MMIDS with 
concomitant reduction to Cu(I),31 but the reversibility of this redox reaction has never been 
examined.  
 To investigate the reaction between Cu(I) and MMIDS, [Cu(CH3CN)4][BF4] and 
MMIDS were combined under air-free conditions (Scheme 4.1). As MMIDS was added to 
the Cu(I) solution, the reaction mixture initially turned blue, indicating Cu(II) formation. 
Upon stirring for 1 hour, the reaction solution returned to a light yellow color, suggesting 
Cu(II) reduction to Cu(I).Red-orange crystals of the [Cu2(MMI)2(MMI
DS)2][BF4]2 (1) 
product were collected, but yield of 1 was extremely low and attempts to re-isolate this 
compound yielded crystals of the [Cu(CH3CN)4][BF4] starting material and a dark yellow 
oil. 
 
Scheme 4.1. Treating Cu(I) with MMIDS under air-free conditions affords the dimeric complex 
[Cu2(MMI)2(MMIDS)2][BF4]2 (1). 
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 The analogous air-free treatment of [Cu(CH3CN)4][BF4] with MMI
DSe was 
performed under similar conditions (Scheme 4.2). Again, the reaction mixture turned blue 
upon MMIDSe addition, but slowly became light red. Orange-red crystals of 
[Cu2(MMI)2(MMI
DS)2][BF4]2 (2) were obtained, but yield of 2 was also low, and efforts to 
re-isolate this product were unsuccessful. In both complexes 1 and 2, the MMI or MMISe 
ligands are protonated, as confirmed in the crystal structure (vide infra), but the origin of 
these protons is not clear. The reduction of an imidazole disulfide to the monosulfide has 
been observed in a reaction with tBu-MMIDS and Ni0, as described by Figueroa and 
coworkers, however, the Ni0 bonded directly with the imidazole nitrogen, not the thione. 
In this case, a Cu(I)-thione bond is observed, and the imidazole nitrogen is protonated. The 
low yield and irreproducibility may be due to a limited proton source, such as adventitious 
water present in the reaction. There is no obvious source of protons to contribute to the 
protonation of the imidazole, but the most obvious source may be water contamination in 
the solvent. 
 The formation of MMIDS or MMIDSe  with Cu(I) from the reaction of MMI and 
SeMMI with Cu(II), respectively, has been previously discussed in Chapter 3:Coordination 
Complexes of Methimazole with Copper: Controlling Redox Reactions and Sulfur 
Extrustion. The reactions that form complexes 1 and 2 involve cleavage of the 
disulfide/diselenide bond to yield copper-coordinated MMI or MMISe. Formation of the 
disulfide-containing MMIDS in the presence of copper also has been reported, 
demonstrating the potential reversibility of thione/disulfide and selone/diselenide 
formation in the presence of copper. Such reactivity is a result of the redox activity of 
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copper in combination with the non-innocent character of the thione/selone ligands. Cu(I) 
can donate electrons to cleave S-S or Se-Se bonds in MMIDS or MMIDSe, and Cu(II) can 
accept electrons to oxidize MMI or MMISe to the corresponding disulfide/diselenide. While 
the solid-state structure suggests that the bridging disulfide ligand (MMIDS) in [Cu2(N,N-
μ-MMIDS)(MMIDS)2][BF4]2 is strained, it is likely that disulfide cleavage is due to electron 
transfer of the Cu(I), with the metal ion playing a role by ligand association. The same 
reversibility was observed in the Cu(I)-MMIDSe reaction, once again resulting in a mixed 
ligand, dinuclear complex. 
 
Scheme 4.2. Copper coordination complexes formed by treating Cu(I) with MMIDSe. 
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 Upon treatment of Cu(NO3)2 with MMI in air, the resulting Cu(II)-containing 
products are coordinated to methimazole monosulfide (MMIMS) ligands that form by sulfur 
elimination from MMIDS.31,46-50 The only comparable reaction of MMIDSe and Cu(ClO4)2 
in air similarly yields [Cu(MMIMSe)2(H2O)2][ClO4]2 with a monoselenide ligand.
44 
Treating Cu(BF4)2 with MMI does not lead to sulfur elimination products, since it contains 
the non-oxidizing BF4
- ion,39so using Cu(BF4)2  in place of Cu(NO3)2 as a starting material 
is useful for examining the coordination chemistry of MMIDS and MMIDSe without 
chalcogen extrusion. 
 To determine whether selenium elimination from MMIDSe occurs when starting 
with Cu(I) rather than Cu(II), [Cu(CH3CN)4][BF4] was treated with MMI
DSe in air (Scheme 
4.2). Initial formation of a blue solution upon MMIDSe addition indicates Cu(I) oxidation 
to Cu(II), but upon stirring for 1 h in air, the reaction mixture became the same orange-red 
color as described for the synthesis of 2. Upon stirring for 24 h in air, the reaction mixture 
slowly turned green, and four different types of crystals were obtained from slow 
evaporation of the dichloromethane/acetonitrile solution: colorless crystals of the 
[Cu(NCCH3)4][BF4] starting material, purple crystals of 
[Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3), green crystals incorporating two mononuclear 
cations in one asymmetric unit, [Cu(MMIDSe)2][Cu(MMI
Se-CH2-MMI
Se)2][BF4]4 (4a and 
4b, respectively), and yellow-green columns of [Cu(MMISe-CH2-MMI
Se)2][BF4]2. 
 The mixed ligand Cu(II) complex [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3) 
forms by oxidation of Cu(I) to Cu(II) in air, with concomitant selenium elimination from 
one copper-coordinated MMIDSe ligand and selenium addition to a second coordinated 
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MMIDSe ligand.  It is the first complex where Cu(II) coordinates both a monoselenide 
(MMIMSe) and a triselenide (MMITSe) ligand. Roy and coworkers44 observed selenide 
elimination from MMIDSe  in the formation of [Cu(MMIMSe)2(H2O)2][ClO4]2, but the 
eliminated selenium was recovered as a CuSeO3 salt. 
 A small number of green crystals were also isolated from the Cu-MMIDSe reaction 
mixture. This product crystallizes with two different, mononuclear, Cu(II) cationic 
structures per unit cell, [Cu(MMIDSe)2]
2+ (4a) and [Cu(MMISe-CH2-MMI
Se)2] (4b; Scheme 
4.2). In the MMISe-CH2-MMI
Se ligands of 4b, a -CH2 group bridges between selenium 
atoms of the original MMIDSe ligand. It is postulated that this ligand forms upon two 
consecutive substitution reactions of MMISe with the dichloromethane solvent. The yellow-
green columns were identified as [Cu(MMISe-CH2-MMI
Se)2][BF4]2, with the same cationic 
structure as 4b. The identity of the columns was confirmed, but the diffraction quality was 
poor, and the chemical aspects have already been discussed with 4b. 
 
Structural Analyses 
 Although yields were limited, the identity of products 1-4 are confirmed by X-ray 
crystallographic analysis. [Cu2(MMI
DS)2(MMI)2][BF4]2 (1) crystallizes in the C2/c space 
group. This mixed-ligand, dinuclear Cu(I) complex incorporates two sulfur-bridged 
methimazole ligands to create a rhombic Cu2S2 core (Figure 4.2, with selected bond lengths 
and angles in Table 4.1), similar to the homoleptic [Cu2(μ-MMI)2(MMI)4][BF4]2 complex 
reported by Raper and coworkers.35 The terminal, bidentate MMIDS ligands bind Cu(I) 
through the imidazole nitrogen atoms, creating a 7-membered chelate ring. The bridging 
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MMI ligand is protonated, as determined by 1) electron density near the nitrogen, 2) the 
long range H-F interactions between the hydrogen and the fluoride of the tetrafluoroborate, 
seen in the crystal packing structure (Figure 4.2A), and 3) the lengthened C1-N1 bond 
distance (1.349(3) Å) in the imidazole ring, compared to the C=N double bond seen in the 
MMIDS ligand (1.328(3) Å39). 
 In 1, each Cu(I) ion is coordinated by two N and two S atoms in a distorted 
tetrahedral geometry, with angles ranging from 101.5˚ to 117.2˚. Cu-N bond lengths are a 
consistent 2.013(2)-2.014(2) Å, but the Cu-S bond lengths are inequivalent at 2.3511(6) Å 
and 2.4461(6) Å. No significant change is observed in the C-S bond lengths for the MMIDS 
ligand (1.746(2) Å and 1.750(2) Å) compared to unbound MMIDS (1.7413(8) Å39) however, 
the bridging MMI ligand had a shorter C-S distance of 1.715(2) Å, consistent with the shift 
of electron density into the imidazole ring. Ring strain is reflected in the stretch of the N3-
C5-S2 (126.23(18)˚) and N5-C9-S3 (126.09(18)˚) bond angles compared to 123.81(6)˚ 
observed in uncoordinated MMIDS. 
 The disulfide S1-S2 bond length in 1 is 2.0676(10) Å, consistent with the terminal 
MMIDS ligands (2.0659(12) Å and 2.06673(13) Å) in [Cu2(N,N-μ-
MMIDS)(MMIDS)2][BF4]2 but slightly shorter than the bridging MMI
DS (2.0813(14) Å) of 
the same molecule. The S-S bond length in 1 (2.0676(10) Å) is also slightly shorter than in 
unbound MMIDS (2.1010(4) Å39), but is consistent with S-S bond lengths in disulfide the 
same molecule. The S-S bond length in 1 (2.0676(10) Å) is also slightly shorter than in 
unbound MMIDS (2.1010(4) Å39), but is consistent with S-S bond lengths in disulfide 
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Figure 4.2. Crystal structure diagrams of  A) [Cu2(MMIDS)2(MMI)2][BF4]2 (1) and B) 
[Cu2(MMIDSe)2(MMISe)2][BF4]2 (2) with 50% probability density ellipsoids. Hydrogen atoms and counterions 
are omitted for clarity. 
 
 
 
 
Table 4.1. Selected bond distances (Å) and angles (˚) for 1 and 2. 
1 2 
Cu1-N3 2.013(2) Cu1-N1 2.0264(16) 
C5-S2 1.746(2) C1-Se1 1.8971(18) 
S2-S3 2.068(1) Se1-Se2 2.3361(3) 
Cu1-S1 2.3511(6) Cu1-Se3 2.4680(3) 
S1-C1 1.715(2) Se3-C9 1.862(2) 
C1-N2 1.349(3) C9-N5  
C5-N3 1.328(3) C1-N1  
Cu-Cu 3.0368(6) Cu-Cu  
N3-Cu1-N5 117.23(8) N1-Cu1-N3 118.83(6) 
C5-S2-S3 103.49(8) C1-Se1-Se2 101.26(6) 
S2-S3-C9 102.92(9) Se1-Se2-C5 97.18(6) 
S1-Cu1-S1 101.48(2) Se3-Cu1-Se3 91.946(11) 
Cu1-S1-Cu1 78.52(2) Cu1-Se3-Cu 88.055(11) 
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complexes of other transition metals (Fe(II), Co2+, Ni2+, Zn2+).41 In a survey of structural 
data for disulfide bonds in extracellular globular proteins, the average S-S bond distance 
was found to be 2.02 Å,2 significantly shorter than the disulfide bonds in coordinated 
imidazole disulfides. C-S-S bond angles of the terminal MMIDS ligands of [Cu(N,N-μ-
MMIDS)(MMIDS)2[BF4]2 do not change from those of unbound MMI
DS (101.72(3)˚39), but 
there is a significant widening in the bridging MMIDS C-S-S angles ( 105.55(12)˚-
105.65(12˚). Complex 1 falls in the middle, with an average C-S-S bond angle of 103.2˚. 
Torsion angles (χ) for 1 are 92.33˚, 99.22˚ and 98.23˚ for the terminal MMIDS ligands in 
[Cu(N,N-μ-MMIDS)(MMIDS)2[BF4]2 and 86.36˚ for the bridging disulfide. In a study by 
Craig and coworkers,51 ranges of 87˚ to 97˚ were measured for torsion angles of structural 
disulfides in a survey of proteins, and deviations from these angles can result in energy 
strain of several kcal/mol.52,53 
Figure 4.3. Packing diagrams for 1 showing A) the F-H interactions between the BF4- anions and the protons 
on the terminal MMIDS and B) the layering of the BF4- ions along the b-axis. Color scheme: dark blue – 
nitrogen; yellow – sulfur; light blue – copper; grey – carbon; white – hydrogen; green – fluorine; and brown 
– boron. 
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  [Cu2(MMI
DSe)2(MMI
Se)2][BF4]2 (2) is the first reported Cu(I)-MMI
DSe complex. 
Similar to 1, it also features a dinuclear Cu(I) core, with two MMISe ligands bridging 
through the Se atom (Figure 4.2, with selected bond lengths and angles in Table 4.1) and a 
rhombic Cu2Se2 core. The distorted tetrahedral geometry with a τ4 of 0.921 around each 
Cu(I) atom is nearly identical tothat found in 1. However, 2 crystalizes in space group P2/n 
as a result of the expansion of the cation structure due to the increased length of the Cu-Se, 
C-Se, and Se-Se bonds compared to 1. Increased bond length is also observed in a longer 
Cu-Cu distance (3.492(4)) for 2 compared to  1 (3.0368(6)). Once again, the imidazole 
nitrogen of the selone is protonated, as indicated by the electron density around the 
imidazole nitrogen atom; the longer bond length of C12-N6 (1.460(3) Å) of the imidazole 
selone ring compared to the C1-N1 (1.329(2) Å) of the imidazole ring of the disulfide; and 
the H-F hydrogen bonding interactions with the BF4
- counterion.  
 Structurally, MMIDSe does not change to a large extent upon Cu(I) coordination. 
Strain on the diselenide bond is only detected through the slight opening of the N1-C1-Se1 
angle (127.85(14)˚) compared to unbound MMIDSe (122.8(3)˚).54 Similar to the Cu(II) 
complex [TpmiPrCu(MMIDSe)][OTf]2,
43 the Se-Se bond is slightly shorter in 2 (2.3361(3) 
Å) compared to unbound MMIDSe (2.3568(15).54 The C-Se bond length of the bridging 
MMISe ligands are slightly shorter (1.862(2) Å) than the C-Se bond length of the MMIDSe 
ligands (1.8971(18) and 1.8859(19) Å), consistent with greater double-bond character in 
the bridging MMISe ligand. 
 From the packing structures of 1 and 2  (Figures 3B and 4), the similarity between 
the cations can be seen. However, the crystal packing is slightly different for these two 
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complexes, since they crystalize in different in the space groups, C2/c (1) and P2/n (2). 
Although the bond angles and metal coordination geometry are similar for both structures, 
the packing effects of the longer Se-Se, Se-C, and Cu-Se bonds, as compared to the sulfur 
analogs, results in changes to the alignment of the BF4
- counterion that changes the 
symmetry of crystal packing.  
 In the structure of [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3; Figure 4.5, with 
selected bond lengths and angles in Table 4.2), the MMIMSe and MMITSe ligands both 
coordinate the Cu(II) center in a bidentate fashion through the imidazole nitrogen atoms. 
Cu(II) adopts near perfect square pyramidal geometry (τ5 = 0.069), with an acetonitrile 
molecule in the axial position. The MMIMSe ligand forms a 6-membered chelate ring with 
a N3-Cu1-N1 internal angle of 90.81(16)˚. The MMITSe ligand forms an 8-membered 
chelate ring with a similar N7-Cu1-N5 internal angle of 90.03(17)˚. Cu(II) coordination 
 
Figure 4.4. Packing diagram for 2 viewed along the b-axis. Color scheme: dark blue – nitrogen; orange – 
selenium; light blue – copper; grey – carbon; white – hydrogen; green – fluorine; and brown – boron. 
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Figure 4.5. Crystal structure diagram of [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3) with 50% probability 
density ellipsoids. Hydrogen atoms and counter ions are omitted for clarity. 
 
Table 4.2. Selected bond distances (Å) and angles (˚) for 3. 
Bond Length (Å) Bond Angle (˚) 
Se4-Se3 2.3319(8) C13-Se4-Se3 99.01(14) 
Se3-Se2 2.3323(9) Se4-Se3-Se2 103.46(3) 
C13-Se4 1.902(5) Se3-Se2-C9 99.61(15) 
C9-Se2 1.908(5) N7-Cu1-N3 90.03(17) 
Cu1-N7 2.011(4) N7-Cu1-N5 90.02(16) 
Cu1-N5 2.007(4) N3-Cu1-N1 90.81(16) 
Cu1-N3 1.989(4) N5-Cu1-N1 88.04(16) 
Cu1-N1 1.998(4) N7-Cu1-N9 92.80(16) 
C5-Se1 1.893(5) N1-Cu1-N9 93.27(16) 
C1-Se1 1.895(5) N3-Cu1-N9 96.56(16) 
Cu1-N9 2.285(4) N5-Cu1-N9 93.82(19) 
  C5-Se1-C1 93.41(19) 
 
in 3 shows a surprising rigidity, maintaining the 90˚ angle expected for equatorial ligands 
and resulting in observed ring buckling to incorporate the triselenide.  
 Although unbound MMIMSe is not reported, Roy and coworkers44 performed DFT 
calculations to predict the structure of this compound. C-Se bond lengths in the MMIMSe 
ligands of 3 range from 1.893(5) to 1.908(5) Å, consistent with the DFT-calculated C-Se 
distance of 1.908 Å for unbound MMIMSe and the C-Se distance of 1.897 Å for copper-
coordinated MMIMSe in [Cu(MMIMSe)2(H2O)2][ClO4]2.
44 The MMIMSe ligands in 3 have 
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longer C-Se bond lengths than the bridging MMISe ligands in 2 (1.862(5) Å), consistent 
with the greater double-bond character of the MMISe ligand. The C5-Se-C1 bond angle of 
93.41(19)˚ in 3 is smaller than the DFT-calculated value of 97.1˚ for the C-Se-C angle in 
unbound MMIMSe.  
 The MMITSe ligand features a triselenide moiety generated in situ. The chelate ring 
is buckled (Figure 4.2) to accommodate the additional Se atom in a ring with little 
flexibility afforded by the N-C bonds of the imidazole rings. The copper-coordinated 
MMITSe ligand in 3 is structurally similar to that in Ru(MMITSe)(PPh3)Cl2,
55 although the 
triselenide buckle is inverted in the ruthenium complex, and a direct ruthenium-selenium 
bond to the central selenium creates two five-membered rings. Significant lengthening of 
the Se-Se bonds (2.4311(11) and 2.4161(11) Å) is observed in the ruthenium complex 
compared to Se-Se bond lengths of 2.3323(9) and 2.33191(8) Å in 3.  
 The crystal packing diagram of 3 (Figure 4.6) clearly shows the nearly 90˚ dihedral 
angle observed for the triselenide along the C-Se-Se-Se angles. The orientation of the 
monoselenide and triselenide away from the coordination plane of the Cu(II), indicates 
relative proximity of the selenium atoms to the other diselenide. This spatial orientation is 
supportive of selenium migration from one ligand to the other. The BF4
- counterions 
provide structural support for the bulky cation, with minimal interactions with the 
imidazole-carbon protons. 
 The co-crystallized product [Cu(MMIDSe)2][Cu(MMI
Se-CH2-MMI
Se)2][BF4]4 (4) 
formed in the same reaction as 3. The unit cell contains three unique cations, 
[Cu(MMIDSe)2]
2+ (4a) and two structural forms of [Cu(MMISe-CH2-MMI
Se)2]
2+ that are  
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Figure 4.6. Packing diagram for 3 along the a-axis. Color scheme: dark blue – nitrogen; orange – selenium; 
light blue – copper; grey – carbon; white – hydrogen; green – fluorine; and brown – boron. 
 
 
 
Figure 4.7. Crystal structure diagram of co-crystallized 4a and 4b with 50% probability density ellipsoids. 
Hydrogen atoms  and counter ions are omitted for clarity.  
 
very similar, such that the cation containing the Cu2 atom will be used for discussion 
purposes (4b; Figure 4.7 and Table 4.3). The packing diagram can be seen in Figure 4.8. 
Variable coordination geometries and oxidation states are notable features of copper. A 
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four-coordinate Cu(II) cation would typically be expected to be nearly square planar,56 but 
4a exhibits significant shifts toward see-saw geometry with bond angles of  96.7(4)˚ – 
99.7(4)˚ for the pseudo-equatorial bonds and a significant in-plane distortion of 137˚, 
resulting in a τ4 value of 0.609. The bidentate MMIDSe ligands are identical and coordinate 
the central Cu(II) through the imidazole nitrogen atoms. MMIDSe coordination forms a 7-
membered chelate ring with a 92˚ torsion angle, contributing to distortion of the Cu(II) 
equatorial plane.  
 In 4b, the [Cu(MMISe-CH2-MMI
Se)2] complex contains two unusual CH2-bridged 
MMIDSe ligands.  These ligands coordinate the Cu(II) center, affording distorted square-
planar geometry with bond angles of 94.5˚-98.9˚ and a planar distortion of 141.8(4)˚, 
similar to 4a (τ4 = 0.553). The Se-C-Se bond angles of 115.8(11) and 117.4(7)˚ in the 
MMISe-CH2-MMI
Se ligand are significantly broader than the Se-Se-Se bond angle of 
103.46(5)˚ in 3.  
 The packing diagram of 4 (Figure 4.8) illustrates the complexity of the crystal 
structure and reaction products. Two unique molecules with the ligands containing the Se-
C-Se bridge are located on the center of symmetry, so only half of each molecule is unique. 
The cations then alternate in sheets, with the tetrafluoroborate counterions and water 
molecules layering between the sheets. The hydrogen-bond interaction between the water 
and tetrafluoroborate ions can be seen in the packing diagram. The formation of multiple 
of Cu-selone complexes obtained from this two-reactant reaction emphasizes the varied 
and interesting nature of selone chemistry.   
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Figure 4.8 Packing diagram for 4 along the b-axis. Color scheme: dark blue – nitrogen; orange – selenium; 
light blue – copper; grey – carbon; white – hydrogen; green – fluorine; red – oxygen, and brown – boron. 
 
4.3  Conclusions 
 Control of formation and cleavage of disulfide and diselenide bonds with electron-
rich metals such as Cu(I) and Ni0 has significant implications for catalysis and protein 
engineering. In this work, copper-mediated cleavage of the disulfide or diselenide bonds 
in MMIDS or MMIDSe was observed. This is essentially the reverse of the reaction that 
yields Cu(I) and MMIDS from Cu(II) and MMI starting materials under airfree conditions. 
Comparable reactions with methimazole diselenide exhibit a greater diversity of ligand-
rearranged products. In one reaction, products containing monoselenide diselenide, 
triselenide, and carbon-bridged selenide ligands coordinated to Cu(II) were obtained 
simultaneously. While true thione/disulfide and selone/diselenide reversibility may be 
obtainable, both these reactions and control over sulfur or selenium elimination and 
insertion reactions need further investigation. The role of copper in initiating the disulfide 
bond formation and/or cleavage with the thione and selone imidazole ligands highlights 
the potential for interaction of these non-innocent ligands within biological systems.  
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4.4  Experimental Methods 
 
General Methods 
  All reactions were performed under an argon atmosphere of Ar using standard air-
free procedures. Acetonitrile and dichloromethane were purified using standard procedures 
and were freshly distilled under an argon atmosphere prior to use. [Cu(CH3CN)4][BF4],
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bis(1-methylimidazolyl)disulfide (MMIDS),41 and bis(1-methylimidazolyl)diselenide 
(MMIDSe)54 were synthesized according to published procedures. 
 
Synthesis of [Cu2(MMI
DS)2(MMI)2][BF4]2  (1) 
 A solution of MMIDS (0.90 mmol, 133 mg) in acetonitrile (10 mL) was added via 
cannula to a solution of [Cu(CH3CN)4][BF4] (0.60 mmol, 189 mg) in acetonitrile (10 mL) 
under argon. Upon addition of the yellow MMIDS solution, the reaction mixture 
immediately turned a green-blue color that slowly changed back to light yellow over the 
course of 1 h. The reaction mixture was stirred for an additional 3 h and diethyl ether (30 
mL) was added. Orange-red crystals of 1 formed overnight and were filtered and dried. 
Yield: 20 mg, 6.8%. 
 
Synthesis of [Cu2(MMI
DSe)2(MMI
Se)2][BF4]2  (2) 
 A solution of MMIDSe (0.90 mmol, 289 mg) was dissolved in dichloromethane (10 
mL) and then added via cannula to a solution of [Cu(CH3CN)4][BF4] (0.60 mmol, 189 mg) 
in acetonitrile (10 mL) under argon. Upon addition of the orange MMIDSe solution, the 
reaction mixture formed a green precipitate that immediately redissolved and then became 
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light green. After stirring for 1 h, the reaction became a light orange-red. After stirring for 
an additional 2 h, the solvent was reduced to approximately 5 mL in vacuo, and crystals 
were obtained from diethyl ether diffusion over the course of 3 d. After filtration, a few 
crystals of 2 suitable for X-ray diffraction analysis were isolated from a larger amount of 
crystallized [Cu(CH3CN)4][BF4] starting material. Yield: 42 mg, 11%. 
 
Synthesis of [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2  (3) and [Cu(MMI
DSe)2][Cu(MMI
Se-
CH2-MMI
Se)2][BF4]4 (4) 
 In air, a solution of MMIDSe (1.0 mmol, 322 mg) in of dichloromethane (15 mL) 
was added to [Cu(CH3CN)4][BF4] (0.50 mmol, 315 mg) in acetonitrile (15 mL). Upon 
MMIDSe addition, the reaction mixture became green. After stirring for 24 h, the reaction 
solution was slowly evaporated over 3 d to yield multiple crystaline products: colorless 
crystals of [Cu(CH3CN)4][BF4], purple crystals of 3, green crystals of 4a and 4b, and 
yellow-green columns of 4b identified but of poor resolution. Crystals of these different 
products were manually separated for analysis, and no overall yields were determined.  
 
X-ray crystallography 
Single crystal X-ray diffraction measurements were collected at 100-140 K with Mo 
Kα (λ = 0.71073 Å) radiation. A Bruker D8 Venture diffractometer with Incoatec 
microfocus source and a Photon 100 CMOS detector was utilized in the data collection. 
The Apex3 software suite was used for  processing and scaling corrections.58,59 Based on 
systematic absences, space group assignments were made. The structures were solved by 
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intrinsic phasing (SHELXT), and refined to convergence by full-matrix least squares using 
the SHELXTL software suite.60 All non-hydrogen atoms were refined anisotropically. 
Hydrogen atoms attached to carbon atoms were placed geometrically and treated using 
appropriate riding models.  Positions of hydrogen atoms attached to nitrogen and oxygen 
atoms were first verified using the difference electron density maps, and then placed in 
geometrically optimized positions using riding models.  The final positions of these 
hydrogen atoms did not differ significantly from where their position was first indicated 
on the difference electron density map. 
The tetrafluoroborate anion in 1 was found to be disordered, and the fluorine atom site 
occupancies were allowed to freely refine with appropriate similarity restraints placed on 
their anisotropic displacement parameters.  In the case of 3, some disorder was observed 
in the triselenide bridging units.  In these cases the site occupancies of the disordered Se 
atoms were allowed to refine as free variables, with appropriate similarity restraints used 
for their anisotropic displacement parameters.  All crystals of 4 tested proved to be non-
merohedral twins, and the reflections of the twin components were distinguished using the 
program Cell_Now (Sheldrick, G. M. (2008). CELL_NOW. Version 2008/4. Georg-
August-Universität Göttingen, Göttingen, Germany), and processed using the TWINABS 
algorithm of Apex3.  The structure was refined as a two component twin with the minor 
twin component contribution refined as 33% according to the batch scale factor. 
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Table 4.3. Summary of crystallographic data for complexes 1 and 2. 
 1 2 
Chemical formula C24H32B2Cu2F8N12S6 C24H32B2Cu2F8N12Se6 
F.W. (g mol-1) 981.67 1263.07 
Temperature, K 100(2) 100(2) 
Wavelength, Å 0.71073 0.71073 
Crystal system Monoclinic Monoclinic 
Space group C2/c P21/n 
a, Å 26.164(2) 14.950(1) 
b, Å 11.5872(8) 8.1531(6) 
c, Å 15.383(1) 16.101(1) 
α, ˚ 90 90 
β, ˚ 125.60(2) 95.801(3) 
γ, ˚ 90 90 
V, Å3 1195.2(2) 1952.5(3) 
Z 4 2  
D, g cm-3 1.721 2.148  
Absorption coefficient, mm-1 1.531 6.758  
Crystal size, mm3 0.046  0.136  0.157 0.116  0.120  0.289  
F(000) 1984 1208  
2θ range, ˚ 2.00 to 26.50 2.54 to 26.50  
Collected reflections 46086 64485  
Unique reflections 3923 4050  
Final R (obs. Data)α, R1 0.0294 0.0169  
wR2 0.0830 0.0389  
 
 
Table 4.4. Summary of crystallographic data for complexes 3 and 4. 
 3 4 
Chemical formula C18H24.43B2CuF8N9O0.72Se4 C32H40B4Cu2F16N16O3Se8 
F.W. (g mol-1) 931.38 1802.80 
Temperature, K 140(2) 140(2) 
Wavelength, Å 0.71073 0.71073 
Crystal system Triclinic Monoclinic 
Space group P-1 C2/c 
a, Å 8.1558(4) 23.8666(15) 
b, Å 19.5369(8) 23.8404(15) 
c, Å 19.7370(9) 21.1884(14) 
α, ˚ 79.287(2) 90 
β, ˚ 89.674(2) 107.908(2) 
γ, ˚ 88.918(2) 90 
V, Å3 1195.2(2) 11471.9(13) 
Z 4 8  
D, g cm-3 2.002 2.088  
Absorption coefficient, mm-1 5.498 5.920  
Crystal size, mm3 0.156  0.177  0.302 0.087  0.145  0.151  
F(000) 1793 6896  
2θ range, ˚ 2.19 to 26.50 2.12 to 25.50  
Collected reflections 123328 18847  
Unique reflections 12805   
Final R (obs. Data)α, R1 0.0416 0.0694  
wR2 0.0936 0.1443  
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CHAPTER FIVE 
EFFECTS OF SULFUR- AND SELENIUM-CONTAINING LIGANDS ON COPPER 
AND IRON COORDINATION 
 
5.1 Conclusions 
 Sulfur- and selenium-containing amino acids and other compounds play critical 
roles in the redox properties of metalloproteins1 and control of cellular reactive oxygen 
species.2 Metal-binding by these compounds is one mechanism by which generation of 
reactive oxygen species is controlled.3-5 Redox-active metals such as copper and iron are 
two of the most abundant6,7 and potentially damaging8,9 transition metals in the cell, and 
loss of homeostasis for these metals that occurs with oxidative stress, protein dysfunction, 
and cell signaling in the brain has serious biological repercussions.10 Production of 
hydroxyl radical via Fenton and Fenton-like reactions and redox-cycling of copper and iron 
can lead to oxidative damage that is an underlying cause of Parkinson’s, Alzheimer’s, and 
cardiovascular diseases.9,11,12 
 Due to their radical scavenging and metal binding abilities, sulfur and selenium 
amino acids as well as imidazole thiones and selones have been identified as potential 
antioxidants that prevent both copper- and iron-mediated oxidative damage,3,13-15 but the 
mechanisms responsible for their antioxidant behavior are unclear and likely differ based 
on both the metal ion and the type of sulfur or selenium compound.  Determination of 
thermodynamic parameters to predict the likelihood of complex formation and 
investigations into the redox reactions of copper with imidazole thiones can provide insight 
199 
 
into the cellular behavior of sulfur- and selenium-containing compounds and mechanisms 
for their prevention of oxidative damage. 
 Stability constants of Cu(II) with glycine, methionine, methylcysteine, 
selenomethionine, and methylselenocysteine were determined by potentiometric titration. 
(Chapter 2). Two species were identified in the best-fit models, [CuL]+ and CuL2, with 
stability constants of approximately 9 and 14, respectively. A novel crystal structure for 
Cu(SeMet)2 was also reported, confirming bidentate coordination of the carboxylate and 
amine groups of selenomethioneine, with no coordination of the selenium atom. Based on 
similarities in IR results and the consistency of stability constants, it can be assumed that 
all the thio- and selenoether complexes bind Cu(II) in a similar fashion.   
 Under oxygen-free conditions, stability constants of Fe(II) with glycine, 
methionine, methylcysteine, selenomethionine, methylselenocysteine, and penicillamine 
were also determined by potentiometric titration. In contrast to Cu(II) titration results, the 
two identified Fe(II) species are [FeL]+ and FeL(OH), highlighting the stability of Fe(II) 
hydrolysis products. Compared to Cu(II), these Fe(II) complexes have significantly lower 
stability constants with the thio- and selenoether-containing amino acids, approximately 3 
and -5 for the [FeL]+ and FeL(OH) species, respectively. IR analyses indicate bidentate 
binding through the carboxylate and amine groups, similar to binding in the Cu(II) 
complexes. The thiol-containing penicillamine has considerably higher Fe(II) stability 
constants than the thio- and selenoether amino acids: 7.48(7) and 13.91(7) for the Fe(Pen) 
and [Fe(Pen)2]2- species, respectively. This considerable difference in stability is likely due 
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to direct coordination of the thiolate group, either in place of the carboxylate oxygen or in 
addition to amine and carboxylate coordination, resulting in tridentate coordination. 
  The stability constants determined in Chapter 2 can be combined with the projected 
speciation graphs in Chapter 1 (Figure 1.13) to predict percent complexation of Cu(II) and 
Fe(II) at biological pH by these amino acids. With stability constants of approximately 9 
and 14 for the Cu(II)-thioether-amino-acid complexes and assumed concentrations of 10 
μM Cu(II) and at least 10 μM of amino acid, 90-100% of available Cu(II) would be 
coordinated by these amino acids in a binary system. In a competitive environment such as 
the cell, other small molecules with higher stability constants, such as histidine or cysteine, 
would outcompete the bindentate-only binding in thio- or selenoamino acids, but labile 
metal ions would almost definitely interact with available, coordinating small molecules. 
Such binding correlates with in vitro inhibition of copper-mediated oxidative DNA damage 
(Figure 2.6).  
 When considering the Fe(II) stability constants of 3 and -5 for thio- and selenoether 
amino acid binding, it is unlikely that any Fe(II) would be coordinated at pH 7. However, 
Fe(II)-penicillamine stability constants are similar to those for Cu(II) binding to thio- and 
selenoether amino acids, so 90-100% of available Fe(II) would be bound by penicillamine 
at pH 7. The inability of thio- and selenoether amino acids to prevent Fe(II)-mediated 
oxidative damage in the biological pH range is consistent with this lack of amino acid 
coordination. When Fe(II) coordination is likely at pH 7, as seen for pencillamine, 
prevention of metal-mediated damage is observed (Table 2.5).  
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 Copper exists both in the +2 and +1 oxidation state, and Cu(I) is more prevalent in 
the reducing cellular environment.16 Cu(I) is also a softer Lewis acid than Cu(II), with 
greater affinity for binding the soft thio- and selenoether groups of amino acids, and it 
produces hydroxyl radical in the presence of hydrogen peroxide. Cu(I) is however, 
extremely difficult to work with in aqueous systems (Chapter 1). Sharma and cowokers17 
suggest sufficient chloride support (>1.0 M) can support the Cu(I) ion so that it does not 
disproportionate in solution. Strict avoidance of oxygen would still be needed if this 
method were to be pursued for stability constant determination. Other methods that have 
proven successful for Cu(I) stability constant determination include competition methods, 
such as the fluorimetric analysis developed for the determination of Cu(I) with cysteine 
and glutathione,18 although weakly binding ligands may not effectively outcompete the 
fluormetric probes. Given the predominance of Cu(I) in cells, the body of knowledge 
needed to accurately predict interactions of transition metal ions with small biomolecules 
will not be complete, or particularly useful, until methods to determine Cu(I) stability 
constants are more fully developed and a more complete database of Cu(I) stability 
constants is available. 
 Methimazole (MMI) is a imidazole thione drug used to treat hyperthyroidism, with 
blood serum concentrations of 5-10 μM in treated patients.19 Although this redox-active 
drug reduces Cu(II) to Cu(I),20 it strongly inhibits Cu(I)-mediated DNA damage in in vitro 
antioxidant assays.13 A variety of mononuclear,21,22 dinuclear,23-26 and polymeric27,28 
complexes of copper with methimazole are reported, and sulfur extrusion from 
methamidazole disulfide also occurs29-33 upon methimazole oxidation in the presence of 
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Cu(II) and oxygen. Studies of copper-methimazole reactions were performed in an effort 
to more completely understand the role of oxygen, solvent, and copper oxidation state in 
the resulting products (Chapter 3).  
 With tetrafluoroborate as a counterion, both Cu(II) and Cu(I) reactions with 
methimazole(MMI) result in formation of the dinculear Cu(I) complex, 
[Cu2(MMI)6][BF4]2, with two bridging and four terminal methimazole ligands coordinated 
solely through the sulfur atoms (Chapter 3). This product was isolated in both air and air-
free reactions and has been previously reported by Raper.34 When the copper source was 
changed to Cu(NO3)2 and the same reaction was performed under air-free conditions, the 
polymeric {[CuI(MMI)2](NO3)}n was generated along with uncoordinated methimazole 
disulfide (MMIDS). The same reaction in air resulted in Cu(I) oxidation to Cu(II) and 
extrusion of a sulfur atom, affording a variety of [CuII(MMIMS)2(H2O)x]2+ (x = 1 or 2) 
complexes with different counterions, including NO3-, CH3SO4-, and HSO4-. When the 
molar ratio of the reaction was reduced to 2:1 methimazole-to-copper, only one MMIMS 
ligand coordinated copper, and direct coordination of a bidentate SO42- ligand was 
observed. Treatment of [CuI(CH3CN)4][BF4] with MMIDS under air-free conditions 
resulted in no sulfur elimination products, instead yielding [Cu2(MMIDS)3][BF4]2, the first 
example of complex with copper coordination to this ligand.  
  From the results of these reactions, the mechanism for sulfur extrusion proposed 
by Lobana29 was further developed (Chapter 3). The requirement for copper coordination 
to promote sulfur elimination and ligand rearrangement was incorporated. The central role 
of the solvent molecule, either water or methanol, in imidazole thiolate formation and 
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sulfate or methylsulfate generation is also indicated from the reaction products. Two areas 
in which the mechanism can be further developed include 1) proof of superoxide formation 
as Cu(I) is oxidized by O2, which could be examined by EPR spectroscopy, and 2) 
determination of Cu(I) oxidation kinetics and the kinetics of subsequent sulfur elimination 
using UV-vis spectrophotometry. 
 In Chapter 4, the potential for reversibility in copper-disulfide and -diselenide 
reduction and oxidation was explored. The air-free reaction of [Cu(CH3CN)4][BF4] and 
MMIDS and the parallel reaction with its selenium analog, MMIDSe, afford 
[Cu2(MMIDS)2(MMI)][BF4]2 and [Cu2(MMIDSe)2(Se-MMI)][BF4]2 in low yields. These 
mixed-ligand products suggest that the reaction between electron-rich Cu(I) and the 
imidazole disulfide or diselenide may be reversible if protons are available to generate 
MMI and MMISe. Treatment of [Cu(CH3CN)4][BF4] with MMIDSe in air yielded multiple 
products from the same reaction mixture, including a mixed tri- and monoselenide Cu(II) 
complex, and formation of a Cu(II) complex with an unusual dimeric methimazole selone-
derived ligand containing a bridging CH2 group between the selenium atoms of two 
methimazole selones. The diverse redox chemistry of both copper and Se likely aids in 
forming such product mixtures and highlights the difficulty in controlling the synthesis of 
specific selenium-containing species. 
 From the studies presented in this dissertation, thermodynamic interactions 
between sulfur- and selenium-containing amino acids and biologically relevant transition 
metals were determined and the biological consequences of these interactions were 
explored. Sulfur- and selenium-containing amino acids are much more likely to coordinate 
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Cu(II) over the Fe(II) in aqueous systems, which is likely related to the antioxidant 
properties of these amino acids. Thiol-containing amino acids show more stable copper 
and iron binding compared to those with thio- and selenoether side chains, but selenol-
containing amino acid stability constants are still undetermined due to the instability and 
redox activity of these compounds.  
 Similar difficulties with redox reactions and complex stability are observed with 
the thione and selone imidazoles in their reactions with copper. In the presence of Cu(I), 
methimazole directly binds this soft metal ion through the thione sulfur, and Cu(I)-bridging 
thiones are observed in dinuclear complexes. Sulfur elimination from the methimazole 
disulfide ligand is observed and is dependent upon copper coordination, the presence of 
oxygen, and the availability of protic solvents, such as methanol and water. This sulfur 
extrusion is a phenomenon that seems unique to copper, since it is not observed with other 
transition metal ions under similar reaction conditions.35,36 Finally, formation of 
methimazole disulfides and diselenides with concomitant Cu(II) reduction to Cu(I) may be 
reversible with a proton source and in an air-free environment. Better understanding these 
copper-methimazole and selenomethimazole reactions will shed light on the diversity of 
coordination chemistry in systems with redox-active metals and non-innocent ligands, 
knowledge that may lead to advances in catalysis and may have implications for the 
biological activity of methimazole. 
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